WO2020178102A1 - Detergent compositions comprising two proteases - Google Patents
Detergent compositions comprising two proteases Download PDFInfo
- Publication number
- WO2020178102A1 WO2020178102A1 PCT/EP2020/055043 EP2020055043W WO2020178102A1 WO 2020178102 A1 WO2020178102 A1 WO 2020178102A1 EP 2020055043 W EP2020055043 W EP 2020055043W WO 2020178102 A1 WO2020178102 A1 WO 2020178102A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protease
- seq
- variant
- relative
- formal charge
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title claims abstract description 744
- 239000004365 Protease Substances 0.000 title claims abstract description 736
- 239000000203 mixture Substances 0.000 title claims abstract description 285
- 239000003599 detergent Substances 0.000 title claims abstract description 161
- 102000035195 Peptidases Human genes 0.000 title description 672
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract 72
- 102200093149 rs77938727 Human genes 0.000 claims description 271
- 238000006467 substitution reaction Methods 0.000 claims description 267
- 102200025035 rs786203989 Human genes 0.000 claims description 101
- 102220528606 Ribonuclease P/MRP protein subunit POP5_S99D_mutation Human genes 0.000 claims description 81
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 70
- 230000000694 effects Effects 0.000 claims description 58
- 102220642080 Lipoma-preferred partner_N43R_mutation Human genes 0.000 claims description 56
- 230000035772 mutation Effects 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 44
- 102220499813 Carbonic anhydrase 2_N62D_mutation Human genes 0.000 claims description 43
- 238000004140 cleaning Methods 0.000 claims description 37
- 239000004744 fabric Substances 0.000 claims description 31
- 239000007788 liquid Substances 0.000 claims description 26
- 239000004753 textile Substances 0.000 claims description 21
- 102220246481 rs147782267 Human genes 0.000 claims description 20
- 102200118280 rs33918343 Human genes 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 17
- 102220528571 Ribonuclease P/MRP protein subunit POP5_S99A_mutation Human genes 0.000 claims description 13
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 13
- 102220036452 rs137882485 Human genes 0.000 claims description 7
- 102220099575 rs878853725 Human genes 0.000 claims description 4
- 102220475366 Iduronate 2-sulfatase_S87N_mutation Human genes 0.000 claims 6
- 102200006535 rs104894361 Human genes 0.000 claims 6
- 102000004190 Enzymes Human genes 0.000 description 151
- 108090000790 Enzymes Proteins 0.000 description 151
- 229940088598 enzyme Drugs 0.000 description 146
- -1 aromatic amino acids Chemical class 0.000 description 62
- 235000001014 amino acid Nutrition 0.000 description 51
- 150000001413 amino acids Chemical class 0.000 description 46
- 229940024606 amino acid Drugs 0.000 description 44
- 102000013142 Amylases Human genes 0.000 description 41
- 108010065511 Amylases Proteins 0.000 description 41
- 235000019418 amylase Nutrition 0.000 description 41
- 229920000642 polymer Polymers 0.000 description 29
- 238000012217 deletion Methods 0.000 description 27
- 230000037430 deletion Effects 0.000 description 27
- 229940025131 amylases Drugs 0.000 description 26
- 108090000765 processed proteins & peptides Proteins 0.000 description 26
- 239000003795 chemical substances by application Substances 0.000 description 25
- 229920001184 polypeptide Polymers 0.000 description 24
- 102000004196 processed proteins & peptides Human genes 0.000 description 24
- 238000003780 insertion Methods 0.000 description 20
- 230000037431 insertion Effects 0.000 description 20
- 238000004364 calculation method Methods 0.000 description 19
- 239000004094 surface-active agent Substances 0.000 description 19
- 235000018102 proteins Nutrition 0.000 description 18
- 102000004169 proteins and genes Human genes 0.000 description 18
- 108090000623 proteins and genes Proteins 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 230000004075 alteration Effects 0.000 description 17
- 239000008187 granular material Substances 0.000 description 17
- 108010084185 Cellulases Proteins 0.000 description 16
- 102000005575 Cellulases Human genes 0.000 description 16
- 108090001060 Lipase Proteins 0.000 description 16
- 239000004367 Lipase Substances 0.000 description 16
- 102000004882 Lipase Human genes 0.000 description 16
- 125000000539 amino acid group Chemical group 0.000 description 16
- 239000007844 bleaching agent Substances 0.000 description 16
- 239000000975 dye Substances 0.000 description 16
- 235000019421 lipase Nutrition 0.000 description 16
- 239000000344 soap Substances 0.000 description 16
- 239000004382 Amylase Substances 0.000 description 15
- 102220509191 Heparin cofactor 2_S87N_mutation Human genes 0.000 description 15
- 238000004851 dishwashing Methods 0.000 description 14
- 239000003752 hydrotrope Substances 0.000 description 14
- 102220214800 rs1060503568 Human genes 0.000 description 14
- 239000002253 acid Substances 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- 150000003839 salts Chemical class 0.000 description 13
- 239000002689 soil Substances 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 238000004061 bleaching Methods 0.000 description 12
- 238000009472 formulation Methods 0.000 description 12
- 108090000637 alpha-Amylases Proteins 0.000 description 11
- 239000000499 gel Substances 0.000 description 11
- 230000001965 increasing effect Effects 0.000 description 11
- 102000016911 Deoxyribonucleases Human genes 0.000 description 10
- 108010053770 Deoxyribonucleases Proteins 0.000 description 10
- 102000004139 alpha-Amylases Human genes 0.000 description 10
- 229920001577 copolymer Polymers 0.000 description 10
- 239000006081 fluorescent whitening agent Substances 0.000 description 10
- 229920002451 polyvinyl alcohol Polymers 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 241000193830 Bacillus <bacterium> Species 0.000 description 9
- 102100032487 Beta-mannosidase Human genes 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 108010055059 beta-Mannosidase Proteins 0.000 description 9
- 238000000576 coating method Methods 0.000 description 9
- 150000004665 fatty acids Chemical class 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 8
- 108010059892 Cellulase Proteins 0.000 description 8
- 102000003992 Peroxidases Human genes 0.000 description 8
- 229940024171 alpha-amylase Drugs 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 8
- 229920002678 cellulose Polymers 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 8
- 108010005400 cutinase Proteins 0.000 description 8
- 230000002538 fungal effect Effects 0.000 description 8
- 108010020132 microbial serine proteinases Proteins 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 7
- 108700020962 Peroxidase Proteins 0.000 description 7
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 7
- 239000004473 Threonine Substances 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 229940119679 deoxyribonucleases Drugs 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 239000012190 activator Substances 0.000 description 6
- 235000004279 alanine Nutrition 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 description 6
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 6
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 6
- 229940105329 carboxymethylcellulose Drugs 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000004220 glutamic acid Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 150000004965 peroxy acids Chemical class 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 5
- 241000194108 Bacillus licheniformis Species 0.000 description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
- 108010006035 Metalloproteases Proteins 0.000 description 5
- 102000005741 Metalloproteases Human genes 0.000 description 5
- 102000004316 Oxidoreductases Human genes 0.000 description 5
- 108090000854 Oxidoreductases Proteins 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 101710135785 Subtilisin-like protease Proteins 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 5
- 239000002738 chelating agent Substances 0.000 description 5
- 239000002270 dispersing agent Substances 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
- 210000002374 sebum Anatomy 0.000 description 5
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 5
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical group CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 5
- 108010083879 xyloglucan endo(1-4)-beta-D-glucanase Proteins 0.000 description 5
- PQHYOGIRXOKOEJ-UHFFFAOYSA-N 2-(1,2-dicarboxyethylamino)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)NC(C(O)=O)CC(O)=O PQHYOGIRXOKOEJ-UHFFFAOYSA-N 0.000 description 4
- NSMMFSKPGXCMOE-UHFFFAOYSA-N 2-[2-(2-sulfophenyl)ethenyl]benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1C=CC1=CC=CC=C1S(O)(=O)=O NSMMFSKPGXCMOE-UHFFFAOYSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 4
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- 108010056079 Subtilisins Proteins 0.000 description 4
- 102000005158 Subtilisins Human genes 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 229940106157 cellulase Drugs 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000002979 fabric softener Substances 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 235000013922 glutamic acid Nutrition 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000004900 laundering Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 4
- 239000010457 zeolite Substances 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 108700016155 Acyl transferases Proteins 0.000 description 3
- 241000193422 Bacillus lentus Species 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 241000223198 Humicola Species 0.000 description 3
- 241001480714 Humicola insolens Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 108010059820 Polygalacturonase Proteins 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 102000012479 Serine Proteases Human genes 0.000 description 3
- 108010022999 Serine Proteases Proteins 0.000 description 3
- 108090000787 Subtilisin Proteins 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 239000003899 bactericide agent Substances 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 235000010338 boric acid Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 108010093305 exopolygalacturonase Proteins 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229920000578 graft copolymer Polymers 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000019832 sodium triphosphate Nutrition 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- VXWBQOJISHAKKM-UHFFFAOYSA-N (4-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=C(C=O)C=C1 VXWBQOJISHAKKM-UHFFFAOYSA-N 0.000 description 2
- LIPJWTMIUOLEJU-UHFFFAOYSA-N 2-(1,2-diamino-2-phenylethenyl)benzenesulfonic acid Chemical class NC(=C(C=1C(=CC=CC1)S(=O)(=O)O)N)C1=CC=CC=C1 LIPJWTMIUOLEJU-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- LKDMKWNDBAVNQZ-WJNSRDFLSA-N 4-[[(2s)-1-[[(2s)-1-[(2s)-2-[[(2s)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-WJNSRDFLSA-N 0.000 description 2
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001328122 Bacillus clausii Species 0.000 description 2
- 0 CC(c1cc(C2O*2(CC(CO**)O)C*2)c2cc1)=N Chemical compound CC(c1cc(C2O*2(CC(CO**)O)C*2)c2cc1)=N 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 2
- 102000005593 Endopeptidases Human genes 0.000 description 2
- 108010059378 Endopeptidases Proteins 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 108010029541 Laccase Proteins 0.000 description 2
- 241000579835 Merops Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000187480 Mycobacterium smegmatis Species 0.000 description 2
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- 108010029182 Pectin lyase Proteins 0.000 description 2
- 229920002319 Poly(methyl acrylate) Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- BGRWYDHXPHLNKA-UHFFFAOYSA-N Tetraacetylethylenediamine Chemical compound CC(=O)N(C(C)=O)CCN(C(C)=O)C(C)=O BGRWYDHXPHLNKA-UHFFFAOYSA-N 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 241000223258 Thermomyces lanuginosus Species 0.000 description 2
- 241001494489 Thielavia Species 0.000 description 2
- 241000223259 Trichoderma Species 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 description 2
- 102000045404 acyltransferase activity proteins Human genes 0.000 description 2
- 108700014220 acyltransferase activity proteins Proteins 0.000 description 2
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 235000021186 dishes Nutrition 0.000 description 2
- PMPJQLCPEQFEJW-GNTLFSRWSA-L disodium;2-[(z)-2-[4-[4-[(z)-2-(2-sulfonatophenyl)ethenyl]phenyl]phenyl]ethenyl]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC=CC=C1\C=C/C1=CC=C(C=2C=CC(\C=C/C=3C(=CC=CC=3)S([O-])(=O)=O)=CC=2)C=C1 PMPJQLCPEQFEJW-GNTLFSRWSA-L 0.000 description 2
- VUJGKADZTYCLIL-YHPRVSEPSA-L disodium;5-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-[(e)-2-[4-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-sulfonatophenyl]ethenyl]benzenesulfonate Chemical compound [Na+].[Na+].C=1C=C(\C=C\C=2C(=CC(NC=3N=C(N=C(NC=4C=CC=CC=4)N=3)N3CCOCC3)=CC=2)S([O-])(=O)=O)C(S(=O)(=O)[O-])=CC=1NC(N=C(N=1)N2CCOCC2)=NC=1NC1=CC=CC=C1 VUJGKADZTYCLIL-YHPRVSEPSA-L 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 description 2
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- 239000006167 equilibration buffer Substances 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000001087 glyceryl triacetate Substances 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 150000003949 imides Chemical class 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 150000002500 ions Chemical group 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 108010076363 licheninase Proteins 0.000 description 2
- 239000004337 magnesium citrate Substances 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920000847 nonoxynol Polymers 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 2
- 229960003330 pentetic acid Drugs 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical class OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920005646 polycarboxylate Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 102220278863 rs1395998044 Human genes 0.000 description 2
- 150000004760 silicates Chemical class 0.000 description 2
- 229940079842 sodium cumenesulfonate Drugs 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 229940048842 sodium xylenesulfonate Drugs 0.000 description 2
- KVCGISUBCHHTDD-UHFFFAOYSA-M sodium;4-methylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1 KVCGISUBCHHTDD-UHFFFAOYSA-M 0.000 description 2
- QEKATQBVVAZOAY-UHFFFAOYSA-M sodium;4-propan-2-ylbenzenesulfonate Chemical compound [Na+].CC(C)C1=CC=C(S([O-])(=O)=O)C=C1 QEKATQBVVAZOAY-UHFFFAOYSA-M 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 150000003871 sulfonates Chemical class 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000002888 zwitterionic surfactant Substances 0.000 description 2
- OCUSNPIJIZCRSZ-ZTZWCFDHSA-N (2s)-2-amino-3-methylbutanoic acid;(2s)-2-amino-4-methylpentanoic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC(C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O OCUSNPIJIZCRSZ-ZTZWCFDHSA-N 0.000 description 1
- RSDQBPGKMDFRHH-MJVIGCOGSA-N (3s,3as,5ar,9bs)-3,5a,9-trimethyl-3a,4,5,7,8,9b-hexahydro-3h-benzo[g][1]benzofuran-2,6-dione Chemical compound O=C([C@]1(C)CC2)CCC(C)=C1[C@@H]1[C@@H]2[C@H](C)C(=O)O1 RSDQBPGKMDFRHH-MJVIGCOGSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- UYXFOIMFLBVYDL-UHFFFAOYSA-N 1,2,4,7-tetramethyl-1,4,7-triazonane Chemical compound CC1CN(C)CCN(C)CCN1C UYXFOIMFLBVYDL-UHFFFAOYSA-N 0.000 description 1
- WLDGDTPNAKWAIR-UHFFFAOYSA-N 1,4,7-trimethyl-1,4,7-triazonane Chemical compound CN1CCN(C)CCN(C)CC1 WLDGDTPNAKWAIR-UHFFFAOYSA-N 0.000 description 1
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- PFBBCIYIKJWDIN-BUHFOSPRSA-N 2-[(e)-tetradec-1-enyl]butanedioic acid Chemical compound CCCCCCCCCCCC\C=C\C(C(O)=O)CC(O)=O PFBBCIYIKJWDIN-BUHFOSPRSA-N 0.000 description 1
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 1
- CIEZZGWIJBXOTE-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]propanoic acid Chemical compound OC(=O)C(C)N(CC(O)=O)CC(O)=O CIEZZGWIJBXOTE-UHFFFAOYSA-N 0.000 description 1
- MHOFGBJTSNWTDT-UHFFFAOYSA-M 2-[n-ethyl-4-[(6-methoxy-3-methyl-1,3-benzothiazol-3-ium-2-yl)diazenyl]anilino]ethanol;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC(N(CCO)CC)=CC=C1N=NC1=[N+](C)C2=CC=C(OC)C=C2S1 MHOFGBJTSNWTDT-UHFFFAOYSA-M 0.000 description 1
- PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 description 1
- ZTGKHKPZSMMHNM-UHFFFAOYSA-N 3-(2-phenylethenyl)benzene-1,2-disulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC(C=CC=2C=CC=CC=2)=C1S(O)(=O)=O ZTGKHKPZSMMHNM-UHFFFAOYSA-N 0.000 description 1
- MHKLKWCYGIBEQF-UHFFFAOYSA-N 4-(1,3-benzothiazol-2-ylsulfanyl)morpholine Chemical compound C1COCCN1SC1=NC2=CC=CC=C2S1 MHKLKWCYGIBEQF-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- GAUWGYGVFJBRRR-UHFFFAOYSA-N 4-decanoyloxybenzenesulfonic acid Chemical compound CCCCCCCCCC(=O)OC1=CC=C(S(O)(=O)=O)C=C1 GAUWGYGVFJBRRR-UHFFFAOYSA-N 0.000 description 1
- QTMHHQFADWIZCP-UHFFFAOYSA-N 4-decanoyloxybenzoic acid Chemical compound CCCCCCCCCC(=O)OC1=CC=C(C(O)=O)C=C1 QTMHHQFADWIZCP-UHFFFAOYSA-N 0.000 description 1
- CAERUOHSFJZTJD-UHFFFAOYSA-N 4-dodecanoyloxybenzenesulfonic acid Chemical compound CCCCCCCCCCCC(=O)OC1=CC=C(S(O)(=O)=O)C=C1 CAERUOHSFJZTJD-UHFFFAOYSA-N 0.000 description 1
- VNEUMNOZRFLRPI-UHFFFAOYSA-N 4-nonanoyloxybenzenesulfonic acid Chemical compound CCCCCCCCC(=O)OC1=CC=C(S(O)(=O)=O)C=C1 VNEUMNOZRFLRPI-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- UXEKKQRJIGKQNP-UHFFFAOYSA-N 5-(4-phenyltriazol-2-yl)-2-[2-[4-(4-phenyltriazol-2-yl)-2-sulfophenyl]ethenyl]benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC(N2N=C(C=N2)C=2C=CC=CC=2)=CC=C1C=CC(C(=C1)S(O)(=O)=O)=CC=C1N(N=1)N=CC=1C1=CC=CC=C1 UXEKKQRJIGKQNP-UHFFFAOYSA-N 0.000 description 1
- CNGYZEMWVAWWOB-VAWYXSNFSA-N 5-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-[(e)-2-[4-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid Chemical compound N=1C(NC=2C=C(C(\C=C\C=3C(=CC(NC=4N=C(N=C(NC=5C=CC=CC=5)N=4)N(CCO)CCO)=CC=3)S(O)(=O)=O)=CC=2)S(O)(=O)=O)=NC(N(CCO)CCO)=NC=1NC1=CC=CC=C1 CNGYZEMWVAWWOB-VAWYXSNFSA-N 0.000 description 1
- UZJGVXSQDRSSHU-UHFFFAOYSA-N 6-(1,3-dioxoisoindol-2-yl)hexaneperoxoic acid Chemical compound C1=CC=C2C(=O)N(CCCCCC(=O)OO)C(=O)C2=C1 UZJGVXSQDRSSHU-UHFFFAOYSA-N 0.000 description 1
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 102000057234 Acyl transferases Human genes 0.000 description 1
- 101100006370 Arabidopsis thaliana CHX2 gene Proteins 0.000 description 1
- 101710152845 Arabinogalactan endo-beta-1,4-galactanase Proteins 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 102220529802 Aurora kinase C_K72R_mutation Human genes 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000193747 Bacillus firmus Species 0.000 description 1
- 241000006382 Bacillus halodurans Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 101000740449 Bacillus subtilis (strain 168) Biotin/lipoyl attachment protein Proteins 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- 241001453380 Burkholderia Species 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- RKWGIWYCVPQPMF-UHFFFAOYSA-N Chloropropamide Chemical compound CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 RKWGIWYCVPQPMF-UHFFFAOYSA-N 0.000 description 1
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 description 1
- 102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 description 1
- 102100025566 Chymotrypsin-like protease CTRL-1 Human genes 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000222511 Coprinus Species 0.000 description 1
- 244000251987 Coprinus macrorhizus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000016559 DNA Primase Human genes 0.000 description 1
- 108010092681 DNA Primase Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 101710147028 Endo-beta-1,4-galactanase Proteins 0.000 description 1
- 101710111935 Endo-beta-1,4-glucanase Proteins 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 101000856199 Homo sapiens Chymotrypsin-like protease CTRL-1 Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 101001003187 Hordeum vulgare Alpha-amylase/subtilisin inhibitor Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 241000824268 Kuma Species 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 101710098556 Lipase A Proteins 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 101710099648 Lysosomal acid lipase/cholesteryl ester hydrolase Proteins 0.000 description 1
- 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 description 1
- 241001344131 Magnaporthe grisea Species 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 description 1
- 108010054377 Mannosidases Proteins 0.000 description 1
- 102000001696 Mannosidases Human genes 0.000 description 1
- 102100030218 Matrix metalloproteinase-19 Human genes 0.000 description 1
- 241001139947 Mida Species 0.000 description 1
- 241001661345 Moesziomyces antarcticus Species 0.000 description 1
- 241000226677 Myceliophthora Species 0.000 description 1
- JYXGIOKAKDAARW-UHFFFAOYSA-N N-(2-hydroxyethyl)iminodiacetic acid Chemical compound OCCN(CC(O)=O)CC(O)=O JYXGIOKAKDAARW-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229920002274 Nalgene Polymers 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- VEQPNABPJHWNSG-UHFFFAOYSA-N Nickel(2+) Chemical compound [Ni+2] VEQPNABPJHWNSG-UHFFFAOYSA-N 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241001072230 Oceanobacillus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101001003186 Oryza sativa subsp. japonica Alpha-amylase/subtilisin inhibitor Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000194109 Paenibacillus lautus Species 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920000805 Polyaspartic acid Polymers 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 101710194948 Protein phosphatase PhpP Proteins 0.000 description 1
- 241000168225 Pseudomonas alcaligenes Species 0.000 description 1
- 241000589755 Pseudomonas mendocina Species 0.000 description 1
- 241000589630 Pseudomonas pseudoalcaligenes Species 0.000 description 1
- 241000577556 Pseudomonas wisconsinensis Species 0.000 description 1
- 108091007187 Reductases Proteins 0.000 description 1
- 241001292348 Salipaludibacillus agaradhaerens Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 241001522306 Serinus serinus Species 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000187392 Streptomyces griseus Species 0.000 description 1
- 241001518258 Streptomyces pristinaespiralis Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- RSDQBPGKMDFRHH-UHFFFAOYSA-N Taurin Natural products C1CC2(C)C(=O)CCC(C)=C2C2C1C(C)C(=O)O2 RSDQBPGKMDFRHH-UHFFFAOYSA-N 0.000 description 1
- 241000203780 Thermobifida fusca Species 0.000 description 1
- 108090001109 Thermolysin Proteins 0.000 description 1
- 241000223257 Thermomyces Species 0.000 description 1
- 241001313536 Thermothelomyces thermophila Species 0.000 description 1
- 241001495429 Thielavia terrestris Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 101001003185 Triticum aestivum Endogenous alpha-amylase/subtilisin inhibitor Proteins 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 102220470553 Tryptase delta_Q87E_mutation Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 241000202898 Ureaplasma Species 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000012867 alanine scanning Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 108010084650 alpha-N-arabinofuranosidase Proteins 0.000 description 1
- REDXJYDRNCIFBQ-UHFFFAOYSA-N aluminium(3+) Chemical compound [Al+3] REDXJYDRNCIFBQ-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
- 230000003254 anti-foaming effect Effects 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000010936 aqueous wash Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 229940005348 bacillus firmus Drugs 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000009141 biological interaction Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- MPBRYMWMMKKRGC-UHFFFAOYSA-M carbocyanin DBTC Chemical compound [Br-].C1=CC=CC2=C([N+](=C(C=C(C)C=C3N(C4=C5C=CC=CC5=CC=C4S3)CC)S3)CC)C3=CC=C21 MPBRYMWMMKKRGC-UHFFFAOYSA-M 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 108010052085 cellobiose-quinone oxidoreductase Proteins 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 150000001868 cobalt Chemical class 0.000 description 1
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000007771 core particle Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 229930007927 cymene Natural products 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- GSPKZYJPUDYKPI-UHFFFAOYSA-N diethoxy sulfate Chemical compound CCOOS(=O)(=O)OOCC GSPKZYJPUDYKPI-UHFFFAOYSA-N 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 239000004316 dimethyl dicarbonate Substances 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 1
- 125000005066 dodecenyl group Chemical group C(=CCCCCCCCCCC)* 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 102220500059 eIF5-mimic protein 2_S54V_mutation Human genes 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002901 elastaselike Effects 0.000 description 1
- 238000002003 electron diffraction Methods 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 239000003248 enzyme activator Substances 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- HGVHMIAKUYLQLL-UHFFFAOYSA-N ethene;propane-1,2,3-triol Chemical compound C=C.OCC(O)CO HGVHMIAKUYLQLL-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000009477 fluid bed granulation Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 108010059345 keratinase Proteins 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 108010062085 ligninase Proteins 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 229940071125 manganese acetate Drugs 0.000 description 1
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 description 1
- RGVLTEMOWXGQOS-UHFFFAOYSA-L manganese(2+);oxalate Chemical compound [Mn+2].[O-]C(=O)C([O-])=O RGVLTEMOWXGQOS-UHFFFAOYSA-L 0.000 description 1
- BQKYBHBRPYDELH-UHFFFAOYSA-N manganese;triazonane Chemical compound [Mn].C1CCCNNNCC1 BQKYBHBRPYDELH-UHFFFAOYSA-N 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 108010009355 microbial metalloproteinases Proteins 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- MHHDXUNFNAZUGB-UHFFFAOYSA-N oxidovanadium(2+) Chemical compound [V+2]=O MHHDXUNFNAZUGB-UHFFFAOYSA-N 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 108010087558 pectate lyase Proteins 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
- 125000005342 perphosphate group Chemical group 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000005222 photoaffinity labeling Methods 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920000196 poly(lauryl methacrylate) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 102200074783 rs144422014 Human genes 0.000 description 1
- 102200128586 rs397508464 Human genes 0.000 description 1
- 102220005204 rs63750783 Human genes 0.000 description 1
- 102220123717 rs759057581 Human genes 0.000 description 1
- 229910052706 scandium Inorganic materials 0.000 description 1
- SIXSYDAISGFNSX-UHFFFAOYSA-N scandium atom Chemical compound [Sc] SIXSYDAISGFNSX-UHFFFAOYSA-N 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 229940077386 sodium benzenesulfonate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019795 sodium metasilicate Nutrition 0.000 description 1
- 229940045872 sodium percarbonate Drugs 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- DGSDBJMBHCQYGN-UHFFFAOYSA-M sodium;2-ethylhexyl sulfate Chemical compound [Na+].CCCCC(CC)COS([O-])(=O)=O DGSDBJMBHCQYGN-UHFFFAOYSA-M 0.000 description 1
- OMSMEHWLFJLBSH-UHFFFAOYSA-M sodium;2-hydroxynaphthalene-1-carboxylate Chemical compound [Na+].C1=CC=CC2=C(C([O-])=O)C(O)=CC=C21 OMSMEHWLFJLBSH-UHFFFAOYSA-M 0.000 description 1
- LIAJJWHZAFEJEZ-UHFFFAOYSA-M sodium;2-hydroxynaphthalene-1-sulfonate Chemical compound [Na+].C1=CC=CC2=C(S([O-])(=O)=O)C(O)=CC=C21 LIAJJWHZAFEJEZ-UHFFFAOYSA-M 0.000 description 1
- AXMCIYLNKNGNOT-UHFFFAOYSA-N sodium;3-[[4-[(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methyl]-n-ethylanilino]methyl]benzenesulfonate Chemical compound [Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](C)C)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S(O)(=O)=O)=C1 AXMCIYLNKNGNOT-UHFFFAOYSA-N 0.000 description 1
- GSYPNDDXWAZDJB-UHFFFAOYSA-M sodium;4-(3,5,5-trimethylhexanoyloxy)benzenesulfonate Chemical compound [Na+].CC(C)(C)CC(C)CC(=O)OC1=CC=C(S([O-])(=O)=O)C=C1 GSYPNDDXWAZDJB-UHFFFAOYSA-M 0.000 description 1
- MZSDGDXXBZSFTG-UHFFFAOYSA-M sodium;benzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=CC=C1 MZSDGDXXBZSFTG-UHFFFAOYSA-M 0.000 description 1
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 1
- 238000010563 solid-state fermentation Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 108010082371 succinyl-alanyl-alanyl-prolyl-phenylalanine-4-nitroanilide Proteins 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000271 synthetic detergent Substances 0.000 description 1
- 108010038851 tannase Proteins 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- VRVDFJOCCWSFLI-UHFFFAOYSA-K trisodium 3-[[4-[(6-anilino-1-hydroxy-3-sulfonatonaphthalen-2-yl)diazenyl]-5-methoxy-2-methylphenyl]diazenyl]naphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].[Na+].COc1cc(N=Nc2cc(c3cccc(c3c2)S([O-])(=O)=O)S([O-])(=O)=O)c(C)cc1N=Nc1c(O)c2ccc(Nc3ccccc3)cc2cc1S([O-])(=O)=O VRVDFJOCCWSFLI-UHFFFAOYSA-K 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000001810 trypsinlike Effects 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38618—Protease or amylase in liquid compositions only
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21062—Subtilisin (3.4.21.62)
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
- C11D2111/10—Objects to be cleaned
- C11D2111/12—Soft surfaces, e.g. textile
Definitions
- the present invention relates to detergent compositions comprising at least a first protease and a second protease with different net charge characteristics that together provide improved cleaning performance compared to individual enzymes, use of the compositions in a cleaning process, in particular for laundry, and novel protease variants.
- Subtilisins are serine proteases from the family S8, in particular from the subfamily S8A, as defined by the MEROPS database (https://www.ebi.ac.uk/merops/index.shtml).
- subfamily S8A the key active site residues Asp, His and Ser are typically found in motifs that differ from those of the S8B subfamily.
- enzymes have for many decades been implemented in detergent compositions for use in laundry or in hard surface cleaning such as dishwashing.
- Enzymes used in such compositions comprise proteases, lipases, amylases, cellulases, mannosidases as well as other enzymes or mixtures thereof.
- the most important enzymes are proteases.
- compositions comprising two proteases that are described in the patent literature are disclosed in the context of automatic dishwashing.
- the present invention addresses this need by providing detergent compositions comprising at least two different protease enzymes with different net formal charge characteristics, where the combination of the two proteases results in an improved wash performance on individual stains and/or covers a broader set of stains compared to the individual enzymes. It is contemplated that the compositions of the invention will be particularly useful as laundry detergent compositions, and especially in liquid laundry detergent compositions.
- the present invention relates to a detergent composition
- a detergent composition comprising at least a first protease and a second protease having different net charge characteristics.
- the invention relates to a detergent composition
- a detergent composition comprising a first protease and a second protease, where
- the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1 ;
- the first protease has a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of -1 , 0 or +1 relative to the protease of SEQ ID NO: 1.
- the detergent composition may comprise a first and second protease where: the first protease has a net formal charge of 0, 1 , 2, 3, 4 or -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +5, +4, +3, +2, +1 , 0 or -1 relative to the protease of SEQ ID NO: 1 ; the first protease has a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1 ; or the first protease has a net formal charge of 0, -1 or -2 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2, +3, +4 or +5 relative to the protease of SEQ ID NO: 1.
- the invention also relates to use of the compositions disclosed herein in a cleaning process, e.g. for laundry or hard-surface cleaning such as dishwashing, in particular for laundry, and to a method of cleaning using the compositions.
- the invention relates to novel protease variants with advantageous properties, e.g. improved wash performance when such proteases are used either alone as a single protease or in detergent compositions with another protease, where the proteases are variants of SEQ ID NO: 1 comprising substitutions in positions 97, 209 and 215.
- SEQ ID NO: 1 is the sequence of the Savinase® protease polypeptide from Bacillus lentus.
- SEQ ID NO: 2 is the sequence of the BPN’ protease polypeptide from Bacillus amyloliquefaciens. Brief Description of the Figures
- Figure 1 is an alignment of the amino acid sequences of subtilisin 309 (SEQ ID NO: 1) and subtilisin BPN’ (SEQ ID NO: 2).
- Subtilase/protease may be used interchangeably herein and refer to an enzyme that hydrolyses peptide bonds in proteins. This includes any enzyme belonging to the EC 3.4 enzyme group (including each of the thirteen subclasses thereof), and in particular endopeptidases (EC 3.4.21).
- the EC number refers to Enzyme Nomenclature 1992 from NC-IUBMB, Academic Press, San Diego, California, including supplements 1-5 published in Eur. J. Biochem. 1994, 223, 1-5; Eur. J. Biochem. 1995, 232, 1-6; Eur. J. Biochem. 1996, 237, 1-5; Eur. J. Biochem. 1997, 250, 1-6; and Eur. J. Biochem. 1999, 264, 610-650; respectively.
- proteolytic activity means a proteolytic activity (EC 3.4), in particular endopeptidase activity (EC 3.4.21).
- protease activity types There are several protease activity types, the three main activity types being: trypsin-like, where there is cleavage of amide substrates following Arg or Lys at P1 , chymotrypsin-like, where cleavage occurs following one of the hydrophobic amino acids at P1 , and elastase-like with cleavage following an Ala at P1.
- protease activity may be determined according to the procedure described in WO 2016/087619.
- Sequence identity The relatedness between two amino acid sequences or between two nucleotide sequences is described by the parameter“sequence identity”.
- the sequence identity between two amino acid sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet. 16: 276-277), preferably version 5.0.0 or later.
- the parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix.
- the output of Needle labeled“longest identity” (obtained using the -nobrief option) is used as the percent identity and is calculated as follows:
- the sequence identity between two deoxyribonucleotide sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, supra) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, supra), preferably version 5.0.0 or later.
- the parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EDNAFULL (EMBOSS version of NCBI NUC4.4) substitution matrix.
- the output of Needle labeled“longest identity” is used as the percent identity and is calculated as follows:
- variant means a polypeptide having protease activity comprising an alteration, i.e., a substitution, insertion, and/or deletion, at one or more positions.
- a substitution means replacement of the amino acid occupying a position with a different amino acid;
- a deletion means removal of the amino acid occupying a position; and
- an insertion means adding an amino acid adjacent to and immediately following the amino acid occupying a position.
- the polypeptide of SEQ ID NO: 2 is used to determine the corresponding amino acid residue number in a variant of SEQ ID NO: 1.
- the amino acid sequence of a variant of SEQ ID NO: 1 is aligned with SEQ ID NO: 2, and based on the alignment, the amino acid position number corresponding to any amino acid residue in the polypeptide of SEQ ID NO: 1 is determined. See the paragraph “Numbering of amino acid positions/residues” below for further information.
- Identification of the corresponding amino acid residue in another subtilase can be determined by an alignment of multiple polypeptide sequences using several computer programs including, but not limited to, MUSCLE (multiple sequence comparison by log-expectation; version
- substitutions For an amino acid substitution, the following nomenclature is used: Original amino acid, position, substituted amino acid. For example, the substitution of a threonine at position 220 with alanine is designated as“T220A”. Multiple substitutions may be separated by addition marks (“+”), e.g.,“T220A + G229V”, representing substitutions at positions 220 and 229 of threonine (T) with alanine (A) and glycine (G) with valine (V), respectively. Multiple substitutions may alternatively be listed with individual mutations separated by a space or a comma. Alternative substitutions in a particular position may be indicated with a slash (7”).
- substitution of threonine in position 220 with either alanine, valine or leucine many be designated“T220A/V/L”.
- An“X” preceding a position means that any original amino acid at the position may be substituted.
- X9E means that any amino acid residue at position 9 other than E is substituted with E.
- Deletions For an amino acid deletion, the following nomenclature is used: Original amino acid, position, *. Accordingly, the deletion of threonine at position 220 is designated as“T220*”. Multiple deletions may be separated by addition marks (“+”), e.g.,“T220* + G229*”, or alternatively may be separated by a space or comma.
- the use of an“X” preceding a position number is as described above for substitutions, e.g.“X131*” means that the amino acid residue at position 131 is deleted.
- Insertions For an amino acid insertion, the following nomenclature is used: Original amino acid, position, original amino acid, inserted amino acid. Accordingly, the insertion of lysine after threonine at position 220 is designated “T220TK”. An insertion of multiple amino acids is designated [Original amino acid, position, original amino acid, inserted amino acid #1 , inserted amino acid #2; etc.]. For example, the insertion of lysine and alanine after threonine at position 220 is indicated as“T220TKA”.
- the inserted amino acid residue(s) are numbered by the addition of lower case letters to the position number of the amino acid residue preceding the inserted amino acid residue(s).
- the sequence would thus be:
- Variants comprising multiple alterations are separated by addition marks (“+”), e.g.,“R170Y+G195E” representing a substitution of arginine and glycine at positions 170 and 195 with tyrosine and glutamic acid, respectively.
- Multiple alterations may alternatively be listed with individual mutations separated by a space or a comma.
- a combination of e.g. a substitution and an insertion may be denoted as follows: S99AD, which represents substitution of a serine residue in position 99 with an alanine residue as well as insertion of an aspartic acid residue.
- the numbering used herein is based on the numbering of SEQ I D NO: 2.
- amino acid residues of SEQ ID NO: 1 are numbered based on the corresponding amino acid residue in SEQ ID NO: 2.
- the numbering is based on the alignment in Table 1 of WO 89/06279, which shows an alignment of five proteases, including the mature polypeptide of the subtilase BPN’ (BASBPN) sequence (sequence c in the table) and the mature polypeptide of subtilisin 309 from Bacillus lentus, also known as Savinase® (BLSAVI) (sequence a in the table).
- BASBPN mature polypeptide of the subtilase BPN’
- BLSAVI Savinase®
- position numbers used for subtilisin 309 and other proteases in the patent literature are often based on the corresponding position numbers of BPN’ according to this alignment.
- the present invention relates to detergent compositions comprising at least a first protease and a second protease, where the first protease and the second protease have different net formal charges relative to the protease of SEQ ID NO: 1.
- net formal charge refers to the net charge of the enzyme, where the amino acid residues aspartic acid (D) and glutamic acid (E) contribute to one negative charge (-1), and the amino acid residues arginine (R) and lysine (K) contribute to one positive charge (+1), and where the charge of these residues in the first protease or second protease is compared to the charge of the residues in the protease of SEQ ID NO: 1.
- replacing an acidic amino acid with a basic amino acid would provide two positive charges, while replacing a basic amino acid with an acidic amino acid would provide two negative charges.
- the net charge of a protease in the detergent compositions of the invention is expressed relative to the net charge of the protease of SEQ ID NO: 1. It may be seen from the sequence of SEQ ID NO: 1 that this protease contains 5 Asp residues, 5 Glu residues, 8 Arg residues and 5 Lys residues, thus SEQ ID NO: 1 has a net charge of +3, and it is this value to which the first and second proteases of the invention are to be compared.
- the net charge of a protease in the compositions of the invention may thus be readily determined by counting the number of acidic and basic amino acids in the amino acid sequence and comparing the calculated net charge with the net charge of the protease of SEQ ID NO: 1.
- the net charge of the first and the second protease determined in this manner is a function of the number of acidic (D and E) and basic (R and K) amino acid residues and is for purposes of the invention independent of the composition having any particular pH value.
- the invention relates in particular to a detergent composition
- a detergent composition comprising a first protease and a second protease, where
- the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1 ;
- the first protease has a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of -1 , 0 or +1 relative to the protease of SEQ ID NO: 1.
- first protease and“second protease” are used herein to differentiate between the two proteases having different net charges in a given composition, and that a protease with a given net formal charge may in some cases, according to the context of the particular composition in which it is included, be considered as either a“first protease” or a “second protease”.
- a protease with a net formal charge of -1 may be referred to as a“first protease” when it is present in a composition comprising another protease with a net formal charge of -2, but may be a“second protease” when it is present in a composition comprising another protease with a net formal charge of -3, -4 or -5.
- the invention thus relates to a detergent composition
- a detergent composition comprising a first protease and a second protease, where the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -3 or -4.
- the first protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -3 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -4 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1.
- the invention in another aspect, relates to a detergent composition
- a detergent composition comprising a first protease and a second protease, where the first protease has a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -1 , 0 or +1 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -3 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +1 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -4 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +1 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -5 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +1 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -3 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -4 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -5 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -3 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -4 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -5 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1.
- the net formal charge difference between the first protease and the second protease in the compositions of the invention may vary, so that the net formal charge of the two proteases in a composition may differ by, e.g., 1 , 2, 3, 4, 5, 6 or 7.
- the detergent composition of the invention comprises a first and a second protease that each have a negative net formal charge relative to the protease of SEQ ID NO: 1 , for example a net formal charge of -1 , -2, -3 or -4, and where the net formal charge of the first and second protease differ from each other by 1 or 2.
- Specific examples of such compositions include compositions comprising: a) a first protease with a net formal charge of -4 and a second protease with a net formal charge of -2 relative to the protease of SEQ ID NO: 1 (charge difference of 2);
- compositions with two proteases having a net formal charge of -1 , -2, -3 or -4 and a charge difference of 1 or 2 are contemplated to be particularly useful when formulated as a liquid laundry detergent composition.
- the invention in another aspect, relates to a detergent composition
- a detergent composition comprising a first protease and a second protease, where the first protease has a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
- the invention relates to a detergent composition
- a detergent composition comprising a first protease and a second protease, where the first protease has a net formal charge of 0, -1 or -2 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2, +3, +4 or +5 relative to the protease of SEQ ID NO: 1. It is contemplated that such compositions wherein one protease has a relatively positive net formal charge relative to the protease of SEQ ID NO: 1 will provide advantageous results in relatively high pH wash settings, for example in automatic dishwashing applications.
- the first protease has a net formal charge of -3 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -4 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -5 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +3 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +3 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +3 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +4 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +4 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +4 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +5 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +5 relative to the protease of SEQ ID NO: 1.
- the first protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of +5 relative to the protease of SEQ ID NO: 1.
- the first protease and the second protease preferably both have an amino acid sequence that has at least 60% sequence identity to SEQ ID NO: 1 , for example at least 70% or at least 80% sequence identity.
- the first protease may thus have at least 85% sequence identity to SEQ I D NO: 1 , such as at least 90%, at least 91 %, at least 92%, at least 93%, at least 94% or at least 95% sequence identity to SEQ ID NO: 1.
- the second protease may have at least 85% sequence identity to SEQ ID NO: 1 , such as at least 90%, at least 91 %, at least 92%, at least 93%, at least 94% or at least 95% sequence identity to SEQ ID NO: 1. It will be understood that if such proteases comprise any additional mutations relative to SEQ ID NO: 1 beyond those specified herein, the proteases should fulfil the relevant net formal charge criteria in relation to SEQ ID NO: 1.
- the first and/or second protease may also have an amino acid sequence that comprises or consists of SEQ ID NO: 1 with the specific mutations defined herein.
- the first protease has a net formal charge of -5, -4 or -3 and comprises, relative to SEQ ID NO: 1 , and comprises one or more mutations that introduce an increased negative charge selected from the group consisting of S9E, K27H, K27M, *36D, N62D, N76D, N77D, G97D, S99D, S101 E, H120D, N140D, S156D, N185E, S188E, G195E, K235L, K235M, K237M, S259D and L262E.
- Preferred substitutions to introduce a negative charge include N76D, G97D, S99D, S101 E and S156D.
- the first protease comprises more than one of these mutations, preferably three or more, such as four, five or six of these mutations.
- a variant having four or more of these mutations that provide an increased negative charge may be combined with one or more mutations, for example one or two mutations, that provide an increased positive charge, so as to result in a net formal charge relative to the protease of SEQ I D NO: 1 of -5, -4 or -3.
- mutations to provide an increased positive charge include e.g. S9R, N43R, N117R, A215K and Q245R.
- the first protease thus comprises, relative to SEQ I D NO: 1 , four or more mutations, such as four, five, six or seven mutations, that introduce an increased negative charge, combined with one or more mutations, such as one or two mutations, that introduce an increased positive charge, so as to result in a net formal charge of -5, -4 or -3 relative to the protease of SEQ ID NO: 1.
- the first protease may thus comprise four or more mutations that introduce an increased negative charge, e.g.
- position numbers are based on the numbering of SEQ ID NO: 2 in accordance with the explanation in the paragraph“Numbering of amino acid positions/residues” above.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S99D+S101 E+S103A+V104I+S156D+G160S+L262E, i.e. having a net formal charge of -4 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27H+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E, i.e. having a net formal charge of -4 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+K235M+Q245R+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+ L262E, i.e. having a net formal charge of -4 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+V205I+Q206L+Y209W+S259D+N261W+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+N185E+S188E+Q191 N+A194P+Q206L+Y209W+S259D+
- L262E i.e. having a net formal charge of -5 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the mutations *36D+N76D+H120D+G195E+K235L, i.e. having a net formal charge of -5 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S99A+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+ L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+N43R+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R +L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+N43R+S99D+S101 E+S103A+V104I+S156D+G160S+N173D+K235M+
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+G97D+S156D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101 E+S156D+A172V+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+N140D+S156D+Y209W+A215K+L262E, i.e. having a net formal charge of -4 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+S101 E+T 180A+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+S101 E+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+S101 E+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+S101 E+V177I+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+N76D+G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+G97D+S156D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N77D+G97D+S156D+Y209W+A215K+L262E, i.e. having a net formal charge of -4 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N76D+G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N62D+G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+G97D+S101 E+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N76D+G97D+Y209W+A215K+L262E+A270T, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N76D+G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N62D+G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+K27M+G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+N 185E+S188E+Q191 N+A194P+Q206L+Y209W+A215K+
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+S188E+Q191 N+A194P+Q206L+Y209W+A215K+S259D+
- L262E i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+N 185E+S188E+Q191 N+A194P+Q206L+Y209W+A215K+
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+N185E+S188E+Q191 N+A194P+Q206L+Y209W+Q245R+ S259D+L262Q, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
- the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitution K27M, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
- the second protease is the polypeptide of SEQ ID NO: 1.
- the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the mutation S99AD (i.e. substitution of S to A, and insertion of D), i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K, i.e. having a net formal charge of 0 relative to SEQ ID NO: 1.
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+N1 17R+Y209W+A215K, i.e. having a net formal charge of +1 relative to SEQ ID NO: 1.
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+N43R+N76D+V205I+Q206L+Y209W+A215K+Q245R+S259D+ N261W+L262E, i.e. having a net formal charge of 0 relative to SEQ ID NO: 1.
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+N43R+N76D+V205I+Q206L+Y209W+A215K+S259D+N261W+L262E, i.e. having a net formal charge of 0 relative to SEQ ID NO: 1.
- the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions S9R+N43R+N76D+V205I+Q206L+Y209W+S259D+N261 W+L262E, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
- the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99A+S101 E+S103A+V104I+S156D+G160S+A215K+K235M+Q245R+ L262E, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
- the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+N43R+S99A+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+Q245R+ L262E, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
- the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+N43R+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+Q245R+L262E, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
- the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions Y167A+R170S+A194P, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+A15T+V68A+N218D+Q245R, i.e. having a net formal charge of +1 relative to SEQ ID NO: 1.
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+A15T+G61 E+V68A+A194P+V205I+Q245R+N261 D, i.e. having a net formal charge of 0 relative to SEQ ID NO: 1.
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+A15T+V68A+S99G+Q245R+N261 D, i.e. having a net formal charge of +1 relative to SEQ ID NO: 1.
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+A15T+V68A+H120D+P131S+Q137H+Q245R, i.e. having a net formal charge of +1 relative to SEQ ID NO: 1.
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+A15T+V68A+H120N+P131S+Q137H+Q245M, i.e. having a net formal charge of +1 relative to SEQ ID NO: 1.
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+A15T+G61 E+V68A+A98S+S99G+N218D+Q245R, i.e. having a net formal charge of 0 relative to SEQ ID NO: 1.
- the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions S3T+V4I+S99D+S101 R+S103A+V104I+G160S+V205I+L217D, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
- the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions S3T+V4I+S99D+S101 R+S103A+V104I+G160S+A194P+V205I+L217D, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
- the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
- the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
- protease variants that may be used as the first or second protease are those that are at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98% or at least 99% identical to any of the proteases disclosed above, and where any additional mutations in the individual protease variants as set forth above result in the same net formal charge.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S99D+S101 E+S103A+V104I+S156D+G160S+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitution K27M.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27H+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitution K27M.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+K235M+Q245R+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitution K27M.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+ L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitution K27M.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S99D+S101 E+S103A+V104I+S156D+G160S+L262E
- the second protease is the polypeptide of SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27H+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E
- the second protease is the polypeptide of SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+ L262E, and the second protease is the polypeptide of SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S99D+S101 E+S103A+V104I+S156D+G160S+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the mutation S99AD.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27H+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the mutation S99AD.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+K235M+Q245R+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the mutation S99AD.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the mutation S99AD.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+ L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the mutation S99AD.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S99D+S101 E+S103A+V104I+S156D+G160S+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K or G97D+N1 17R+Y209W+A215K.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+V205I+Q206L+Y209W+S259D+N261W+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K or G97D+N117R+Y209W+A215K.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+N185E+S188E+Q191 N+A194P+Q206L+Y209W+S259D+ L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K or G97D+N1 17R+Y209W+A215K.
- the first protease is a variant of SEQ ID NO: 1 comprising the mutations *36D+N76D+H120D+G195E+K235L
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K or G97D+N1 17R+Y209W+A215K.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitution K27M
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E.
- the first protease is the polypeptide of SEQ ID NO: 1
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+ S103A+V104I+S156D+G160S+Q245R+L262E.
- the first protease is a variant of SEQ ID NO: 1 comprising the mutation S99AD
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+N 140D+S156D+Y209W+A215K+L262E
- the second protease is the polypeptide of SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+N 140D+S156D+Y209W+A215K+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+N 140D+S156D+Y209W+A215K+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K+L262E.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N77D+G97D+S156D+Y209W+A215K+L262E, and the second protease is the polypeptide of SEQ ID NO: 1.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N77D+G97D+S156D+Y209W+A215K+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N77D+G97D+S156D+Y209W+A215K+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K+L262E.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+N117R+Y209W+A215K
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+N76D+G97D+Y209W+A215K+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+S101 E+V177I+Y209W+A215K+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+S101 E+Y209W+A215K+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101 E+S156D+A172V+Y209W+A215K+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+N 140D+S156D+Y209W+A215K+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
- the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N77D+G97D+S156D+Y209W+A215K+L262E
- the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
- the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1 and is a variant of SEQ ID NO: 1 with the substitutions G97D+S156D+Y209W+A215K+L262E or S9R+S99D+S101 E+S103A+V104I+S156D+G160S+ Q245R+L262E, preferably G97D+S156D+Y209W+A215K+L262E.
- the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1
- the first protease is a variant of SEQ ID NO: 1 having a set of mutations selected from the group consisting of:
- the second protease preferably is a variant of SEQ ID NO: 1 with the substitutions G97D+S156D+Y209W+A215K+L262E or S9R+S99D+S101 E+S103A+V104I+S156D+G160S+ Q245R+L262E, preferably G97D+S156D+Y209W+A215K+L262E.
- the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1
- the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1
- the second protease is a variant of SEQ ID NO: 1 having a set of mutations selected from the group consisting of:
- the first protease may be a variant of SEQ ID NO: 1 comprising a set of mutations selected from the group consisting of:
- the second protease may be the protease of SEQ ID NO: 1 or a variant of SEQ ID NO: 1 comprising a set of mutations selected from the group consisting of:
- the first protease may be a variant of SEQ ID NO: 1 having a set of mutations selected from the group consisting of:
- the second protease may be the protease of SEQ ID NO: 1 or a variant thereof having a set of mutations selected from the group consisting of:
- the first protease having a net formal charge of 0, -1 or -2 may, for example, be selected from the polypeptide of SEQ ID NO: 1 and variants of SEQ ID NO: 1 having a set of mutations selected from the group consisting of:
- the first protease may have a net formal charge of -2 relative to SEQ ID NO: 1
- the second protease may have a net formal charge of -1 , 0 or +1 relative to SEQ ID NO: 1.
- the first protease may be a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+ G160S+Q245R+L262E
- the second protease may be the polypeptide of SEQ ID NO: 1 or a variant of SEQ ID NO: 1 comprising the substitution K27M or comprising the mutation S99AD.
- the detergent composition of the invention does not comprise two proteases wherein one protease is comprised in a solid enzyme formulation and the other protease is comprised in a liquid enzyme formulation.
- the detergent composition of the invention does not comprise the protease of SEQ ID NO: 8 disclosed in US 2017/0198243. In one embodiment, the detergent composition of the invention does not comprise the protease of SEQ ID NO: 9 disclosed in US 2017/0198243. In a further embodiment, the two proteases in the detergent composition of the invention are not the protease of SEQ ID NO: 8 and the protease of SEQ ID NO: 9 disclosed in US 2017/0198243.
- the detergent composition of the invention comprising a first protease and a second protease as defined above has an improved wash performance compared to the same composition comprising either the first protease or the second protease.
- the improved wash performance may be improved performance on one or more individual stains and/or improved overall performance on a set of stains, e.g. 2, 3, 4, 5 or more stains.
- Wash performance may e.g. be determined using the AMSA method described herein, for example using the model detergent set forth in Table 1. Performance may be tested on any suitable stain(s) for the intended application, e.g. laundry or automatic dishwashing. Examples of such stains are e.g. the standard laundry stains PC-10 and/or PC-03.
- Proteases with a relatively negative net formal charge of e.g. -4 or -3 compared to SEQ ID NO: 1 tend to be better at removing certain types of protein stains, for example cocoa- containing stains.
- proteases with a more positive, relatively neutral net formal charge of e.g. -1 or 0 tend to be better at removing other types of protein stains, for example sebum stains and other oil-containing protein stains. It was therefore surprising that the detergent compositions of the invention comprising two proteases with different net formal charge characteristics could provide improved cleaning of different types of stains without increasing the total amount of protease enzyme.
- the detergent composition of the invention comprising a first protease and a second protease has an improved wash performance on PC-10 compared to the same composition comprising either the first protease or the second protease.
- the detergent composition of the invention comprising a first protease and a second protease has an improved overall wash performance on PC-10 and PC- 03 compared to the same composition comprising either the first protease or the second protease.
- the relative wash performance of the detergent composition of the invention comprising a first protease and a second protease is improved over the wash performance of a composition comprising either the first protease or the second protease by at least 1 %, preferably at least 2%, at least 3%, at least 4% or at least 5%, such as at least 6%, at least 7%, at least 8%, at least 9% or at least 10%, e.g. at least 15% or at least 20%.
- This improved relative wash performance is preferably obtained at least on the PC-10 stain from Center for Testmaterials (CFT).
- this improved relative wash performance is an improved overall wash performance on a set of stains comprising PC-10 and PC-03 (both from CFT), and optionally comprising one or more additional standard stains.
- additional stains that may be used are one or more of C-S-05S, C-S-67, C-S-75, C-S-95, C-H151 , C-H163, C- H252, C-S-60, all from Center for Testmaterials (CFT), and French Mustard WE5FSMWKC, 01 1 KC WC PC PE Bacon Grease, 028 KC WC PC PE Cheese Spread, 080 KC WC PC PE Mayonnaise, all from Warwick Equest.
- Relative wash performance may e.g. be determined based on the sums of delta intensity as described in Example 1.
- compositions being compared will contain the same total amount of protease enzyme protein (by weight).
- the invention relates to novel protease variants with advantageous properties, where the proteases are variants of SEQ ID NO: 1 comprising substitutions in positions 97, 209 and 215.
- Such proteases have been found to not only have beneficial properties when used in detergent compositions with another protease having a different net formal charge such as those disclosed herein, but also to have beneficial properties, e.g. improved laundry wash performance, when used alone.
- the invention relates to a protease variant comprising the substitutions X97D, X209W and X215K, e.g. G97D, Y209W and A215K, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease variant comprises one or more additional substitutions, preferably in one or more positions, for example in one, two, three or four positions, selected from positions 27, 62, 76, 77, 87, 101 , 104, 1 17, 1 18, 140, 156, 172, 177, 194 and 262.
- additional substitutions include, in particular, X9E (e.g. S9E), X27M (e.g. K27M), X62D (e.g. N62D), X76D (e.g. N76D), X77D (e.g. N77D), X87N (e.g. S87N), X101 E/G/N (e.g.
- X104N e.g. V104N
- X117R e.g. N1 17R
- X1 18V e.g. G118V
- X140D e.g. N140D
- X156D e.g. S156D
- X172V e.g. A172V
- X177I e.g. V177I
- X194P e.g. A194P
- X262E e.g. L262E
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+N117R+Y209W+A215K, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N77D+G97D+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+N76D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+S101 E+V177I+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+S101 E+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+N140D+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101 E+S156D+A172V+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N62D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+G97D+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+G97D+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+S101 E+T180A+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+S101 E+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N76D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N62D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+G97D+S101 E+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N76D+G97D+Y209W+A215K+L262E+A270T, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N76D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+K27M+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101 E+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the invention relates to a protease which is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E and optionally at least one additional substitution selected from S87N, S101 G/N, V104N, G118V and A194P.
- proteases are provided below.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions S87N+G97D+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101G+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101 N+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+V104N+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+G118V+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+A194P+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions S87N+G97D+S101 G+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions S87N+G97D+S101 N+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions S87N+G97D+V104N+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions S87N+G97D+G118V+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions S87N+G97D+S156D+A194P+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101G+G118V+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101G+S156D+A194P+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101 N+V104N+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
- the protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
- one or both of the proteases may be a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K, and optionally other substitutions as set forth herein, as long as the two proteases fulfill the relevant net formal charge criteria relative to SEQ ID NO: 1.
- a protease variant in a composition of the invention may comprise additional alterations at one or more other positions.
- additional alterations may be of a minor nature, that is typically conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein, and which do not alter the net formal charge as described herein; small deletions, typically of 1-30 amino acids; or small amino- or carboxyl-terminal extensions.
- conservative substitutions are within the groups of basic amino acids (arginine, lysine and histidine), acidic amino acids (glutamic acid and aspartic acid), polar amino acids (glutamine and asparagine), hydrophobic amino acids (leucine, isoleucine and valine), aromatic amino acids (phenylalanine, tryptophan and tyrosine), and small amino acids (glycine, alanine, serine, threonine and methionine).
- Amino acid substitutions that do not generally alter specific activity are known in the art and are described, for example, by H. Neurath and R.L. Hill, 1979, in The Proteins, Academic Press, New York.
- amino acid changes are of such a nature that the physico-chemical properties of the polypeptides are altered.
- amino acid changes may improve the thermal stability of the polypeptide, alter the substrate specificity, change the pH optimum, and the like.
- Essential amino acids in a polypeptide can be identified according to procedures known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (Cunningham and Wells, 1989, Science 244: 1081-1085). In the latter technique, single alanine mutations are introduced at every residue in the molecule, and the resultant mutant molecules are tested for protease activity to identify amino acid residues that are critical to the activity of the molecule. See also, Hilton et ai, 1996, J. Biol. Chem. 271 : 4699-4708.
- the active site of the enzyme or other biological interaction can also be determined by physical analysis of structure, as determined by such techniques as nuclear magnetic resonance, crystallography, electron diffraction, or photoaffinity labeling, in conjunction with mutation of putative contact site amino acids. See, for example, de Vos et ai, 1992, Science 255: 306-312; Smith et ai, 1992, J. Mol. Biol. 224: 899- 904; Wlodaver et al., 1992, FEBS Lett. 309: 59-64.
- the identity of essential amino acids can also be inferred from an alignment with a related polypeptide.
- the detergent composition of the invention may be in any convenient form, e.g., a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, a bar, or a regular, compact or concentrated liquid.
- both the first protease and the second protease as described elsewhere herein are present in the same formulation, e.g. in the same liquid or solid phase.
- a liquid formulation in the form of e.g. a liquid or gel
- both the first and second protease would be present the liquid or gel phase.
- a solid formulation for example a powder, granulate or tablet
- both the first and second protease would be present in the solid phase.
- the detergent composition of the invention is a laundry composition, and in particular a liquid laundry composition.
- a laundry composition and in particular a liquid laundry composition.
- the use of two proteases with different net charge characteristics according to the invention allows flexibility with respect to incorporation into different liquid laundry detergent compositions, e.g. surfactant composition and/or level, and with respect to use under different wash conditions, e.g. wash pH and/or water hardness.
- the invention relates to a detergent composition as described above comprising at least a first protease and a second protease and further comprising one or more additional enzymes selected from the group consisting of amylases, catalases, cellulases (e.g., endoglucanases), cutinases, deoxyribonucleases, haloperoxygenases, lipases, mannanases, pectinases, pectin lyases, peroxidases, proteases, xanthanases, lichenases and xyloglucanases, or any mixture thereof.
- additional enzymes selected from the group consisting of amylases, catalases, cellulases (e.g., endoglucanases), cutinases, deoxyribonucleases, haloperoxygenases, lipases, mannanases, pectinases, pectin lyases, peroxidases, protea
- a detergent composition is within the skill of the artisan and includes conventional ingredients, including the exemplary non-limiting components set forth below.
- the choice of components may include, for fabric care, the consideration of the type of fabric to be cleaned, the type and/or degree of soiling, the temperature at which cleaning is to take place, and the formulation of the detergent product.
- a detergent composition comprises the first and second protease and one or more non-naturally occurring detergent components, such as surfactants, hydrotropes, builders, co-builders, chelators or chelating agents, bleaching system or bleach components, polymers, fabric hueing agents, fabric conditioners, foam boosters, suds suppressors, dispersants, dye transfer inhibitors, fluorescent whitening agents, perfume, optical brighteners, bactericides, fungicides, soil suspending agents, soil release polymers, anti redeposition agents, enzyme inhibitors or stabilizers, enzyme activators, antioxidants, and solubilizers.
- the detergent composition will typically comprise at least a surfactant and a builder.
- the protease may be added to a detergent composition in an amount corresponding to 0.01-200 mg of enzyme protein per liter of wash liquor, preferably 0.05-50 mg of enzyme protein per liter of wash liquor, in particular 0.1-10 mg of enzyme protein per liter of wash liquor.
- a granulated composition for laundry may for example include 0.001 %-20%, such as 0.01 %-10%, such as 0.05%-5% of enzyme protein by weight of the composition.
- An automatic dishwashing (ADW) composition may for example include 0.001 %-30%, such as 0.01 %-20%, such as 0.1-15%, such as 0.5-10% of enzyme protein by weight of the composition.
- the enzymes such as the protease may be stabilized using conventional stabilizing agents, e.g., a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4- formylphenyl boronic acid, and the composition may be formulated as described in, for example, WO 92/19709 and WO 92/19708 or the protease may be stabilized using peptide aldehydes or ketones such as described in WO 2005/105826 and WO 2009/118375.
- a polyol such as propylene glycol or glycerol
- a sugar or sugar alcohol lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4- formylphenyl
- the detergent composition may be formulated into a granular detergent for laundry.
- Such detergent may e.g. comprise;
- composition a) at least 0.01 mg protease per gram of composition
- anionic surfactant preferably 5 wt % to 50 wt %
- nonionic surfactant preferably 1 wt % to 8 wt %
- d) builder preferably 5 wt % to 40 wt %, such as carbonates, zeolites, phosphate builder, calcium sequestering builders or complexing agents.
- the detergent composition may comprise one or more surfactants, which may be anionic and/or cationic and/or non-ionic and/or semi-polar and/or zwitterionic, or a mixture thereof.
- the detergent composition includes a mixture of one or more nonionic surfactants and one or more anionic surfactants.
- the surfactant(s) is typically present at a level of from about 0.1 % to 60% by weight, such as about 1 % to about 40%, or about 3% to about 20%, or about 3% to about 10%.
- the surfactant(s) is chosen based on the desired cleaning application, and includes any conventional surfactant(s) known in the art. Any surfactant known in the art for use in detergents may be utilized. Surfactants lower the surface tension in the detergent, which allows the stain being cleaned to be lifted and dispersed and then washed away.
- the detergent When included therein, the detergent will usually contain from about 1 % to about 40% by weight, such as from about 5% to about 30%, including from about 5% to about 15%, or from about 20% to about 25% of an anionic surfactant.
- anionic surfactants include sulfates and sulfonates, in particular, linear alkylbenzenesulfonates (LAS), isomers of LAS, branched alkylbenzenesulfonates (BABS), phenylalkanesulfonates, alpha-olefinsulfonates (AOS), olefin sulfonates, alkene sulfonates, alkane-2, 3-diylbis(sulfates), hydroxyalkanesulfonates and disulfonates, alkyl sulfates (AS) such as sodium dodecyl sulfate (SDS), fatty alcohol sulfates (FAS), primary alcohol sulfates (PAS
- the detergent When included therein, the detergent will usually contain from about 0% to about 10% by weight of a cationic surfactant.
- cationic surfactants include alklydimethylethanolamine quat (ADMEAQ), cetyltrimethylammonium bromide (CTAB), dimethyldistearylammonium chloride (DSDMAC), and alkylbenzyldimethylammonium, alkyl quaternary ammonium compounds, alkoxylated quaternary ammonium (AQA) compounds, and combinations thereof.
- the detergent When included therein, the detergent will usually contain from about 0.2% to about 40% by weight of a non-ionic surfactant, for example from about 0.5% to about 30%, in particular from about 1 % to about 20%, from about 3% to about 10%, such as from about 3% to about 5%, or from about 8% to about 12%.
- a non-ionic surfactant for example from about 0.5% to about 30%, in particular from about 1 % to about 20%, from about 3% to about 10%, such as from about 3% to about 5%, or from about 8% to about 12%.
- Non-limiting examples of non-ionic surfactants include alcohol ethoxylates (AE or AEO), alcohol propoxylates, propoxylated fatty alcohols (PFA), alkoxylated fatty acid alkyl esters, such as ethoxylated and/or propoxylated fatty acid alkyl esters, alkylphenol ethoxylates (APE), nonylphenol ethoxylates (NPE), alkylpolyglycosides (APG), alkoxylated amines, fatty acid monoethanolamides (FAM), fatty acid diethanolamides (FADA), ethoxylated fatty acid monoethanolamides (EFAM), propoxylated fatty acid monoethanolamides (PFAM), polyhydroxy alkyl fatty acid amides, or /V-acyl /V-alkyl derivatives of glucosamine (glucamides, GA, or fatty acid glucamide, FAGA), as well as products available under the trade names SPAN and TW
- the detergent When included therein, the detergent will usually contain from about 0% to about 10% by weight of a semipolar surfactant.
- semipolar surfactants include amine oxides (AO) such as alkyldimethylamineoxide, N-(coco alkyl)-/ ⁇ /,/ ⁇ /-dimethylamine oxide and N- (tallow-alkyl)-/ ⁇ /,/ ⁇ /-bis(2-hydroxyethyl)amine oxide, fatty acid alkanolamides and ethoxylated fatty acid alkanolamides, and combinations thereof.
- AO amine oxides
- the detergent When included therein, the detergent will usually contain from about 0% to about 10% by weight of a zwitterionic surfactant.
- zwitterionic surfactants include betaine, alkyldimethylbetaine, sulfobetaine, and combinations thereof.
- the detergent composition may contain about 0-65% by weight, such as about 5% to about 45% of a detergent builder or co-builder, or a mixture thereof.
- the level of builder is typically 40-65%, particularly 50-65%.
- Builders and chelators soften, e.g., the wash water by removing the metal ions form the liquid.
- the builder and/or co-builder may particularly be a chelating agent that forms water-soluble complexes with Ca and Mg. Any builder and/or co-builder known in the art for use in laundry detergents may be utilized.
- Non-limiting examples of builders include zeolites, diphosphates (pyrophosphates), triphosphates such as sodium triphosphate (STP or STPP), carbonates such as sodium carbonate, soluble silicates such as sodium metasilicate, layered silicates (e.g., SKS-6 from Hoechst), ethanolamines such as 2- aminoethan-1-ol (MEA), diethanolamine (DEA, also known as iminodiethanol), triethanolamine (TEA, also known as 2,2’,2”-nitrilotri ethanol), and carboxymethyl inulin (CMI), and combinations thereof.
- zeolites diphosphates (pyrophosphates), triphosphates such as sodium triphosphate (STP or STPP), carbonates such as sodium carbonate, soluble silicates such as sodium metasilicate, layered silicates (e.g., SKS-6 from Hoechst), ethanolamines such as 2- aminoethan-1-ol (MEA), diethanolamine (DEA
- the detergent composition is phosphate-free.
- the detergent composition may also contain 0-20% by weight, such as about 5% to about 10%, of a detergent co-builder, or a mixture thereof.
- the detergent composition may include a co-builder alone, or in combination with a builder, for example a zeolite builder.
- co-builders include homopolymers of polyacrylates or copolymers thereof, such as poly(acrylic acid) (PAA) or copoly(acrylic acid/maleic acid) (PAA/PMA).
- PAA/PMA poly(acrylic acid)
- Further non-limiting examples include citrate, chelators such as aminocarboxylates, aminopolycarboxylates and phosphonates, and alkyl- or alkenylsuccinic acid.
- NTA 2, 2’, 2”- nitrilotriacetic acid
- EDTA ethylenediaminetetraacetic acid
- DTPA diethylenetriaminepentaacetic acid
- IDS iminodisuccinic acid
- EDDS ethylenediamine-/ ⁇ /,/ ⁇ /’-disuccinic acid
- MGDA methylglycinediacetic acid
- GLDA glutamic acid-N,N-diacetic acid
- HEDP ethylenediaminetetra-(methylenephosphonic acid)
- DTPMPA or DTMPA diethylenetriaminepentakis (methylenephosphonic acid)
- EDG N-( 2- hydroxyethyl)iminodiacetic acid
- ASMA aspartic acid-/ ⁇ /-monoacetic acid
- ASDA aspartic acid-/V, /V-diacetic acid
- the first and second protease of the invention may also be formulated into a dishwashing composition, preferably an automatic dishwashing composition (ADW), comprising:
- 10-50 wt % builder preferably selected from citric acid, methylglycine-N,N-diacetic acid (MGDA) and/or glutamic acid-N,N-diacetic acid (GLDA) and mixtures thereof, and
- the detergent may contain 0-50% by weight, such as about 0.1 % to about 25%, of a bleaching system.
- Bleach systems remove discolor often by oxidation, and many bleaches also have strong bactericidal properties, and are used for disinfecting and sterilizing. Any bleaching system known in the art for use in laundry detergents may be utilized. Suitable bleaching system components include bleaching catalysts, photobleaches, bleach activators, sources of hydrogen peroxide such as sodium percarbonate and sodium perborates, preformed peracids and mixtures thereof.
- Suitable preformed peracids include, but are not limited to, peroxycarboxylic acids and salts, percarbonic acids and salts, perimidic acids and salts, peroxymonosulfuric acids and salts, for example, Oxone (R), and mixtures thereof.
- bleaching systems include peroxide-based bleaching systems, which may comprise, for example, an inorganic salt, including alkali metal salts such as sodium salts of perborate (usually mono- or tetra- hydrate), percarbonate, persulfate, perphosphate, persilicate salts, in combination with a peracid-forming bleach activator.
- bleach activator is meant herein as a compound which reacts with peroxygen bleach like hydrogen peroxide to form a peracid.
- the peracid thus formed constitutes the activated bleach.
- Suitable bleach activators to be used herein include those belonging to the class of esters amides, imides or anhydrides.
- Suitable examples are tetracetylethylene diamine (TAED), sodium 4-[(3,5,5-trimethylhexanoyl)oxy]benzene sulfonate (ISONOBS), diperoxy dodecanoic acid, 4- (dodecanoyloxy)benzenesulfonate (LOBS), 4-(decanoyloxy)benzenesulfonate, 4- (decanoyloxy)benzoate (DOBS), 4-(nonanoyloxy)-benzenesulfonate (NOBS), and/or those disclosed in WO 98/17767.
- TAED tetracetylethylene diamine
- ISONOBS sodium 4-[(3,5,5-trimethylhexanoyl)oxy]benzene sulfonate
- DOBS 4-(decanoyloxy)benzenesulfonate
- NOBS 4-(nonanoyloxy)-benzenesulfonate
- ATC acetyl triethyl citrate
- ATC or a short chain triglyceride like triacetin has the advantage that it is environmentally friendly as it eventually degrades into citric acid and alcohol.
- acetyl triethyl citrate and triacetin have good hydrolytic stability in the product upon storage and are efficient bleach activators.
- ATC provides a good building capacity to the laundry additive.
- the bleaching system may comprise peroxyacids of, for example, the amide, imide, or sulfone type.
- the bleaching system may also comprise peracids such as 6-(phthalimido)peroxyhexanoic acid (PAP).
- PAP 6-(phthalimido)peroxyhexanoic acid
- the bleaching system may also include a bleach catalyst or a booster.
- bleach catalysts that may be used in the compositions of the present invention include manganese oxalate, manganese acetate, manganese-collagen, cobalt-amine catalysts and manganese triazacyclononane (MnTACN) catalysts; particularly preferred are complexes of manganese with 1 ,4,7-trimethyl-1 ,4,7-triazacyclononane (Me3- TACN) or 1 ,2,4,7-tetramethyl-1 ,4,7-triazacyclononane (Me4-TACN), in particular Me3-TACN, such as the dinuclear manganese complex [(Me3-TACN)Mn(0)3Mn(Me3-TACN)](PF6)2, and [2,2',2"-nitrilotris(ethane-1 ,2-diylazanylylidene-KN-methanylylidene)triphenolato- K30]manganese(lll).
- the bleach component may be an organic catalyst selected from the group consisting of organic catalysts having the following formula:
- each R 1 is independently a branched alkyl group containing from 9 to 24 carbons or linear alkyl group containing from 11 to 24 carbons, preferably each R 1 is independently a branched alkyl group containing from 9 to 18 carbons or linear alkyl group containing from 1 1 to 18 carbons, more preferably each R 1 is independently selected from the group consisting of 2-propylheptyl, 2-butyloctyl, 2-pentylnonyl, 2-hexyldecyl, n-dodecyl, n- tetradecyl, n-hexadecyl, n-octadecyl, iso-nonyl, iso-decyl, iso-tridecyl and iso-pentadecyl.
- Suitable bleaching systems are described, e.g., in WO 2007/087258, WO 2007/087244, WO 2007/087259 and WO 2007/087242.
- Suitable photobleaches may for example be sulfonated zinc phthalocyanine.
- a hydrotrope is a compound that solubilizes hydrophobic compounds in aqueous solutions (or oppositely, polar substances in a non-polar environment).
- hydrotropes have both hydrophilic and hydrophobic characters (so-called amphiphilic properties as known from surfactants); however, the molecular structures of hydrotropes generally do not favour spontaneous self-aggregation, see, e.g., review by Hodgdon and Kaler, 2007, Current Opinion in Colloid & Interface Science 12: 121-128.
- Hydrotropes do not display a critical concentration above which self-aggregation occurs as found for surfactants and lipids forming miceller, lamellar or other well defined meso-phases.
- hydrotropes show a continuous-type aggregation process where the sizes of aggregates grow as concentration increases.
- many hydrotropes alter the phase behaviour, stability, and colloidal properties of systems containing substances of polar and non-polar character, including mixtures of water, oil, surfactants, and polymers.
- Hydrotropes are classically used across industries from pharma, personal care and food to technical applications.
- Use of hydrotropes in detergent compositions allows for example more concentrated formulations of surfactants (as in the process of compacting liquid detergents by removing water) without inducing undesired phenomena such as phase separation or high viscosity.
- the detergent may contain 0-5% by weight, such as about 0.5 to about 5%, or about 3% to about 5%, of a hydrotrope.
- a hydrotrope Any hydrotrope known in the art for use in detergents may be utilized.
- Non-limiting examples of hydrotropes include sodium benzene sulfonate, sodium p- toluene sulfonate (STS), sodium xylene sulfonate (SXS), sodium cumene sulfonate (SCS), sodium cymene sulfonate, amine oxides, alcohols and polyglycolethers, sodium hydroxynaphthoate, sodium hydroxynaphthalene sulfonate, sodium ethylhexyl sulfate, and combinations thereof.
- the detergent may contain 0-10% by weight, such as 0.5-5%, 2-5%, 0.5-2% or 0.2-1 % of a polymer. Any polymer known in the art for use in detergents may be utilized.
- the polymer may function as a co-builder as mentioned above, or may provide antiredeposition, fiber protection, soil release, dye transfer inhibition, grease cleaning and/or anti-foaming properties. Some polymers may have more than one of the above-mentioned properties and/or more than one of the below-mentioned motifs.
- Exemplary polymers include (carboxymethyl)cellulose (CMC), poly(vinyl alcohol) (PVA), poly(vinylpyrrolidone) (PVP), poly(ethyleneglycol) or poly(ethylene oxide) (PEG), ethoxylated poly(ethyleneimine), carboxymethyl inulin (CMI), and polycarboxylates such as PAA, PAA/PMA, poly-aspartic acid, and lauryl methacrylate/acrylic acid copolymers, hydrophobically modified CMC (HM-CMC) and silicones, copolymers of terephthalic acid and oligomeric glycols, copolymers of poly(ethylene terephthalate) and poly(oxyethene terephthalate) (PET-POET), PVP, poly(vinylimidazole) (PVI), poly(vinylpyridine-A/-oxide) (PVPO or PVPNO) and polyvinylpyrrolidone-vinylimidazole
- exemplary polymers include sulfonated polycarboxylates, polyethylene oxide and polypropylene oxide (PEO-PPO) and diquaternium ethoxy sulfate.
- PEO-PPO polypropylene oxide
- diquaternium ethoxy sulfate diquaternium ethoxy sulfate.
- Other exemplary polymers are disclosed in, e.g., WO 2006/130575. Salts of the above-mentioned polymers are also contemplated.
- the detergent compositions of the present invention may also include fabric hueing agents such as dyes or pigments, which when formulated in detergent compositions can deposit onto a fabric when the fabric is contacted with a wash liquor comprising the detergent compositions and thus altering the tint of the fabric through absorption/reflection of visible light.
- fabric hueing agents alter the tint of a surface as they absorb at least a portion of the visible light spectrum.
- Suitable fabric hueing agents include dyes and dye-clay conjugates, and may also include pigments.
- Suitable dyes include small molecule dyes and polymeric dyes.
- Suitable small molecule dyes include small molecule dyes selected from the group consisting of dyes falling into the Colour Index (C.l.) classifications of Direct Blue, Direct Red, Direct Violet, Acid Blue, Acid Red, Acid Violet, Basic Blue, Basic Violet and Basic Red, or mixtures thereof, for example as described in WO 2005/003274, WO 2005/003275, WO 2005/003276 and EP 1876226 (hereby incorporated by reference).
- the detergent composition preferably comprises from about 0.00003 wt. % to about 0.2 wt. %, from about 0.00008 wt. % to about 0.05 wt. %, or even from about 0.0001 wt. % to about 0.04 wt. % fabric hueing agent.
- the composition may comprise from 0.0001 wt % to 0.2 wt. % fabric hueing agent, this may be especially preferred when the composition is in the form of a unit dose pouch.
- Suitable hueing agents are also disclosed in, e.g., WO 2007/087257 and WO 2007/087243.
- a detergent additive or detergent composition may comprise one or more additional enzymes such as an amylase, an arabinase, a carbohydrase, a cellulase (e.g., endoglucanase), a cutinase, a deoxyribonuclease, a galactanase, a haloperoxygenase, a lipase, a mannanase, an oxidase, e.g., a laccase and/or peroxidase, a pectinase, a pectin lyase, an additional protease, a xylanase, a xanthanase or a xyloglucanase.
- additional enzymes such as an amylase, an arabinase, a carbohydrase, a cellulase (e.g., endoglucanase), a cut
- the properties of the selected enzyme(s) should be compatible with the selected detergent (e.g. pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.).
- Suitable cellulases include mono-component and mixtures of enzymes of bacterial or fungal origin. Chemically modified or protein engineered mutants are also contemplated.
- the cellulase may for example be a mono-component or a mixture of mono-component endo-1 ,4- beta-glucanase also referred to as endoglucanase.
- Suitable cellulases include those from the genera Bacillus, Pseudomonas, Humicola, Myceliophthora, Fusarium, Thielavia, Trichoderma, and Acremonium.
- Exemplary cellulases include a fungal cellulase from Humicola insolens (US 4,435,307) or from Trichoderma, e.g. T. reesei or T. viride.
- Other suitable cellulases are from Thielavia e.g.
- Thielavia terrestris as described in WO 96/29397 or the fungal cellulases produced from Myceliophthora thermophila and Fusarium oxysporum disclosed in US 5,648,263, US 5,691 , 178, US 5,776,757, WO 89/09259 and WO 91/17244.
- cellulases from Bacillus as described in WO 02/099091 and JP 2000210081. Suitable cellulases are alkaline or neutral cellulases having care benefits. Examples of cellulases are described in EP 0 495 257, EP 0 531 372, WO 96/1 1262, WO 96/29397, WO 98/08940.
- cellulase variants such as those described in WO 94/07998, EP 0 531 315, US 5,457,046, US 5,686,593, US 5,763,254, WO 95/24471 , WO 98/12307.
- cellulases are endo-beta-1 ,4-glucanase enzyme having a sequence of at least 97% identity to the amino acid sequence of position 1 to position 773 of SEQ ID NO:2 of WO 2002/099091 or a family 44 xyloglucanase, which a xyloglucanase enzyme having a sequence of at least 60% identity to positions 40-559 of SEQ ID NO: 2 of WO 2001/062903.
- cellulases include Carezyme®, Carezyme® Premium, Celluzyme®, Celluclean®, Celluclast®, Endolase®, Renozyme®; Whitezyme® Celluclean® Classic, Cellusoft® (Novozymes A/S), Puradax®, Puradax HA, and Puradax EG (available from Genencor International Inc.) and KAC-500(B)TM (Kao Corporation).
- Suitable mannanases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included.
- the mannanase may be an alkaline mannanase of Family 5 or 26. It may be a wild-type from Bacillus or Humicola, particularly B. agaradhaerens, B. licheniformis, B. halodurans, B. clausii, or H. insolens.
- Suitable mannanases are described in WO 1999/064619. A commercially available mannanase is Mannaway® (Novozymes A/S).
- the composition may, in addition to the first and second proteases as disclosed herein, comprise one or more additional proteases including those of bacterial, fungal, plant, viral or animal origin.
- protease may be an alkaline protease, such as a serine protease or a metalloprotease.
- a serine protease may for example be of the S1 family, such as trypsin, or the S8 family such as subtilisin.
- a metalloprotease may for example be a thermolysin from, e.g., family M4 or another metalloprotease such as those from M5, M7 or M8 families.
- metalloproteases are the neutral metalloproteases as described in WO 2007/044993 (Genencor Int.) such as those derived from Bacillus amyloliquefaciens.
- Suitable commercially available protease enzymes include those sold under the trade names Alcalase®, Duralase Tm , Durazym Tm , Relase®, Relase® Ultra, Savinase®, Savinase® Ultra, Primase®, Polarzyme®, Kannase®, Liquanase®, Liquanase® Ultra, Ovozyme®, Coronase®, Coronase® Ultra, Blaze®, Blaze Evity® 100T, Blaze Evity® 125T, Blaze Evity® 150T, Neutrase®, Everlase®, Esperase®, Progress® Uno and Progress® Excel (Novozymes A/S), those sold under the tradenames Maxatase®, Maxacal®, Maxapem®, Purafect®TM, Purafect® Ox, Purafect® OxP, Purafect Prime®, Puramax®, FN2®, FN3®, FN4®, Excellase®, Excellenz P
- Suitable lipases and cutinases include those of bacterial or fungal origin. Chemically modified or protein engineered mutant enzymes are included. Examples include lipase from Thermomyces, e.g., from T. lanuginosus (previously named Humicola lanuginosa) as described in EP 258068 and EP 305216, cutinase from Humicola, e.g., H. insolens (WO 96/13580), lipase from strains of Pseudomonas (some of these now renamed to Burkholderia), e.g., P. alcaligenes or P. pseudoalcaligenes (EP 218272), P. cepacia (EP 331376), P.
- Thermomyces e.g., from T. lanuginosus (previously named Humicola lanuginosa) as described in EP 258068 and EP 305216
- cutinase from Humicola e.
- sp. strain SD705 (WO 95/06720 & WO 96/27002), P. wisconsinensis (WO 96/12012), GDSL-type Streptomyces lipases (WO 2010/065455), cutinase from Magnaporthe grisea (WO 2010/107560), cutinase from Pseudomonas mendocina (US 5,389,536), lipase from Thermobifida fusca (WO 2011/084412), Geobacillus stearothermophilus lipase (WO 2011/084417), lipase from Bacillus subtilis (WO 201 1/084599), and lipase from Streptomyces griseus (WO 2011/150157) and S. pristinaespiralis (WO 2012/137147).
- lipase variants such as those described in EP 407225, WO 92/05249, WO 94/01541 , WO 94/25578, WO 95/14783, WO 95/30744, WO 95/35381 , WO 95/22615, WO 96/00292, WO 97/04079, WO 97/07202, WO 00/34450, WO 00/60063, WO 01/92502, WO 2007/87508 and WO 2009/109500.
- Preferred commercial lipase products include LipolaseTM, LipexTM; LipolexTM and LipocleanTM (Novozymes A/S), Lumafast (originally from Genencor) and Lipomax (originally from Gist-Brocades).
- lipases sometimes referred to as acyltransferases or perhydrolases, e.g., acyltransferases with homology to Candida antarctica lipase A (WO 2010/11 1143), acyltransferase from Mycobacterium smegmatis (WO 2005/056782), perhydrolases from the CE 7 family (WO 2009/067279), and variants of the M. smegmatis perhydrolase, in particular the S54V variant used in the commercial product Gentle Power Bleach from Huntsman Textile Effects Pte Ltd (WO 2010/100028).
- Amylases acyltransferases with homology to Candida antarctica lipase A (WO 2010/11 1143), acyltransferase from Mycobacterium smegmatis (WO 2005/056782), perhydrolases from the CE 7 family (WO 2009/067279), and variants of the M. smegmatis perhydrolase, in particular the S
- Suitable amylases which can be used together with the protease may be an alpha- amylase or a glucoamylase and may be of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, alpha-amylases obtained from Bacillus, e.g., a special strain of Bacillus licheniformis, described in more detail in GB 1 ,296,839.
- Suitable amylases include amylases having SEQ ID NO: 2 in WO 95/10603 or variants having 90% sequence identity to SEQ ID NO: 3 thereof. Preferred variants are described in WO 94/02597, WO 94/18314, WO 97/43424 and SEQ ID NO: 4 of WO 99/19467, such as variants with substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 178, 179, 181 , 188, 190, 197, 201 , 202, 207, 208, 209, 211 , 243, 264, 304, 305, 391 , 408, and 444.
- amylases having SEQ ID NO: 6 in WO 02/10355 or variants thereof having 90% sequence identity to SEQ ID NO: 6.
- Preferred variants of SEQ ID NO: 6 are those having a deletion in positions 181 and 182 and a substitution in position 193.
- amylases which are suitable are hybrid alpha-amylases comprising residues 1-33 of the alpha-amylase derived from B. amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006/066594 and residues 36-483 of the B. licheniformis alpha-amylase shown in SEQ ID NO: 4 of WO 2006/066594 or variants having 90% sequence identity thereof.
- Preferred variants of this hybrid alpha-amylase are those having a substitution, a deletion or an insertion in one of more of the following positions: G48, T49, G107, H156, A181 , N 190, M197, 1201 , A209 and Q264.
- hybrid alpha-amylase comprising residues 1-33 of the alpha-amylase derived from B. amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006/066594 and residues 36- 483 of SEQ ID NO: 4 are those having the substitutions:
- amylases having the sequence of SEQ ID NO: 6 in WO 99/19467 or variants thereof having 90% sequence identity to SEQ ID NO: 6.
- Preferred variants of SEQ ID NO: 6 are those having a substitution, a deletion or an insertion in one or more of the following positions: R181 , G182, H183, G184, N195, I206, E212, E216 and K269.
- Particularly preferred amylases are those having deletion in positions R181 and G182, or positions H183 and G184.
- Additional amylases which can be used are those having SEQ ID NO: 1 , SEQ ID NO: 3, SEQ ID NO: 2 or SEQ ID NO: 7 of WO 96/23873 or variants thereof having 90% sequence identity to SEQ ID NO: 1 , SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 7.
- Preferred variants of SEQ ID NO: 1 , SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 7 are those having a substitution, a deletion or an insertion in one or more of the following positions: 140, 181 , 182, 183, 184, 195, 206, 212, 243, 260, 269, 304 and 476, using SEQ ID 2 of WO 96/23873 for numbering. More preferred variants are those having a deletion in two positions selected from 181 , 182, 183 and 184, such as 181 and 182, 182 and 183, or positions 183 and 184.
- Most preferred amylase variants of SEQ ID NO: 1 , SEQ ID NO: 2 or SEQ ID NO: 7 are those having a deletion in positions 183 and 184 and a substitution in one or more of positions 140, 195, 206, 243, 260, 304 and 476.
- amylases which can be used are amylases having SEQ ID NO: 2 of WO 2008/153815, SEQ ID NO: 10 in WO 01/66712 or variants thereof having 90% sequence identity to SEQ ID NO: 2 of WO 2008/153815 or 90% sequence identity to SEQ ID NO: 10 in WO 01/66712.
- Preferred variants of SEQ ID NO: 10 in WO 01/66712 are those having a substitution, a deletion or an insertion in one of more of the following positions: 176, 177, 178, 179, 190, 201 , 207, 21 1 and 264.
- amylases having SEQ ID NO: 2 of WO 2009/061380 or variants having 90% sequence identity to SEQ ID NO: 2 thereof.
- Preferred variants of SEQ ID NO: 2 are those having a truncation of the C-terminus and/or a substitution, a deletion or an insertion in one of more of the following positions: Q87, Q98, S125, N128, T131 , T165, K178, R180, S181 , T182, G183, M201 , F202, N225, S243, N272, N282, Y305, R309, D319, Q320, Q359, K444 and G475.
- More preferred variants of SEQ ID NO: 2 are those having the substitution in one of more of the following positions: Q87E,R, Q98R, S125A, N128C, T131 I, T165I, K178L, T182G, M201 L, F202Y, N225E.R, N272E.R, S243Q,A,E,D, Y305R, R309A, Q320R, Q359E, K444E and G475K and/or deletion in position R180 and/or S181 or of T182 and/or G183.
- Most preferred amylase variants of SEQ ID NO: 2 are those having the substitutions:
- variants are C-terminally truncated and optionally further comprise a substitution at position 243 and/or a deletion at position 180 and/or position 181.
- amylases having SEQ ID NO: 1 of WO 2013/184577 or variants having 90% sequence identity to SEQ ID NO: 1 thereof.
- Preferred variants of SEQ ID NO: 1 are those having a substitution, a deletion or an insertion in one of more of the following positions: K176, R178, G179, T180, G181 , E187, N192, M199, I203, S241 , R458, T459, D460, G476 and G477.
- SEQ ID NO: 1 More preferred variants of SEQ ID NO: 1 are those having the substitution in one of more of the following positions: K176L, E187P, N192FYH, M199L, I203YF, S241QADN, R458N, T459S, D460T, G476K and G477K and/or a deletion in position R178 and/or S179 or of T180 and/or G181.
- Most preferred amylase variants of SEQ ID NO: 1 comprise the substitutions:
- amylases having SEQ ID NO: 1 of WO 2010/104675 or variants having 90% sequence identity to SEQ ID NO: 1 thereof.
- Preferred variants of SEQ ID NO: 1 are those having a substitution, a deletion or an insertion in one of more of the following positions: N21 , D97, V128 K177, R179, S180, 1181 , G182, M200, L204, E242, G477 and G478.
- More preferred variants of SEQ ID NO: 1 are those having the substitution in one of more of the following positions: N21 D, D97N, V128I K177L, M200L, L204YF, E242QA, G477K and G478K and/or a deletion in position R179 and/or S180 or of 1181 and/or G182.
- Most preferred amylase variants of SEQ ID NO: 1 comprise the substitutions N21 D+D97N+V128I, and optionally further comprise a substitution at position 200 and/or a deletion at position 180 and/or position 181.
- amylases are the alpha-amylase having SEQ ID NO: 12 in WO 01/66712 or a variant having at least 90% sequence identity to SEQ ID NO: 12.
- Preferred amylase variants are those having a substitution, a deletion or an insertion in one of more of the following positions of SEQ ID NO: 12 in WO 01/66712: R28, R118, N 174; R181 , G182, D183, G184, G186, W189, N195, M202, Y298, N299, K302, S303, N306, R310, N314; R320, H324, E345, Y396, R400, W439, R444, N445, K446, Q449, R458, N471 , N484.
- amylases include variants having a deletion of D183 and G184 and having the substitutions R1 18K, N195F, R320K and R458K, and a variant additionally having substitutions in one or more position selected from the group: M9, G149, G182, G186, M202, T257, Y295, N299, M323, E345 and A339, most preferred a variant that additionally has substitutions in all these positions.
- amylase variants such as those described in WO 201 1/098531 , WO 2013/001078 and WO 2013/001087.
- Commercially available amylases include DuramylTM, TermamylTM, FungamylTM, StainzymeTM, Stainzyme PlusTM, NatalaseTM, Liquozyme X, BANTM, Amplify® and Amplify® Prime (from Novozymes A/S), and RapidaseTM, PurastarTM/EffectenzTM, Powerase, Preferenz S1000, Preferenz S100 and Preferenz S110 (from Genencor International Inc./DuPont).
- One preferred amylase is a variant of the amylase having SEQ ID NO: 13 in WO 2016/180748 with the alterations H1*+N54S+ V56T+ K72R+G109A+ F113Q+ R1 16Q+ W167F+ Q172G+ A174S+ G182*+D183*+ G184T+ N195F+ V206L+ K391A+ P473R+ G476K.
- Another preferred amylase is a variant of the amylase having SEQ ID NO: 1 in WO 2013/001078 with the alterations D183 * +G184 * +W140Y+N195F+V206Y+Y243F+E260G+ G304R+G476K.
- Another preferred amylase is a variant of the amylase having SEQ ID NO: 1 in WO 2018/141707 with the alterations H1*+G7A+G109A+W140Y+G182*+D183*+N195F+V206Y+ Y243F+E260G+N280S+G304R+E391A+G476K.
- a further preferred amylase is a variant of the amylase having SEQ ID NO: 1 in WO 2017/191160 with the alterations L202M + T246V.
- Suitable peroxidases/oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g., from C. cinereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257.
- peroxidases include GuardzymeTM (Novozymes A/S).
- DNases Deoxyribonucleases
- Suitable deoxyribonucleases are any enzyme that catalyzes the hydrolytic cleavage of phosphodiester linkages in the DNA backbone, thus degrading DNA.
- Bacterial DNases are preferred, in particular a DNase which is obtainable from a species of Bacillus is preferred, in particular a DNase which is obtainable from Bacillus subtilis or Bacillus licheniformis. Examples of such DNases are described in WO 201 1/098579 and WO 2014/087011.
- any detergent components known in the art for use in laundry detergents may also be utilized.
- Other optional detergent components include anti-corrosion agents, anti-shrink agents, anti-soil redeposition agents, anti-wrinkling agents, bactericides, binders, corrosion inhibitors, disintegrants/disintegration agents, dyes, enzyme stabilizers (including boric acid, borates, CMC, and/or polyols such as propylene glycol), fabric conditioners including clays, fillers/processing aids, fluorescent whitening agents/optical brighteners, foam boosters, foam (suds) regulators, perfumes, soil-suspending agents, softeners, suds suppressors, tarnish inhibitors, and wicking agents, either alone or in combination.
- Any ingredient known in the art for use in laundry detergents may be utilized. The choice of such ingredients is well within the skill of the artisan.
- the detergent compositions of the present invention can also contain dispersants.
- powdered detergents may comprise dispersants.
- Suitable water-soluble organic materials include the homo- or co-polymeric acids or their salts, in which the polycarboxyl ic acid comprises at least two carboxyl radicals separated from each other by not more than two carbon atoms.
- Suitable dispersants are for example described in Powdered Detergents, Surfactant Science Series, volume 71 , Marcel Dekker, Inc., 1997.
- the detergent compositions of the present invention may also include one or more dye transfer inhibiting agents.
- Suitable polymeric dye transfer inhibiting agents include, but are not limited to, polyvinylpyrrolidone polymers, polyamine N-oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof.
- the dye transfer inhibiting agents may be present at levels from about 0.0001 % to about 10%, from about 0.01 % to about 5% or even from about 0.1 % to about 3% by weight of the composition.
- Fluorescent whitening agent The detergent compositions of the present invention will preferably also contain additional components that may tint articles being cleaned, such as fluorescent whitening agent or optical brighteners. Where present the brightener is preferably at a level of about 0.01 % to about 05%. Any fluorescent whitening agent suitable for use in a laundry detergent composition may be used in the composition of the present invention. The most commonly used fluorescent whitening agents are those belonging to the classes of diaminostilbene-sulphonic acid derivatives, diarylpyrazoline derivatives and bisphenyl-distyryl derivatives.
- diaminostilbene-sulphonic acid derivative type of fluorescent whitening agents include the sodium salts of: 4,4'-bis-(2-diethanolamino-4-anilino-s-triazin-6- ylamino) stilbene-2,2'-disulphonate; 4,4'-bis-(2,4-dianilino-s-triazin-6-ylamino) stilbene-2.2'- disulphonate; 4,4'-bis-(2-anilino-4(N-methyl-N-2-hydroxy-ethylamino)-s-triazin-6-ylamino) stilbene-2,2'-disulphonate, 4,4'-bis-(4-phenyl-2, 1 ,3-triazol-2-yl)stilbene-2,2'-disulphonate; 4,4'- bis-(2-anilino-4(1-methyl-2-hydroxy-ethylamino)-s-triazin-6-ylamino) stilbene-2,2'-d
- Preferred fluorescent whitening agents are Tinopal DMS and Tinopal CBS available from Ciba-Geigy AG, Basel, Switzerland.
- Tinopal DMS is the disodium salt of 4,4'-bis-(2-morpholino-4 anilino-s-triazin-6-ylamino) stilbene disulphonate.
- Tinopal CBS is the disodium salt of 2,2'-bis-(phenyl-styryl) disulphonate.
- fluorescent whitening agents is the commercially available Parawhite KX, supplied by Paramount Minerals and Chemicals, Mumbai, India.
- Other fluorescers suitable for use in the invention include the 1-3-diaryl pyrazolines and the 7-alkylaminocoumarins.
- Suitable fluorescent brightener levels include lower levels of from about 0.01 , from 0.05, from about 0.1 or even from about 0.2 wt. % to upper levels of 0.5 or even 0.75 wt. %.
- the detergent compositions of the present invention may also include one or more soil release polymers which aid the removal of soils from fabrics such as cotton and polyester based fabrics, in particular the removal of hydrophobic soils from polyester based fabrics.
- the soil release polymers may for example be nonionic or anionic terephthalte based polymers, polyvinyl caprolactam and related copolymers, vinyl graft copolymers, polyester polyamides see for example Chapter 7 in Powdered Detergents, Surfactant science series volume 71 , Marcel Dekker, Inc.
- Another type of soil release polymers are amphiphilic alkoxylated grease cleaning polymers comprising a core structure and a plurality of alkoxylate groups attached to that core structure.
- the core structure may comprise a polyalkylenimine structure or a polyalkanolamine structure as described in detail in WO 2009/087523 (hereby incorporated by reference).
- random graft co-polymers are suitable soil release polymers Suitable graft co-polymers are described in more detail in WO 2007/138054, WO 2006/108856 and WO 2006/113314 (hereby incorporated by reference).
- Other soil release polymers are substituted polysaccharide structures especially substituted cellulosic structures such as modified cellulose deriviatives such as those described in EP 1867808 or WO 03/040279 (both are hereby incorporated by reference).
- Suitable cellulosic polymers include cellulose, cellulose ethers, cellulose esters, cellulose amides and mixtures thereof. Suitable cellulosic polymers include anionically modified cellulose, nonionically modified cellulose, cationically modified cellulose, zwitterionically modified cellulose, and mixtures thereof. Suitable cellulosic polymers include methyl cellulose, carboxy methyl cellulose, ethyl cellulose, hydroxyl ethyl cellulose, hydroxyl propyl methyl cellulose, ester carboxy methyl cellulose, and mixtures thereof.
- the detergent compositions of the present invention may also include one or more anti-redeposition agents such as carboxymethylcellulose (CMC), polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), polyoxyethylene and/or polyethyleneglycol (PEG), homopolymers of acrylic acid, copolymers of acrylic acid and maleic acid, and ethoxylated polyethyleneimines.
- CMC carboxymethylcellulose
- PVA polyvinyl alcohol
- PVP polyvinylpyrrolidone
- PEG polyethyleneglycol
- homopolymers of acrylic acid copolymers of acrylic acid and maleic acid
- the cellulose based polymers described under soil release polymers above may also function as anti-redeposition agents.
- adjunct materials include, but are not limited to, anti-shrink agents, anti wrinkling agents, bactericides, binders, carriers, dyes, enzyme stabilizers, fabric softeners, fillers, foam regulators, hydrotropes, perfumes, pigments, sod suppressors, solvents, and structurants for liquid detergents and/or structure elasticizing agents.
- the detergent enzymes i.e. the first and second proteases and optionally one or more additional enzymes, may be included in a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising these enzymes.
- the detergent composition may, e.g., be in the form of a powder, a granulate, a tablet, a pouch, a paste, a gel or a liquid.
- Pouches can be configured as single or multiple compartments and can be of any form, shape and material suitable to hold the composition, without allowing the release of the composition from the pouch prior to water contact.
- the pouch is made from water soluble film which encloses an inner volume.
- the inner volume can be divided into compartments of the pouch.
- Preferred films are polymeric materials, preferably polymers which are formed into a film or sheet.
- Preferred polymers, copolymers or derivates thereof are selected from polyacrylates, and water-soluble acrylate copolymers, methyl cellulose, carboxy methyl cellulose, sodium dextrin, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, maltodextrin, polymethacrylates, most preferably polyvinyl alcohol copolymers and hydroxypropyl methyl cellulose (HPMC).
- the level of polymer in the film for example PVA is at least about 60%.
- the preferred average molecular weight will typically be about 20,000 to about 150,000.
- Films can also be of blend compositions comprising hydrolytically degradable and water-soluble polymer blends such as polylactide and polyvinyl alcohol (known under the Trade reference M8630 as sold by Chris Craft In. Prod of Gary, Indiana, US) plus plasticizers like glycerol, ethylene glycerol, propylene glycol, sorbitol and mixtures thereof.
- the pouches can for example comprise a solid laundry detergent composition or part components and/or a liquid cleaning composition or part components separated by the water-soluble film.
- the compartment for liquid components can be different in composition than compartments containing solids. See, e.g., US 2009/001 1970.
- Detergent ingredients can be separated physically from each other by compartments in water dissolvable pouches or in different layers of tablet, thereby avoiding negative storage interaction between components. Different dissolution profiles of each of the compartments can also give rise to delayed dissolution of selected components in the wash solution.
- a liquid or gel detergent which is not unit dosed may be aqueous, typically containing at least 20% by weight and up to 95% water, such as up to about 70% water, up to about 65% water, up to about 55% water, up to about 45% water, up to about 35% water.
- Other types of liquids including without limitation, alkanols, amines, diols, ethers and polyols may be included in an aqueous liquid or gel.
- An aqueous liquid or gel detergent may contain from 0-30% organic solvent.
- a liquid or gel detergent may also be non-aqueous.
- Enzymes in the form of granules comprising an enzyme-containing core and optionally one or more coatings, are commonly used in granular (powder) detergents.
- Various methods for preparing the core are well-known in the art and include, for example, a) spray drying of a liquid enzyme-containing solution, b) production of layered products with an enzyme coated as a layer around a pre-formed inert core particle, e.g.
- a fluid bed apparatus c) absorbing an enzyme onto and/or into the surface of a pre-formed core, d) extrusion of an enzyme-containing paste, e) suspending an enzyme-containing powder in molten wax and atomization to result in prilled products, f) mixer granulation by adding an enzyme-containing liquid to a dry powder composition of granulation components, g) size reduction of enzyme-containing cores by milling or crushing of larger particles, pellets, etc., and h) fluid bed granulation.
- the enzyme-containing cores may be dried, e.g. using a fluid bed drier or other known methods for drying granules in the feed or enzyme industry, to result in a water content of typically 0.1 -10% w/w water.
- the enzyme-containing cores are optionally provided with a coating to improve storage stability and/or to reduce dust formation.
- a coating typically an inorganic salt coating, which may e.g. be applied as a solution of the salt using a fluid bed.
- Other coating materials that may be used are, for example, polyethylene glycol (PEG), methyl hydroxy-propyl cellulose (MHPC) and polyvinyl alcohol (PVA).
- PEG polyethylene glycol
- MHPC methyl hydroxy-propyl cellulose
- PVA polyvinyl alcohol
- the granules may contain more than one coating, for example a salt coating followed by an additional coating of a material such as PEG, MHPC or PVA.
- the enzyme of the invention may be formulated as a granule for example as a co-granule that combines one or more enzymes. Each enzyme will then be present in more granules securing a more uniform distribution of enzymes in the detergent. This also reduces the physical segregation of different enzymes due to different particle sizes.
- Methods for producing multi enzyme co-granulates for the detergent industry are disclosed in the IP.com disclosure I PCOM000200739D.
- WO 2013/188331 Another example of formulation of enzymes by the use of co-granulates are disclosed in WO 2013/188331 , which relates to a detergent composition comprising (a) a multi-enzyme co granule; (b) less than 10 wt% zeolite (anhydrous basis); and (c) less than 10 wt% phosphate salt (anhydrous basis), wherein said enzyme co-granule comprises from 10 to 98 wt% moisture sink components and the composition additionally comprises from 20 to 80 wt% detergent moisture sink components.
- WO 2013/188331 also relates to a method of treating and/or cleaning a surface, preferably a fabric surface comprising the steps of (i) contacting said surface with the detergent composition as claimed and described herein in an aqueous wash liquor, (ii) rinsing and/or drying the surface.
- the multi-enzyme co-granule may comprise an enzyme of the invention and (a) one or more enzymes selected from the group consisting of first- wash lipases, cleaning cellulases, xyloglucanases, perhydrolases, peroxidases, lipoxygenases, laccases and mixtures thereof; and (b) one or more enzymes selected from the group consisting of hemicellulases, proteases, care cellulases, cellobiose dehydrogenases, xylanases, phospho lipases, esterases, cutinases, pectinases, mannanases, pectate lyases, keratinases, reductases, oxidases, phenoloxidases, ligninases, pullulanases, tannases, pentosanases, lichenases glucanases, arabinosidases, hyaluronidase, chondroitinase, amy
- the polypeptides of the invention may be added to laundry soap bars and used for hand washing laundry, fabrics and/or textiles.
- laundry soap bar includes laundry bars, soap bars, combo bars, syndet bars and detergent bars.
- the types of bar usually differ in the type of surfactant they contain, and the term laundry soap bar includes those containing soaps from fatty acids and/or synthetic soaps.
- the laundry soap bar has a physical form which is solid and not a liquid, gel or a powder at room temperature.
- the term solid is defined as a physical form which does not significantly change over time, i.e. if a solid object (e.g. laundry soap bar) is placed inside a container, the solid object does not change to fill the container it is placed in.
- the bar is a solid typically in bar form but can be in other solid shapes such as round or oval.
- Bar soaps for hand laundry may be in the form of either“soap bars” (oil-based) or“non soap detergent” (NSD) bars.
- non-soap detergent bars are characterized by a lack of fatty acid soap ingredients from plant or animal sources, and instead are based on synthetic detergents such as LAS (linear alkylbenzene sulfonate).
- Laundry bars comprising the first and second protease of the invention may be produced by methods conventionally known and used to produce soap bars and using conventional laundry bar making equipment such as but not limited to: mixers, plodders, e.g. a two-stage vacuum plodder, extruders, roll mills, cutters, logo-stampers, cooling tunnels and wrappers.
- plodders e.g. a two-stage vacuum plodder, extruders, roll mills, cutters, logo-stampers, cooling tunnels and wrappers.
- the present invention is also directed to methods for using the detergent compositions in laundering of textiles and fabrics, including household laundry and industrial laundry applications.
- the invention also relates to use of a composition of the present in a cleaning process, such as laundry or hard surface cleaning such as dishwashing.
- the compositions of the invention are designed for and used in laundry applications.
- the composition may be in the form of a liquid laundry formulation.
- a detergent composition of the present invention may be formulated, for example, as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations.
- the cleaning process or the textile care process may for example be a laundry process, a dishwashing process or cleaning of hard surfaces such as bathroom tiles, floors, table tops, drains, sinks and washbasins.
- Laundry processes can for example be household laundering, but may also be industrial laundering.
- the invention relates to a process for laundering of fabrics and/or garments, where the process comprises treating fabrics with a washing solution containing a detergent composition of the invention.
- the cleaning process or a textile care process can for example be carried out in a machine washing or manually.
- the washing solution can for example be an aqueous washing solution containing a detergent composition.
- the invention further concerns the use of the detergent compositions in a proteinaceous stain removing process.
- the proteinaceous stains may be stains such as food stains, e.g., baby food, cocoa, egg or milk, or other stains such as sebum, blood, ink or grass, or a combination hereof.
- This aspect further relates to a method of cleaning, especially for cleaning fabrics or textiles, or for dishwashing, comprising contacting fabrics/textiles or dishes with the detergent composition of this aspect under conditions suitable for cleaning the fabrics/textiles or dishes.
- the first and second proteases in the composition according to this aspect, and for use thereof and a method of cleaning, may be any of the proteases described herein.
- the present invention provides a method of cleaning, especially for cleaning fabrics or textiles, i.e. laundry, or for dishwashing, with a detergent composition of the invention comprising a first protease and a second protease.
- the method of cleaning comprises contacting an object with a detergent composition comprising the first and second protease under conditions suitable for cleaning the object.
- a detergent composition comprising the first and second protease under conditions suitable for cleaning the object.
- the detergent composition is used in a laundry process.
- Another embodiment relates to a method for removing stains from fabrics or textiles, which comprises contacting the fabric or textile with a composition of the invention under conditions suitable for cleaning the object.
- Another embodiment relates to a method for removing stains from dishware, which comprises contacting the dishware with a composition of the invention under conditions suitable for cleaning the object.
- compositions may be employed at concentrations from about 100 ppm, preferably 500 ppm to about 15,000 ppm in solution.
- the water temperatures typically range from about 5°C to about 95°C, including about 10°C, about 15°C, about 20°C, about 25°C, about 30°C, about 35°C, about 40°C, about 45°C, about 50°C, about 55°C, about 60°C, about 65°C, about 70°C, about 75°C, about 80°C, about 85°C and about 90°C.
- the water to fabric ratio is typically from about 1 : 1 to about 30: 1.
- the composition may be formulated as described in, e.g., WO 92/19709, WO 92/19708 and US 6,472,364.
- the enzymes employed herein are stabilized by the presence of water-soluble sources of zinc (II), calcium (II) and/or magnesium (II) ions in the finished compositions that provide such ions to the enzymes, as well as other metal ions (e.g., barium (II), scandium (II), iron (II), manganese (II), aluminum (III), Tin (II), cobalt (II), copper (II), Nickel (II), and oxovanadium (IV)).
- barium (II), scandium (II), iron (II), manganese (II), aluminum (III), Tin (II), cobalt (II), copper (II), Nickel (II), and oxovanadium (IV) e.g., barium (II), scandium (II), iron (II),
- the first and second protease may be produced by standard methods that are well-known in the art, using cultivation of host cells cultivated in a suitable nutrient medium
- the host cell may be any cell useful in recombinant enzyme production, e.g., a prokaryote or a eukaryote.
- the prokaryotic host cell will typically be a Gram-positive or Gram-negative bacterium, such as a Gram-positive bacterium selected from Bacillus, Clostridium, Enterococcus, Geobacillus, Lactobacillus, Lactococcus, Oceanobacillus, Staphylococcus, Streptococcus and Streptomyces, or a Gram-negative bacterium selected from Campylobacter, E. coli, Flavobacterium, Fusobacterium, Helicobacter, llyobacter, Neisseria, Pseudomonas, Salmonella and Ureaplasma.
- a Gram-positive bacterium selected from Bacillus, Clostridium, Enterococcus, Geobacillus, Lactobacillus, Lactococcus, Oceanobacillus, Staphylococcus, Streptococcus and Streptomyces
- a Gram-negative bacterium selected from Campylobacter, E. coli, Flavobacterium,
- the bacterial host cell may e.g. be a Bacillus cell selected from Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus firmus, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus pumilus, Bacillus stearothermophilus, Bacillus subtilis and Bacillus thuringiensis cells.
- Host cells may, for example, be cultivated by shake flask cultivation, or small-scale or large-scale fermentation (including continuous, batch, fed-batch, or solid-state fermentations) in laboratory or industrial fermentors performed in a suitable medium and under conditions allowing the variant to be expressed and/or isolated.
- the cultivation takes place in a suitable nutrient medium comprising carbon and nitrogen sources and inorganic salts, using procedures known in the art.
- suitable media are available from commercial suppliers or may be prepared according to published compositions (e.g., in catalogues of the American Type Culture Collection). If the variant is secreted into the nutrient medium, the variant can be recovered directly from the medium. If the variant is not secreted, it can be recovered from cell lysates.
- the variant may be detected using methods known in the art that are specific for the variants with protease activity, and may be recovered and purified using methods known in the art. See e.g. WO 2017/207762 for further information.
- the present invention is further described by the following examples that should not be construed as limiting the scope of the invention.
- B. subtilis constructs encoding subtilase polypeptides were inoculated into and cultivated in a complex medium (TBgly) for 24h at 37°C.
- Shake flasks containing a rich media PS-1 : 100 g/L Sucrose (Danisco cat.no. 109-0429), 40 g/L crust soy (soy bean flour), 10g/L Na 2 HPC> 4 .12H 2 0 (Merck cat.no. 106579), 0.1 ml/L Dowfax63N10 (Dow) were inoculated in a ratio of 1 :100 with the overnight culture.
- Shake flask cultivation was performed for 4 days at 30°C shaking at 270 rpm.
- the culture broth is centrifuged at 26000 x g for 20 minutes and the supernatant is carefully decanted from the precipitate.
- the supernatant is filtered through a Nalgene 0.2 pm filtration unit in order to remove the remains of the host cells.
- the pH in the 0.2 pm filtrate is adjusted to pH 8 with 3 M Tris base and the pH-adjusted filtrate is applied to a MEP Hypercel column (Pall Corporation) equilibrated in 20 mM Tris/HCI, 1 mM CaCh, pH 8.0. After washing the column with the equilibration buffer, the column is step-eluted with 20 mM CHsCOOH/NaOH, 1 mM CaCh, pH 4.5.
- Fractions from the column are analyzed for protease activity using the Suc-AAPF-pNA assay at pH 9 and peak fractions are pooled.
- the pH of the pool from the MEP Hypercel column is adjusted to pH 6 with 20% (v/v) CH 3 COOH or 3 M Tris base and the pH-adjusted pool is diluted with deionized water to the same conductivity as 20 mM MES/NaOH, 2 mM CaCh, pH 6.0.
- the diluted pool is applied to an SP-Sepharose® Fast Flow column (GE Healthcare) equilibrated in 20 mM MES/NaOH, 2 mM CaCh, pH 6.0.
- the protease variant After washing the column with the equilibration buffer, the protease variant is eluted with a linear NaCI gradient (0 0.5 M) in the same buffer over five column volumes. Fractions from the column are analyzed for protease activity using the Suc- AAPF- pNA assay at pH 9 and active fractions are analyzed by SDS-PAGE. Fractions in which only one band is observed on the Coomassie stained SDS-PAGE gel are pooled as the purified preparation and used for further experiments.
- the performance of the enzyme variants and blends thereof was in this example measured as the brightness of the colour of textile samples washed with a specific protease or a protease blend.
- the brightness can be expressed as the intensity of the light reflected from the textile sample when illuminated with white light.
- the intensity of the reflected light is lower than that of a clean textile. Therefore, the intensity of the reflected light can be used to measure wash performance of the proteases and the protease blends.
- a specially designed software application is used ( Novozymes Color Vector Analyzer).
- the program retrieves the values from the image and converts them into values for red, green and blue (RGB).
- the intensity value (Int) is calculated by adding the RGB values together as vectors and then taking the length of the resulting vector:
- Standard textile pieces were obtained from Center for Testmaterials BV, P.O. Box 120, 3133 KT Vlaardingen, The Netherlands.
- the detergent for the wash performance tests was a liquid laundry model detergent.
- the composition of the detergent as well as other test parameters are given in the table below.
- Table 2 outlines the proteases that were tested. These were SEQ ID NO: 1 and variants thereof, with position numbers based on the numbering of SEQ ID NO: 2, and with the net formal charge relative to SEQ ID NO: 1 indicated.
- a delta intensity value was calculated for the single enzymes and the 1 :1 mixtures as the intensity value (Int) of a test material washed with the detergent containing a single enzyme or mixture minus the intensity value of a test material washed with the detergent alone, i.e. without any enzyme.
- the delta intensity values for each of the four enzyme concentrations were added together for each treatment (single enzyme or 1 :1 mixture) to obtain a sum of delta intensity for each treatment for each of the two stains PC-10 and PC-03.
- Table 5 Relative performance of charge mixtures with SEQ ID NO: 1 against single enzymes (a) (b) (c)
- Table 12 Relative performance of charge mixtures with variant G97D N117R Y209W A215K against variant G97D N117R Y209W A215K alone
- the mixture has resulted in a poorer performance on PC-03, but this has been outweighed by improved wash performance on PC-10, so that the overall performance of the mixtures on PC-03 + PC-10 is still better than that of the single enzymes.
- Table 15 the mixtures are compared to the single enzymes (enzymes (a), (b), (c) listed in the column“Variant / single enzyme”), while Table 16 compares the mixtures to the N76D G97D N140D S156D Y209W A215K L262E variant alone.
- Table 15 Relative performance of charge mixtures with N76D G97D N140D S156D Y209W A215K L262E against single enzymes (a), (b), (c)
- Table 21 Relative performance of variants of SEQ ID NO: 1 compared to SEQ ID NO: 1
- Table 22 Relative performance of variants of SEQ ID NO: 1 compared to SEQ ID NO: 1 +
- Table 22 shows that all of the tested variants exhibited improved wash performance over the reference protease SEQ ID NO: 1 + S99D+S101 E+S103A+V104I+G160S, which in itself exhibits good cleaning performance.
- the tested variants had at least on-par performance, and in most cases improved performance over the reference protease, while on the PC-10 stain all of the tested variants had improved performance over the reference protease.
- the PC-10 stain mimics natural sebum stains, thus providing a good indication of how an enzymatic detergent composition will perform on this difficult to remove natural stain.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Enzymes And Modification Thereof (AREA)
- Detergent Compositions (AREA)
Abstract
The invention relates to detergent compositions comprising a first protease and a second protease having different net charge characteristics as well as novel protease variants.
Description
DETERGENT COMPOSITIONS COMPRISING TWO PROTEASES
Reference to a Sequence Listing
This application contains a sequence listing in computer readable form, which is incorporated herein by reference.
FIELD OF THE INVENTION
The present invention relates to detergent compositions comprising at least a first protease and a second protease with different net charge characteristics that together provide improved cleaning performance compared to individual enzymes, use of the compositions in a cleaning process, in particular for laundry, and novel protease variants.
BACKGROUND OF THE INVENTION
Subtilisins are serine proteases from the family S8, in particular from the subfamily S8A, as defined by the MEROPS database (https://www.ebi.ac.uk/merops/index.shtml). In subfamily S8A the key active site residues Asp, His and Ser are typically found in motifs that differ from those of the S8B subfamily.
In the detergent industry, enzymes have for many decades been implemented in detergent compositions for use in laundry or in hard surface cleaning such as dishwashing. Enzymes used in such compositions comprise proteases, lipases, amylases, cellulases, mannosidases as well as other enzymes or mixtures thereof. Commercially, the most important enzymes are proteases.
It is known that different protease enzymes may perform differently on different types of stains. There have been attempts to address this and improve wash performance by including two different proteases in a single detergent composition. Such compositions are disclosed in e.g. WO 2009/021867, WO 2014/177430, WO 2016/000970 and WO 2016/000971.
However, while some such compositions comprising two different proteases are disclosed in the patent literature, in practice, detergent compositions comprising two different proteases have not been met with any widespread commercial success.
Further, the relatively few compositions comprising two proteases that are described in the patent literature are disclosed in the context of automatic dishwashing. In contrast, there has not been a focus on developing detergent compositions with two different proteases adapted to the conditions and requirements found in laundry.
Thus, given that individual protease enzymes used in currently available detergent compositions are not able to effectively remove all relevant protein-based stains in any given setting, especially in laundry settings, there remains a need for detergent compositions with improved protein stain-removal properties.
The present invention addresses this need by providing detergent compositions comprising at least two different protease enzymes with different net formal charge characteristics, where the combination of the two proteases results in an improved wash performance on individual stains and/or covers a broader set of stains compared to the individual enzymes. It is contemplated that the compositions of the invention will be particularly useful as laundry detergent compositions, and especially in liquid laundry detergent compositions.
SUMMARY OF THE INVENTION
The present invention relates to a detergent composition comprising at least a first protease and a second protease having different net charge characteristics.
In one embodiment, the invention relates to a detergent composition comprising a first protease and a second protease, where
1) the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1 ; or
2) the first protease has a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -1 , 0 or +1 relative to the protease of SEQ ID NO: 1.
In other embodiments, the detergent composition may comprise a first and second protease where: the first protease has a net formal charge of 0, 1 , 2, 3, 4 or -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +5, +4, +3, +2, +1 , 0 or -1 relative to the protease of SEQ ID NO: 1 ; the first protease has a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1 ; or the first protease has a net formal charge of 0, -1 or -2 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2, +3, +4 or +5 relative to the protease of SEQ ID NO: 1.
The invention also relates to use of the compositions disclosed herein in a cleaning process, e.g. for laundry or hard-surface cleaning such as dishwashing, in particular for laundry, and to a method of cleaning using the compositions.
In another aspect, the invention relates to novel protease variants with advantageous properties, e.g. improved wash performance when such proteases are used either alone as a single protease or in detergent compositions with another protease, where the proteases are variants of SEQ ID NO: 1 comprising substitutions in positions 97, 209 and 215.
Overview of sequences
SEQ ID NO: 1 is the sequence of the Savinase® protease polypeptide from Bacillus lentus.
SEQ ID NO: 2 is the sequence of the BPN’ protease polypeptide from Bacillus amyloliquefaciens.
Brief Description of the Figures
Figure 1 is an alignment of the amino acid sequences of subtilisin 309 (SEQ ID NO: 1) and subtilisin BPN’ (SEQ ID NO: 2).
DEFINITIONS
Subtilase/protease: The terms“subtilase” and“protease” may be used interchangeably herein and refer to an enzyme that hydrolyses peptide bonds in proteins. This includes any enzyme belonging to the EC 3.4 enzyme group (including each of the thirteen subclasses thereof), and in particular endopeptidases (EC 3.4.21). The EC number refers to Enzyme Nomenclature 1992 from NC-IUBMB, Academic Press, San Diego, California, including supplements 1-5 published in Eur. J. Biochem. 1994, 223, 1-5; Eur. J. Biochem. 1995, 232, 1-6; Eur. J. Biochem. 1996, 237, 1-5; Eur. J. Biochem. 1997, 250, 1-6; and Eur. J. Biochem. 1999, 264, 610-650; respectively.
Protease activity: The term“protease activity” means a proteolytic activity (EC 3.4), in particular endopeptidase activity (EC 3.4.21). There are several protease activity types, the three main activity types being: trypsin-like, where there is cleavage of amide substrates following Arg or Lys at P1 , chymotrypsin-like, where cleavage occurs following one of the hydrophobic amino acids at P1 , and elastase-like with cleavage following an Ala at P1. Protease activity may be determined according to the procedure described in WO 2016/087619.
Sequence identity: The relatedness between two amino acid sequences or between two nucleotide sequences is described by the parameter“sequence identity”.
For purposes of the present invention, the sequence identity between two amino acid sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet. 16: 276-277), preferably version 5.0.0 or later. The parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix. The output of Needle labeled“longest identity” (obtained using the -nobrief option) is used as the percent identity and is calculated as follows:
(Identical Residues x 100)/(Length of Alignment - Total Number of Gaps in Alignment)
For purposes of the present invention, the sequence identity between two deoxyribonucleotide sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, supra) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, supra), preferably version 5.0.0 or later. The parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EDNAFULL (EMBOSS version of NCBI NUC4.4) substitution
matrix. The output of Needle labeled“longest identity” (obtained using the -nobrief option) is used as the percent identity and is calculated as follows:
(Identical Deoxyribonucleotides x 100)/(Length of Alignment - Total Number of Gaps in Alignment)
Variant: The term“variant” means a polypeptide having protease activity comprising an alteration, i.e., a substitution, insertion, and/or deletion, at one or more positions. A substitution means replacement of the amino acid occupying a position with a different amino acid; a deletion means removal of the amino acid occupying a position; and an insertion means adding an amino acid adjacent to and immediately following the amino acid occupying a position.
Conventions for Designation of Variants
For purposes of the present invention, the polypeptide of SEQ ID NO: 2 is used to determine the corresponding amino acid residue number in a variant of SEQ ID NO: 1. The amino acid sequence of a variant of SEQ ID NO: 1 is aligned with SEQ ID NO: 2, and based on the alignment, the amino acid position number corresponding to any amino acid residue in the polypeptide of SEQ ID NO: 1 is determined. See the paragraph “Numbering of amino acid positions/residues” below for further information.
Identification of the corresponding amino acid residue in another subtilase can be determined by an alignment of multiple polypeptide sequences using several computer programs including, but not limited to, MUSCLE (multiple sequence comparison by log-expectation; version
3.5 or later; Edgar, 2004, Nucleic Acids Research 32: 1792-1797), MAFFT (version 6.857 or later; Katoh and Kuma, 2002, Nucleic Acids Research 30: 3059-3066; Katoh et ai, 2005, Nucleic Acids Research 33: 51 1-518; Katoh and Toh, 2007, Bioinformatics 23: 372-374; Katoh et al., 2009, Methods in Molecular Biology 537: 39-64; Katoh and Toh, 2010, Bioinformatics 26 : 1899-1900) , and EMBOSS EMMA employing ClustalW (1.83 or later; Thompson et al., 1994, Nucleic Acids Research 22: 4673-4680), using their respective default parameters.
In describing the variants of the present invention, the nomenclature described below is adapted for ease of reference. The accepted lUPAC single letter or three letter amino acid abbreviation is employed. The terms “alteration” or“mutation” may be used interchangeably herein to refer to substitutions, insertions and deletions.
Substitutions. For an amino acid substitution, the following nomenclature is used: Original amino acid, position, substituted amino acid. For example, the substitution of a threonine at position 220 with alanine is designated as“T220A”. Multiple substitutions may be separated by addition marks (“+”), e.g.,“T220A + G229V”, representing substitutions at positions 220 and 229 of threonine (T) with alanine (A) and glycine (G) with valine (V), respectively. Multiple substitutions may alternatively be listed with individual mutations separated by a space or a comma. Alternative substitutions in a particular position may be indicated with a slash (7”). For example, substitution
of threonine in position 220 with either alanine, valine or leucine many be designated“T220A/V/L”. An“X” preceding a position means that any original amino acid at the position may be substituted. For example, X9E means that any amino acid residue at position 9 other than E is substituted with E.
Deletions. For an amino acid deletion, the following nomenclature is used: Original amino acid, position, *. Accordingly, the deletion of threonine at position 220 is designated as“T220*”. Multiple deletions may be separated by addition marks (“+”), e.g.,“T220* + G229*”, or alternatively may be separated by a space or comma. The use of an“X” preceding a position number is as described above for substitutions, e.g.“X131*” means that the amino acid residue at position 131 is deleted.
Insertions. For an amino acid insertion, the following nomenclature is used: Original amino acid, position, original amino acid, inserted amino acid. Accordingly, the insertion of lysine after threonine at position 220 is designated “T220TK”. An insertion of multiple amino acids is designated [Original amino acid, position, original amino acid, inserted amino acid #1 , inserted amino acid #2; etc.]. For example, the insertion of lysine and alanine after threonine at position 220 is indicated as“T220TKA”.
In such cases the inserted amino acid residue(s) are numbered by the addition of lower case letters to the position number of the amino acid residue preceding the inserted amino acid residue(s). In the above example, the sequence would thus be:
Multiple alterations. Variants comprising multiple alterations are separated by addition marks (“+”), e.g.,“R170Y+G195E” representing a substitution of arginine and glycine at positions 170 and 195 with tyrosine and glutamic acid, respectively. Multiple alterations may alternatively be listed with individual mutations separated by a space or a comma.
A combination of e.g. a substitution and an insertion may be denoted as follows: S99AD, which represents substitution of a serine residue in position 99 with an alanine residue as well as insertion of an aspartic acid residue.
Different alterations. Where different alterations can be introduced at a position, the different alterations may be separated by a comma, e.g.,“R170Y,E” represents a substitution of arginine at position 170 with tyrosine or glutamic acid. Thus,‘Y167G,A + R170G.A” designates the following variants:
“Y167G+R170G”,“Y167G+R170A”,“Y167A+R170G”, and‘Y167A+R170A”.
Different alterations in a position may also be indicated with a slash (7”), for example “T220A/V/L” as explained above. Alternatively, different alterations may be indicated using brackets, e.g., R170 [Y,G].
Numbering of amino acid positions/residues. The numbering used herein is based on the numbering of SEQ I D NO: 2. Thus, amino acid residues of SEQ ID NO: 1 are numbered based on the corresponding amino acid residue in SEQ ID NO: 2. Specifically, the numbering is based on the alignment in Table 1 of WO 89/06279, which shows an alignment of five proteases, including the mature polypeptide of the subtilase BPN’ (BASBPN) sequence (sequence c in the table) and the mature polypeptide of subtilisin 309 from Bacillus lentus, also known as Savinase® (BLSAVI) (sequence a in the table). Persons skilled in the art will know that position numbers used for subtilisin 309 and other proteases in the patent literature are often based on the corresponding position numbers of BPN’ according to this alignment.
The accompanying Figure 1 is provided for reference purposes and shows an alignment between SEQ ID NO: 1 and SEQ ID NO: 2, based on Table 1 of WO 89/06279, from which position numbers corresponding to positions of SEQ ID NO: 2 may be readily determined.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to detergent compositions comprising at least a first protease and a second protease, where the first protease and the second protease have different net formal charges relative to the protease of SEQ ID NO: 1.
The term“net formal charge”, or“net charge”, refers to the net charge of the enzyme, where the amino acid residues aspartic acid (D) and glutamic acid (E) contribute to one negative charge (-1), and the amino acid residues arginine (R) and lysine (K) contribute to one positive charge (+1), and where the charge of these residues in the first protease or second protease is compared to the charge of the residues in the protease of SEQ ID NO: 1. This means that replacing a neutral amino acid, e.g. a neutral amino acid in SEQ ID NO: 1 , with an acidic amino acid (D or E) provides one negative charge, while replacing a neutral amino acid with a basic amino acid (R or K) provides one positive charge. Similarly, replacing an acidic amino acid with a basic amino acid would provide two positive charges, while replacing a basic amino acid with an acidic amino acid would provide two negative charges.
As explained above, the net charge of a protease in the detergent compositions of the invention is expressed relative to the net charge of the protease of SEQ ID NO: 1. It may be seen from the sequence of SEQ ID NO: 1 that this protease contains 5 Asp residues, 5 Glu residues, 8 Arg residues and 5 Lys residues, thus SEQ ID NO: 1 has a net charge of +3, and it is this value to which the first and second proteases of the invention are to be compared. The net charge of a protease in the compositions of the invention may thus be readily determined by counting the number of acidic and basic amino acids in the amino acid sequence and comparing the calculated
net charge with the net charge of the protease of SEQ ID NO: 1. It will be apparent that the net charge of the first and the second protease determined in this manner is a function of the number of acidic (D and E) and basic (R and K) amino acid residues and is for purposes of the invention independent of the composition having any particular pH value.
The invention relates in particular to a detergent composition comprising a first protease and a second protease, where
1) the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1 ; or
2) the first protease has a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -1 , 0 or +1 relative to the protease of SEQ ID NO: 1.
It will be apparent that the terms“first protease” and“second protease” are used herein to differentiate between the two proteases having different net charges in a given composition, and that a protease with a given net formal charge may in some cases, according to the context of the particular composition in which it is included, be considered as either a“first protease” or a “second protease”. For example, a protease with a net formal charge of -1 may be referred to as a“first protease” when it is present in a composition comprising another protease with a net formal charge of -2, but may be a“second protease” when it is present in a composition comprising another protease with a net formal charge of -3, -4 or -5.
In one aspect, the invention thus relates to a detergent composition comprising a first protease and a second protease, where the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1. In a preferred embodiment of this aspect, the first protease has a net formal charge of -3 or -4.
In one embodiment, the first protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -3 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1.
In another aspect, the invention relates to a detergent composition comprising a first protease and a second protease, where the first protease has a net formal charge of -3, -4 or -5
relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -1 , 0 or +1 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -3 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +1 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +1 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +1 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -3 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -3 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1.
It will be apparent that the net formal charge difference between the first protease and the second protease in the compositions of the invention may vary, so that the net formal charge of the two proteases in a composition may differ by, e.g., 1 , 2, 3, 4, 5, 6 or 7.
In certain preferred embodiments, the detergent composition of the invention comprises a first and a second protease that each have a negative net formal charge relative to the protease of SEQ ID NO: 1 , for example a net formal charge of -1 , -2, -3 or -4, and where the net formal charge of the first and second protease differ from each other by 1 or 2. Specific examples of such compositions include compositions comprising:
a) a first protease with a net formal charge of -4 and a second protease with a net formal charge of -2 relative to the protease of SEQ ID NO: 1 (charge difference of 2);
b) a first protease with a net formal charge of -3 and a second protease with a net formal charge of -2 relative to the protease of SEQ ID NO: 1 (charge difference of 1); and
c) a first protease with a net formal charge of -3 and a second protease with a net formal charge of -1 relative to the protease of SEQ ID NO: 1 (charge difference of 2).
Such compositions with two proteases having a net formal charge of -1 , -2, -3 or -4 and a charge difference of 1 or 2 are contemplated to be particularly useful when formulated as a liquid laundry detergent composition.
As mentioned above, use of the combination of at least two different protease enzymes with different net formal charge characteristics has been found to result in an improved wash performance on individual stains and/or to provide improved overall performance on a broader set of stains, e.g. in laundry detergent formulations, compared to the individual enzymes. Use of this concept of different net formal charges of the individual proteases allows the blend to be tailored to different wash conditions to achieve an optimal charge blend for improved performance on targeted stains.
In particular, it has been found that by use of this concept it is possible, without increasing the total protease enzyme content, to provide increased cleaning performance on certain difficult to remove stains, for example oil-containing protein stains such as sebum stains, while at the same time substantially maintaining or improving performance on other protein-based stains, such as cocoa stains. The overall result is an improved cleaning performance on a broader stain set using the same amount of enzyme protein.
In another aspect, the invention relates to a detergent composition comprising a first protease and a second protease, where the first protease has a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
In a further aspect, the invention relates to a detergent composition comprising a first protease and a second protease, where the first protease has a net formal charge of 0, -1 or -2 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2, +3, +4 or +5 relative to the protease of SEQ ID NO: 1. It is contemplated that such compositions wherein one protease has a relatively positive net formal charge relative to the protease of SEQ ID NO: 1 will provide advantageous results in relatively high pH wash settings, for example in automatic dishwashing applications.
In one embodiment, the first protease has a net formal charge of -3 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +3 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +3 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +3 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +4 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +4 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +4 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of 0 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +5 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +5 relative to the protease of SEQ ID NO: 1.
In one embodiment, the first protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +5 relative to the protease of SEQ ID NO: 1.
In any of the detergent compositions of the invention, the first protease and the second protease preferably both have an amino acid sequence that has at least 60% sequence identity to SEQ ID NO: 1 , for example at least 70% or at least 80% sequence identity. The first protease may thus have at least 85% sequence identity to SEQ I D NO: 1 , such as at least 90%, at least 91 %, at least 92%, at least 93%, at least 94% or at least 95% sequence identity to SEQ ID NO: 1. Similarly, the second protease may have at least 85% sequence identity to SEQ ID NO: 1 , such as at least 90%, at least 91 %, at least 92%, at least 93%, at least 94% or at least 95% sequence identity to SEQ ID NO: 1. It will be understood that if such proteases comprise any additional mutations relative to SEQ ID NO: 1 beyond those specified herein, the proteases should fulfil the relevant net formal charge criteria in relation to SEQ ID NO: 1. The first and/or second protease may also have an amino acid sequence that comprises or consists of SEQ ID NO: 1 with the specific mutations defined herein.
In one embodiment, the first protease has a net formal charge of -5, -4 or -3 and comprises, relative to SEQ ID NO: 1 , and comprises one or more mutations that introduce an increased negative charge selected from the group consisting of S9E, K27H, K27M, *36D, N62D, N76D, N77D, G97D, S99D, S101 E, H120D, N140D, S156D, N185E, S188E, G195E, K235L, K235M, K237M, S259D and L262E. Preferred substitutions to introduce a negative charge include N76D, G97D, S99D, S101 E and S156D. In preferred embodiments, the first protease comprises more than one of these mutations, preferably three or more, such as four, five or six of these mutations. In some embodiments, a variant having four or more of these mutations that provide an increased negative charge may be combined with one or more mutations, for example one or two mutations, that provide an increased positive charge, so as to result in a net formal charge relative to the protease of SEQ I D NO: 1 of -5, -4 or -3. Examples of such mutations to provide an increased positive charge include e.g. S9R, N43R, N117R, A215K and Q245R.
In one embodiment, the first protease thus comprises, relative to SEQ I D NO: 1 , four or more mutations, such as four, five, six or seven mutations, that introduce an increased negative charge, combined with one or more mutations, such as one or two mutations, that introduce an increased positive charge, so as to result in a net formal charge of -5, -4 or -3 relative to the protease of SEQ ID NO: 1. The first protease may thus comprise four or more mutations that introduce an increased negative charge, e.g. selected from the group consisting of S9E, K27H, K27M, *36D, N62D, N76D, N77D, G97D, S99D, S101 E, H120D, N140D, S156D, N185E, S188E,
G195E, K235L, K235M, K237M, S259D and L262E, together with one or two mutations that introduce an increased positive charge, e.g. selected from the group consisting of S9R, N43R, N1 17R, A215K and Q245R, where the protease has a net formal charge of -5, -4 or -3 relative to the protease of SEQ ID NO: 1.
In all of the embodiments below and elsewhere herein comprising a protease which is a variant of SEQ ID NO: 1 , position numbers are based on the numbering of SEQ ID NO: 2 in accordance with the explanation in the paragraph“Numbering of amino acid positions/residues” above.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S99D+S101 E+S103A+V104I+S156D+G160S+L262E, i.e. having a net formal charge of -4 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27H+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E, i.e. having a net formal charge of -4 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+K235M+Q245R+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+ L262E, i.e. having a net formal charge of -4 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+V205I+Q206L+Y209W+S259D+N261W+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+N185E+S188E+Q191 N+A194P+Q206L+Y209W+S259D+
L262E, i.e. having a net formal charge of -5 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the mutations *36D+N76D+H120D+G195E+K235L, i.e. having a net formal charge of -5 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S99A+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+ L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+
Q245R+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+N43R+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R +L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+N43R+S99D+S101 E+S103A+V104I+S156D+G160S+N173D+K235M+
Q245R+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+G97D+S156D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101 E+S156D+A172V+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+N140D+S156D+Y209W+A215K+L262E, i.e. having a net formal charge of -4 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+S101 E+T 180A+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+S101 E+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+S101 E+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+S101 E+V177I+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+N76D+G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+G97D+S156D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N77D+G97D+S156D+Y209W+A215K+L262E, i.e. having a net formal charge of -4 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N76D+G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N62D+G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+G97D+S101 E+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N76D+G97D+Y209W+A215K+L262E+A270T, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N76D+G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N62D+G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+K27M+G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+N 185E+S188E+Q191 N+A194P+Q206L+Y209W+A215K+
Q245R+S259D+L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+S188E+Q191 N+A194P+Q206L+Y209W+A215K+S259D+
L262E, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+N 185E+S188E+Q191 N+A194P+Q206L+Y209W+A215K+
S259D+L262Q, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+N185E+S188E+Q191 N+A194P+Q206L+Y209W+Q245R+ S259D+L262Q, i.e. having a net formal charge of -3 relative to SEQ ID NO: 1.
In one embodiment, the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitution K27M, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
In one embodiment, the second protease is the polypeptide of SEQ ID NO: 1.
In one embodiment, the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the mutation S99AD (i.e. substitution of S to A, and insertion of D), i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
In one embodiment, the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K, i.e. having a net formal charge of 0 relative to SEQ ID NO: 1.
In one embodiment, the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+N1 17R+Y209W+A215K, i.e. having a net formal charge of +1 relative to SEQ ID NO: 1.
In one embodiment, the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+N43R+N76D+V205I+Q206L+Y209W+A215K+Q245R+S259D+ N261W+L262E, i.e. having a net formal charge of 0 relative to SEQ ID NO: 1.
In one embodiment, the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+N43R+N76D+V205I+Q206L+Y209W+A215K+S259D+N261W+L262E, i.e. having a net formal charge of 0 relative to SEQ ID NO: 1.
In one embodiment, the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions S9R+N43R+N76D+V205I+Q206L+Y209W+S259D+N261 W+L262E, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
In one embodiment, the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99A+S101 E+S103A+V104I+S156D+G160S+A215K+K235M+Q245R+ L262E, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
In one embodiment, the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+N43R+S99A+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+Q245R+ L262E, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
In one embodiment, the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions
S9R+K27M+N43R+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+Q245R+L262E, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
In one embodiment, the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions Y167A+R170S+A194P, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
In one embodiment, the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+A15T+V68A+N218D+Q245R, i.e. having a net formal charge of +1 relative to SEQ ID NO: 1.
In one embodiment, the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+A15T+G61 E+V68A+A194P+V205I+Q245R+N261 D, i.e. having a net formal charge of 0 relative to SEQ ID NO: 1.
In one embodiment, the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+A15T+V68A+S99G+Q245R+N261 D, i.e. having a net formal charge of +1 relative to SEQ ID NO: 1.
In one embodiment, the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+A15T+V68A+H120D+P131S+Q137H+Q245R, i.e. having a net formal charge of +1 relative to SEQ ID NO: 1.
In one embodiment, the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+A15T+V68A+H120N+P131S+Q137H+Q245M, i.e. having a net formal charge of +1 relative to SEQ ID NO: 1.
In one embodiment, the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+A15T+G61 E+V68A+A98S+S99G+N218D+Q245R, i.e. having a net formal charge of 0 relative to SEQ ID NO: 1.
In one embodiment, the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions S3T+V4I+S99D+S101 R+S103A+V104I+G160S+V205I+L217D, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
In one embodiment, the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions S3T+V4I+S99D+S101 R+S103A+V104I+G160S+A194P+V205I+L217D, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
In one embodiment, the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K+L262E, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
In one embodiment, the second protease (or first protease, where the second protease has a net formal charge of -2) is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K, i.e. having a net formal charge of -1 relative to SEQ ID NO: 1.
Other suitable protease variants that may be used as the first or second protease are those that are at least 80%, at least 81 %, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98% or at least 99% identical to any of the proteases disclosed above, and where any additional mutations in the individual protease variants as set forth above result in the same net formal charge.
Exemplary, non-limiting embodiments of the invention with specific first and second proteases are provided in the following.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S99D+S101 E+S103A+V104I+S156D+G160S+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitution K27M.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27H+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitution K27M.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+K235M+Q245R+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitution K27M.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+ L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitution K27M.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S99D+S101 E+S103A+V104I+S156D+G160S+L262E, and the second protease is the polypeptide of SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27H+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E, and the second protease is the polypeptide of SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+ L262E, and the second protease is the polypeptide of SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S99D+S101 E+S103A+V104I+S156D+G160S+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the mutation S99AD.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27H+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the mutation S99AD.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+K235M+Q245R+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the mutation S99AD.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the mutation S99AD.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+ L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the mutation S99AD.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S99D+S101 E+S103A+V104I+S156D+G160S+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K or G97D+N1 17R+Y209W+A215K.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+V205I+Q206L+Y209W+S259D+N261W+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K or G97D+N117R+Y209W+A215K.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N43R+N76D+N185E+S188E+Q191 N+A194P+Q206L+Y209W+S259D+ L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K or G97D+N1 17R+Y209W+A215K.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the mutations *36D+N76D+H120D+G195E+K235L, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K or G97D+N1 17R+Y209W+A215K.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitution K27M, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E.
In one embodiment, the first protease is the polypeptide of SEQ ID NO: 1 , and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+ S103A+V104I+S156D+G160S+Q245R+L262E.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the mutation S99AD, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+N 140D+S156D+Y209W+A215K+L262E, and the second protease is the polypeptide of SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+N 140D+S156D+Y209W+A215K+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+N 140D+S156D+Y209W+A215K+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K+L262E.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N77D+G97D+S156D+Y209W+A215K+L262E, and the second protease is the polypeptide of SEQ ID NO: 1.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N77D+G97D+S156D+Y209W+A215K+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N77D+G97D+S156D+Y209W+A215K+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K+L262E.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+N117R+Y209W+A215K, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+N76D+G97D+Y209W+A215K+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+S101 E+V177I+Y209W+A215K+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+S101 E+Y209W+A215K+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101 E+S156D+A172V+Y209W+A215K+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+N 140D+S156D+Y209W+A215K+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
In one embodiment, the first protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N77D+G97D+S156D+Y209W+A215K+L262E, and the second protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E.
In one embodiment, the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1 and is a variant of SEQ ID NO: 1 with the substitutions G97D+S156D+Y209W+A215K+L262E or S9R+S99D+S101 E+S103A+V104I+S156D+G160S+ Q245R+L262E, preferably G97D+S156D+Y209W+A215K+L262E.
In one embodiment, the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1 , wherein the first protease is a variant of SEQ ID NO: 1 having a set of mutations selected from the group consisting of:
• K27M;
• S99AD;
• G97D+S156D+Y209W+A215K;
• G97D+Y209W+A215K+L262E;
• S9R+S99D+S101 E+S103A+V104I+S156D+G160S+K235M+Q245R+L262E;
• S9R+S99D+S101 E+S103A+V104I+S156D+G160S+L262E;
• S9E+N43R+N76D+V205I+Q206L+Y209W+S259D+N261W+L262E;
• N62D+N76D+G97D+Y209W+A215K+L262E;
• N62D+G97D+S101 E+V177I+Y209W+A215K+L262E;
• N62D+G97D+S101 E+Y209W+A215K+L262E;
• G97D+S101 E+S156D+A172V+Y209W+A215K+L262E;
• S99D+S101 E+S103A+V104I+S156D+G160S+L262E;
• K27H+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E;
• S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+L262E;
• N76D+G97D+N140D+S156D+Y209W+A215K+L262E; and
• K27M+N77D+G97D+S156D+Y209W+A215K+L262E;
and where the second protease preferably is a variant of SEQ ID NO: 1 with the substitutions G97D+S156D+Y209W+A215K+L262E or S9R+S99D+S101 E+S103A+V104I+S156D+G160S+ Q245R+L262E, preferably G97D+S156D+Y209W+A215K+L262E.
In one embodiment, the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -2 relative to the
protease of SEQ ID NO: 1 , wherein the second protease is a variant of SEQ ID NO: 1 having a set of mutations selected from the group consisting of:
• S87N+G97D+S156D+Y209W+A215K+L262E;
• G97D+S101 G+S156D+Y209W+A215K+L262E;
• G97D+V104N+S156D+Y209W+A215K+L262E;
• G97D+G1 18V+S156D+Y209W+A215K+L262E;
• G97D+S156D+A194P+Y209W+A215K+L262E;
• S87N+G97D+S101G+S156D+Y209W+A215K+L262E;
• S87N+G97D+S101 N+S156D+Y209W+A215K+L262E;
• S87N+G97D+V104N+S156D+Y209W+A215K+L262E;
• S87N+G97D+G118V+S156D+Y209W+A215K+L262E;
• S87N+G97D+S156D+A194P+Y209W+A215K+L262E;
• G97D+S101 G+G118V+S156D+Y209W+A215K+L262E;
• G97D+S101 G+S156D+A194P+Y209W+A215K+L262E; and
• G97D+S101 N+V104N+S156D+Y209W+A215K+L262E.
When the first protease has a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1 and a second protease has a net formal charge of -1 , 0 or +1 relative to the protease of SEQ ID NO: 1 , the first protease may be a variant of SEQ ID NO: 1 comprising a set of mutations selected from the group consisting of:
• S99D+S101 E+S103A+V104I+S156D+G160S+L262E;
• K27H+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E;
• S9R+S99D+S101 E+S103A+V104I+S156D+G160S+K235M+Q245R+L262E;
• S9R+S99D+S101 E+S103A+V104I+S156D+G160S+L262E;
• S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+L262E;
• S9E+N43R+N76D+V205I+Q206L+Y209W+S259D+N261W+L262E;
• S9E+N43R+N76D+N185E+S188E+Q191 N+A194P+Q206L+Y209W+S259D+L262E;
• *36D+N76D+H120D+G195E+K235L;
• S9R+K27M+S99A+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+L262E;
• S9R+K27M+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+L262E;
• S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+Q245R+ L262E;
• S9R+K27M+N43R+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+ L262E;
• S9R+N43R+S99D+S101 E+S103A+V104I+S156D+G160S+N173D+K235M+Q245R +L262E;
• S9E+G97D+S156D+Y209W+A215K+L262E;
• G97D+S101 E+S156D+A172V+Y209W+A215K+L262E;
• N76D+G97D+N140D+S156D+Y209W+A215K+L262E;
• N76D+G97D+S101 E+T180A+Y209W+A215K+L262E;
• N76D+G97D+S101 E+Y209W+A215K+L262E;
• N62D+G97D+S101 E+Y209W+A215K+L262E;
• N62D+G97D+S101 E+V177I+Y209W+A215K+L262E;
• N62D+N76D+G97D+Y209W+A215K+L262E;
• K27M+G97D+S156D+Y209W+A215K+L262E;
• K27M+N77D+G97D+S156D+Y209W+A215K+L262E;
• K27M+N76D+G97D+Y209W+A215K+L262E;
• K27M+N62D+G97D+Y209W+A215K+L262E;
• S9E+G97D+S101 E+Y209W+A215K+L262E;
• S9E+N76D+G97D+Y209W+A215K+L262E+A270T;
• S9E+N76D+G97D+Y209W+A215K+L262E;
• S9E+N62D+G97D+Y209W+A215K+L262E;
• S9E+K27M+G97D+Y209W+A215K+L262E;
• S9E+N43R+N76D+N 185E+S188E+Q191 N+A194P+Q206L+Y209W+A215K+Q245R +S259D+L262E;
• S9E+N43R+N76D+S188E+Q191 N+A194P+Q206L+Y209W+A215K+S259D+L262E;
• S9E+N43R+N76D+N 185E+S188E+Q191 N+A194P+Q206L+Y209W+A215K+S259D +L262Q; and
• S9E+N43R+N76D+N185E+S188E+Q191 N+A194P+Q206L+Y209W+Q245R+S259D +L262Q;
and the second protease may be the protease of SEQ ID NO: 1 or a variant of SEQ ID NO: 1 comprising a set of mutations selected from the group consisting of:
• K27M;
• S99AD;
• G97 D+ Y209W+A215 K;
• G97D+N117R+Y209W+A215K;
• S9R+K27M+N43R+N76D+V205I+Q206L+Y209W+A215K+Q245R+S259D+N261W+ L262E;
• S9R+N43R+N76D+V205I+Q206L+Y209W+A215K+S259D+N261W+L262E;
• S9R+N43R+N76D+V205I+Q206L+Y209W+S259D+N261W+L262E;
• S9R+S99A+S101 E+S103A+V104I+S156D+G160S+A215K+K235M+Q245R+L262E;
• S9R+K27M+N43R+S99A+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+ Q245R+L262E;
• S9R+K27M+N43R+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+Q245R +L262E;
• Y167A+R170S+A194P;
• S9R+A15T +V68A+N218D+Q245R;
• S9R+A15T+G61 E+V68A+A194P+V205I+Q245R+N261 D;
• S9R+A15T +V68A+S99G+Q245R+N261 D;
• S9R+A15T+V68A+H 120D+P131 S+Q137H+Q245R;
• S9R+A15T+V68A+H 120N+R131 S+Q137H+Q245M;
• S9R+A15T+G61 E+V68A+A98S+S99G+N218D+Q245R;
• S3T+V4I+S99D+S101 R+S103A+V104I+G160S+V205I+L217D;
• S3T+V4I+S99D+S101 R+S103A+V104I+G160S+A194P+V205I+L217D;
• G97D+Y209W+A215K+L262E; and
• G97D+S156D+Y209W+A215K.
In some preferred embodiments, where the first protease has a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1 and the second protease has a net formal charge of -1 , 0 or +1 relative to the protease of SEQ ID NO: 1 , the first protease may be a variant of SEQ ID NO: 1 having a set of mutations selected from the group consisting of:
• S9E+N43R+N76D+N185E+S188E+Q191 N+A194P+Q206L+Y209W+S259D+L262E;
• *36D+N76D+H120D+G195E+K235L;
• S99D+S101 E+S103A+V104I+S156D+G160S+L262E;
• K27H+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E;
• S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+L262E;
• N76D+G97D+N140D+S156D+Y209W+A215K+L262E;
• K27M+N77D+G97D+S156D+Y209W+A215K+L262E;
• S9R+S99D+S101 E+S103A+V104I+S156D+G160S+K235M+Q245R+L262E;
• S9R+S99D+S101 E+S103A+V104I+S156D+G160S+L262E;
• S9E+N43R+N76D+V205I+Q206L+Y209W+S259D+N261W+L262E;
• N62D+N76D+G97D+Y209W+A215K+L262E;
• N62D+G97D+S101 E+V177I+Y209W+A215K+L262E;
• N62D+G97D+S101 E+Y209W+A215K+L262E; and
• G97D+S101 E+S156D+A172V+Y209W+A215K+L262E;
and the second protease may be the protease of SEQ ID NO: 1 or a variant thereof having a set of mutations selected from the group consisting of:
• K27M;
• S99AD;
• G97D+S156D+Y209W+A215K;
• G97D+Y209W+A215K+L262E;
• G97D+Y209W+A215K; and
• G97D+N117R+Y209W+A215K.
In the aspect of the invention where the first protease has a net formal charge of 0, -1 or -2 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of +2, +3, +4 or +5 relative to the protease of SEQ ID NO: 1 , the first protease having a net formal charge of 0, -1 or -2 may, for example, be selected from the polypeptide of SEQ ID NO: 1 and variants of SEQ ID NO: 1 having a set of mutations selected from the group consisting of:
• G97D+Y209W+A215K
• S9R+K27M+N43R+N76D+V205I+Q206L+Y209W+A215K+Q245R+S259D+
N261 W+L262E
• S9R+N43R+N76D+V205I+Q206L+Y209W+A215K+S259D+N261W+L262E
• S9R+A15T+G61 E+V68A+A194P+V205I+Q245R+N261 D
• S9R+A15T +G61 E+V68A+A98S+S99G+N218D+Q245R
• K27M
• S99AD
• S9R+N43R+N76D+V205I+Q206L+Y209W+S259D+N261 W+L262E
• S9R+S99A+S101 E+S103A+V104I+S156D+G160S+A215K+K235M+Q245R+L262E
• S9R+K27M+N43R+S99A+S101 E+S103A+V104I+S156D+G160S+A215K+K237M +Q245R+L262E
• S9R+K27M+N43R+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+Q245R +L262E
• Y167A+R170S+A194P
• S3T+V4I+S99D+S101 R+S103A+V104I+G160S+V205I+L217D
• S3T+V4I+S99D+S101 R+S103A+V104I+G160S+A194P+V205I+L217D
• G97D+Y209W+A215K+L262E
• G97D+S156D+Y209W+A215K
• S9R+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E;
• S9R+K27M+N43R+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+L262E;
• S9R+K27M+N43R+S99D+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+ Q245R+L262E;
• S9R+S99A+S101 E+S103A+V104I+A151 V+S156D+G160S+K235M+Q245R+L262E;
• S9R+S99A+S101 E+S103A+V104I+S156D+G160S+K235M+Q245R+L262E;
• S9R+S99D+S101 E+S103A+V104I+S156D+G160S+A215K+K235M+Q245R+L262E;
• N62D+G97D+Y209W+A215K+L262E;
• G97D+S156D+Y209W+A215K+L262E;
• G97D+S101 E+Y209W+A215K+L262E;
• N76D+G97D+Y209W+A215K+L262E;
• K27M+G97D+Y209W+A215K+L262E;
• S9E+G97D+Y209W+A215K+L262E;
• S9R+N43R+N76D+N185E+Q191 N+A194P+Q206L+Y209W+S259D+L262E; and
• S9E+N43R+N76D+V205I+Q206L+Y209W+Q245R+S259D+N261 W+L262E.
In an additional aspect, the first protease may have a net formal charge of -2 relative to SEQ ID NO: 1 , and the second protease may have a net formal charge of -1 , 0 or +1 relative to SEQ ID NO: 1.
As an example of an embodiment of this aspect, the first protease may be a variant of SEQ ID NO: 1 comprising the substitutions S9R+S99D+S101 E+S103A+V104I+S156D+ G160S+Q245R+L262E, and the second protease may be the polypeptide of SEQ ID NO: 1 or a variant of SEQ ID NO: 1 comprising the substitution K27M or comprising the mutation S99AD.
In one embodiment of the invention, the detergent composition of the invention does not comprise two proteases wherein one protease is comprised in a solid enzyme formulation and the other protease is comprised in a liquid enzyme formulation.
In one embodiment, the detergent composition of the invention does not comprise the protease of SEQ ID NO: 8 disclosed in US 2017/0198243. In one embodiment, the detergent composition of the invention does not comprise the protease of SEQ ID NO: 9 disclosed in US 2017/0198243. In a further embodiment, the two proteases in the detergent composition of the invention are not the protease of SEQ ID NO: 8 and the protease of SEQ ID NO: 9 disclosed in US 2017/0198243.
Preferably, the detergent composition of the invention comprising a first protease and a second protease as defined above has an improved wash performance compared to the same composition comprising either the first protease or the second protease. The improved wash performance may be improved performance on one or more individual stains and/or improved overall performance on a set of stains, e.g. 2, 3, 4, 5 or more stains. Wash performance may e.g. be determined using the AMSA method described herein, for example using the model detergent set forth in Table 1. Performance may be tested on any suitable stain(s) for the intended application, e.g. laundry or automatic dishwashing. Examples of such stains are e.g. the standard laundry stains PC-10 and/or PC-03.
Proteases with a relatively negative net formal charge of e.g. -4 or -3 compared to SEQ ID NO: 1 tend to be better at removing certain types of protein stains, for example cocoa- containing stains. On the other hand, proteases with a more positive, relatively neutral net formal charge of e.g. -1 or 0 tend to be better at removing other types of protein stains, for example sebum stains and other oil-containing protein stains. It was therefore surprising that the detergent compositions of the invention comprising two proteases with different net formal charge
characteristics could provide improved cleaning of different types of stains without increasing the total amount of protease enzyme.
It was also surprising that it was possible to obtain significantly better removal of the oily PC-10 stain using a mixture of the two different proteases with different charge characteristics rather than relying on a relatively neutral protease that is otherwise better at removing oil- containing protein stains. The PC-10 stain (pigment, oil, milk) mimics natural sebum stains that contain both protein and oil/fat, thus providing a good indication of how a detergent composition will perform on this difficult to remove natural stain.
In one embodiment, the detergent composition of the invention comprising a first protease and a second protease has an improved wash performance on PC-10 compared to the same composition comprising either the first protease or the second protease.
In another embodiment, the detergent composition of the invention comprising a first protease and a second protease has an improved overall wash performance on PC-10 and PC- 03 compared to the same composition comprising either the first protease or the second protease.
In one embodiment, the relative wash performance of the detergent composition of the invention comprising a first protease and a second protease is improved over the wash performance of a composition comprising either the first protease or the second protease by at least 1 %, preferably at least 2%, at least 3%, at least 4% or at least 5%, such as at least 6%, at least 7%, at least 8%, at least 9% or at least 10%, e.g. at least 15% or at least 20%. This improved relative wash performance is preferably obtained at least on the PC-10 stain from Center for Testmaterials (CFT). More preferably, this improved relative wash performance is an improved overall wash performance on a set of stains comprising PC-10 and PC-03 (both from CFT), and optionally comprising one or more additional standard stains. Examples of such additional stains that may be used are one or more of C-S-05S, C-S-67, C-S-75, C-S-95, C-H151 , C-H163, C- H252, C-S-60, all from Center for Testmaterials (CFT), and French Mustard WE5FSMWKC, 01 1 KC WC PC PE Bacon Grease, 028 KC WC PC PE Cheese Spread, 080 KC WC PC PE Mayonnaise, all from Warwick Equest. Relative wash performance may e.g. be determined based on the sums of delta intensity as described in Example 1.
It will be understood that when comparing the wash performance of a composition of the invention with a corresponding composition comprising only a single enzyme, i.e. either the first protease or the second protease, the compositions being compared will contain the same total amount of protease enzyme protein (by weight).
In a further aspect, the invention relates to novel protease variants with advantageous properties, where the proteases are variants of SEQ ID NO: 1 comprising substitutions in positions 97, 209 and 215. Such proteases have been found to not only have beneficial properties when used in detergent compositions with another protease having a different net formal charge such
as those disclosed herein, but also to have beneficial properties, e.g. improved laundry wash performance, when used alone.
In this aspect the invention relates to a protease variant comprising the substitutions X97D, X209W and X215K, e.g. G97D, Y209W and A215K, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. In some embodiments of this aspect of the invention, the protease variant comprises one or more additional substitutions, preferably in one or more positions, for example in one, two, three or four positions, selected from positions 27, 62, 76, 77, 87, 101 , 104, 1 17, 1 18, 140, 156, 172, 177, 194 and 262. Such additional substitutions include, in particular, X9E (e.g. S9E), X27M (e.g. K27M), X62D (e.g. N62D), X76D (e.g. N76D), X77D (e.g. N77D), X87N (e.g. S87N), X101 E/G/N (e.g. S101 E/G/N), X104N (e.g. V104N), X117R (e.g. N1 17R), X1 18V (e.g. G118V), X140D (e.g. N140D), X156D (e.g. S156D), X172V (e.g. A172V), X177I (e.g. V177I), X194P (e.g. A194P) and X262E (e.g. L262E). Particular embodiments of this aspect of the invention are provided below.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+N117R+Y209W+A215K, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering
of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N77D+G97D+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+N76D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+S101 E+V177I+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+S101 E+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+N140D+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101 E+S156D+A172V+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N62D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as
at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+G97D+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+G97D+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions N62D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+S101 E+T180A+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+S101 E+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N76D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+N62D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+G97D+S101 E+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N76D+G97D+Y209W+A215K+L262E+A270T, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+N76D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+K27M+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101 E+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions N76D+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions K27M+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions S9E+G97D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of
SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one aspect, the invention relates to a protease which is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E and optionally at least one additional substitution selected from S87N, S101 G/N, V104N, G118V and A194P. Examples of such proteases are provided below.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions S87N+G97D+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101G+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101 N+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+V104N+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+G118V+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+A194P+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions S87N+G97D+S101 G+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions S87N+G97D+S101 N+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions S87N+G97D+V104N+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions S87N+G97D+G118V+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions S87N+G97D+S156D+A194P+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101G+G118V+S156D+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101G+S156D+A194P+Y209W+A215K+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
In one embodiment, the protease is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S101 N+V104N+S156D+Y209W+A215K+L262E, wherein position numbers are based on
the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80%, such as at least 85%, at least 90% or at least 95%, but less than 100% sequence identity to SEQ ID NO: 1. The protease may e.g. comprise or consist of SEQ ID NO: 1 with this set of substitutions.
It will be apparent from the description above and the examples below that in the detergent compositions of the invention comprising two proteases with different net charge characteristics, one or both of the proteases may be a variant of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K, and optionally other substitutions as set forth herein, as long as the two proteases fulfill the relevant net formal charge criteria relative to SEQ ID NO: 1.
In addition to the amino acid alterations specifically disclosed herein, a protease variant in a composition of the invention may comprise additional alterations at one or more other positions. These additional alterations may be of a minor nature, that is typically conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein, and which do not alter the net formal charge as described herein; small deletions, typically of 1-30 amino acids; or small amino- or carboxyl-terminal extensions.
Examples of conservative substitutions are within the groups of basic amino acids (arginine, lysine and histidine), acidic amino acids (glutamic acid and aspartic acid), polar amino acids (glutamine and asparagine), hydrophobic amino acids (leucine, isoleucine and valine), aromatic amino acids (phenylalanine, tryptophan and tyrosine), and small amino acids (glycine, alanine, serine, threonine and methionine). Amino acid substitutions that do not generally alter specific activity are known in the art and are described, for example, by H. Neurath and R.L. Hill, 1979, in The Proteins, Academic Press, New York. Common conservative substitution groups include, but are not limited to: G=A=S; l=V=L=M; D=E; Y=F; and N=Q (where e.g. “G=A=S” means that these three amino acids may be substituted for each other).
Alternatively, the amino acid changes are of such a nature that the physico-chemical properties of the polypeptides are altered. For example, amino acid changes may improve the thermal stability of the polypeptide, alter the substrate specificity, change the pH optimum, and the like.
Essential amino acids in a polypeptide can be identified according to procedures known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (Cunningham and Wells, 1989, Science 244: 1081-1085). In the latter technique, single alanine mutations are introduced at every residue in the molecule, and the resultant mutant molecules are tested for protease activity to identify amino acid residues that are critical to the activity of the molecule. See also, Hilton et ai, 1996, J. Biol. Chem. 271 : 4699-4708. The active site of the enzyme or other biological interaction can also be determined by physical analysis of structure, as determined by such techniques as nuclear magnetic resonance, crystallography, electron diffraction, or photoaffinity labeling, in conjunction with mutation of putative contact site amino acids. See, for example, de Vos et ai, 1992, Science 255: 306-312; Smith et ai, 1992, J. Mol. Biol. 224: 899-
904; Wlodaver et al., 1992, FEBS Lett. 309: 59-64. The identity of essential amino acids can also be inferred from an alignment with a related polypeptide.
Detergent compositions
The detergent composition of the invention may be in any convenient form, e.g., a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, a bar, or a regular, compact or concentrated liquid.
In one embodiment, both the first protease and the second protease as described elsewhere herein are present in the same formulation, e.g. in the same liquid or solid phase. For example, in the case of a liquid formulation in the form of e.g. a liquid or gel, both the first and second protease would be present the liquid or gel phase. Similarly, in the case of a solid formulation, for example a powder, granulate or tablet, both the first and second protease would be present in the solid phase.
In a preferred embodiment, the detergent composition of the invention is a laundry composition, and in particular a liquid laundry composition. The use of two proteases with different net charge characteristics according to the invention allows flexibility with respect to incorporation into different liquid laundry detergent compositions, e.g. surfactant composition and/or level, and with respect to use under different wash conditions, e.g. wash pH and/or water hardness.
In one embodiment, the invention relates to a detergent composition as described above comprising at least a first protease and a second protease and further comprising one or more additional enzymes selected from the group consisting of amylases, catalases, cellulases (e.g., endoglucanases), cutinases, deoxyribonucleases, haloperoxygenases, lipases, mannanases, pectinases, pectin lyases, peroxidases, proteases, xanthanases, lichenases and xyloglucanases, or any mixture thereof.
The choice of additional components for a detergent composition is within the skill of the artisan and includes conventional ingredients, including the exemplary non-limiting components set forth below. The choice of components may include, for fabric care, the consideration of the type of fabric to be cleaned, the type and/or degree of soiling, the temperature at which cleaning is to take place, and the formulation of the detergent product.
In a particular embodiment, a detergent composition comprises the first and second protease and one or more non-naturally occurring detergent components, such as surfactants, hydrotropes, builders, co-builders, chelators or chelating agents, bleaching system or bleach components, polymers, fabric hueing agents, fabric conditioners, foam boosters, suds suppressors, dispersants, dye transfer inhibitors, fluorescent whitening agents, perfume, optical brighteners, bactericides, fungicides, soil suspending agents, soil release polymers, anti redeposition agents, enzyme inhibitors or stabilizers, enzyme activators, antioxidants, and solubilizers. The detergent composition will typically comprise at least a surfactant and a builder.
In one embodiment, the protease may be added to a detergent composition in an amount corresponding to 0.01-200 mg of enzyme protein per liter of wash liquor, preferably 0.05-50 mg of enzyme protein per liter of wash liquor, in particular 0.1-10 mg of enzyme protein per liter of wash liquor.
A granulated composition for laundry may for example include 0.001 %-20%, such as 0.01 %-10%, such as 0.05%-5% of enzyme protein by weight of the composition.
An automatic dishwashing (ADW) composition may for example include 0.001 %-30%, such as 0.01 %-20%, such as 0.1-15%, such as 0.5-10% of enzyme protein by weight of the composition.
The enzymes such as the protease may be stabilized using conventional stabilizing agents, e.g., a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4- formylphenyl boronic acid, and the composition may be formulated as described in, for example, WO 92/19709 and WO 92/19708 or the protease may be stabilized using peptide aldehydes or ketones such as described in WO 2005/105826 and WO 2009/118375.
The detergent composition may be formulated into a granular detergent for laundry. Such detergent may e.g. comprise;
a) at least 0.01 mg protease per gram of composition
b) anionic surfactant, preferably 5 wt % to 50 wt %
c) nonionic surfactant, preferably 1 wt % to 8 wt %
d) builder, preferably 5 wt % to 40 wt %, such as carbonates, zeolites, phosphate builder, calcium sequestering builders or complexing agents.
Although components mentioned below are categorized by general header according to a particular functionality, this is not to be construed as a limitation, as a component may comprise additional functionalities as will be appreciated by the person skilled in the art.
Surfactants
The detergent composition may comprise one or more surfactants, which may be anionic and/or cationic and/or non-ionic and/or semi-polar and/or zwitterionic, or a mixture thereof. In a particular embodiment, the detergent composition includes a mixture of one or more nonionic surfactants and one or more anionic surfactants. The surfactant(s) is typically present at a level of from about 0.1 % to 60% by weight, such as about 1 % to about 40%, or about 3% to about 20%, or about 3% to about 10%. The surfactant(s) is chosen based on the desired cleaning application, and includes any conventional surfactant(s) known in the art. Any surfactant known in the art for use in detergents may be utilized. Surfactants lower the surface tension in the detergent, which allows the stain being cleaned to be lifted and dispersed and then washed away.
When included therein, the detergent will usually contain from about 1 % to about 40% by
weight, such as from about 5% to about 30%, including from about 5% to about 15%, or from about 20% to about 25% of an anionic surfactant. Non-limiting examples of anionic surfactants include sulfates and sulfonates, in particular, linear alkylbenzenesulfonates (LAS), isomers of LAS, branched alkylbenzenesulfonates (BABS), phenylalkanesulfonates, alpha-olefinsulfonates (AOS), olefin sulfonates, alkene sulfonates, alkane-2, 3-diylbis(sulfates), hydroxyalkanesulfonates and disulfonates, alkyl sulfates (AS) such as sodium dodecyl sulfate (SDS), fatty alcohol sulfates (FAS), primary alcohol sulfates (PAS), alcohol ethersulfates (AES or AEOS or FES, also known as alcohol ethoxysulfates or fatty alcohol ether sulfates), secondary alkanesulfonates (SAS), paraffin sulfonates (PS), ester sulfonates, sulfonated fatty acid glycerol esters, alpha-sulfo fatty acid methyl esters (alpha-SFMe or SES) including methyl ester sulfonate (MES), alkyl- or alkenylsuccinic acid, dodecenyl/tetradecenyl succinic acid (DTSA), fatty acid derivatives of amino acids, diesters and monoesters of sulfo-succinic acid or soap, and combinations thereof.
When included therein, the detergent will usually contain from about 0% to about 10% by weight of a cationic surfactant. Non-limiting examples of cationic surfactants include alklydimethylethanolamine quat (ADMEAQ), cetyltrimethylammonium bromide (CTAB), dimethyldistearylammonium chloride (DSDMAC), and alkylbenzyldimethylammonium, alkyl quaternary ammonium compounds, alkoxylated quaternary ammonium (AQA) compounds, and combinations thereof.
When included therein, the detergent will usually contain from about 0.2% to about 40% by weight of a non-ionic surfactant, for example from about 0.5% to about 30%, in particular from about 1 % to about 20%, from about 3% to about 10%, such as from about 3% to about 5%, or from about 8% to about 12%. Non-limiting examples of non-ionic surfactants include alcohol ethoxylates (AE or AEO), alcohol propoxylates, propoxylated fatty alcohols (PFA), alkoxylated fatty acid alkyl esters, such as ethoxylated and/or propoxylated fatty acid alkyl esters, alkylphenol ethoxylates (APE), nonylphenol ethoxylates (NPE), alkylpolyglycosides (APG), alkoxylated amines, fatty acid monoethanolamides (FAM), fatty acid diethanolamides (FADA), ethoxylated fatty acid monoethanolamides (EFAM), propoxylated fatty acid monoethanolamides (PFAM), polyhydroxy alkyl fatty acid amides, or /V-acyl /V-alkyl derivatives of glucosamine (glucamides, GA, or fatty acid glucamide, FAGA), as well as products available under the trade names SPAN and TWEEN, and combinations thereof.
When included therein, the detergent will usually contain from about 0% to about 10% by weight of a semipolar surfactant. Non-limiting examples of semipolar surfactants include amine oxides (AO) such as alkyldimethylamineoxide, N-(coco alkyl)-/\/,/\/-dimethylamine oxide and N- (tallow-alkyl)-/\/,/\/-bis(2-hydroxyethyl)amine oxide, fatty acid alkanolamides and ethoxylated fatty acid alkanolamides, and combinations thereof.
When included therein, the detergent will usually contain from about 0% to about 10% by weight of a zwitterionic surfactant. Non-limiting examples of zwitterionic surfactants include
betaine, alkyldimethylbetaine, sulfobetaine, and combinations thereof.
Builders and Co-Builders
The detergent composition may contain about 0-65% by weight, such as about 5% to about 45% of a detergent builder or co-builder, or a mixture thereof. In a dishwashing detergent, the level of builder is typically 40-65%, particularly 50-65%. Builders and chelators soften, e.g., the wash water by removing the metal ions form the liquid. The builder and/or co-builder may particularly be a chelating agent that forms water-soluble complexes with Ca and Mg. Any builder and/or co-builder known in the art for use in laundry detergents may be utilized. Non-limiting examples of builders include zeolites, diphosphates (pyrophosphates), triphosphates such as sodium triphosphate (STP or STPP), carbonates such as sodium carbonate, soluble silicates such as sodium metasilicate, layered silicates (e.g., SKS-6 from Hoechst), ethanolamines such as 2- aminoethan-1-ol (MEA), diethanolamine (DEA, also known as iminodiethanol), triethanolamine (TEA, also known as 2,2’,2”-nitrilotri ethanol), and carboxymethyl inulin (CMI), and combinations thereof.
In a preferred embodiment, the detergent composition is phosphate-free.
The detergent composition may also contain 0-20% by weight, such as about 5% to about 10%, of a detergent co-builder, or a mixture thereof. The detergent composition may include a co-builder alone, or in combination with a builder, for example a zeolite builder. Non-limiting examples of co-builders include homopolymers of polyacrylates or copolymers thereof, such as poly(acrylic acid) (PAA) or copoly(acrylic acid/maleic acid) (PAA/PMA). Further non-limiting examples include citrate, chelators such as aminocarboxylates, aminopolycarboxylates and phosphonates, and alkyl- or alkenylsuccinic acid. Additional specific examples include 2, 2’, 2”- nitrilotriacetic acid (NTA), ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), iminodisuccinic acid (IDS), ethylenediamine-/\/,/\/’-disuccinic acid (EDDS), methylglycinediacetic acid (MGDA), glutamic acid-N,N-diacetic acid (GLDA), 1-hydroxyethane- 1 , 1-diphosphonic acid (HEDP), ethylenediaminetetra-(methylenephosphonic acid) (EDTMPA), diethylenetriaminepentakis (methylenephosphonic acid) (DTPMPA or DTMPA), N-( 2- hydroxyethyl)iminodiacetic acid (EDG), aspartic acid-/\/-monoacetic acid (ASMA), aspartic acid- /V, /V-diacetic acid (ASDA), aspartic acid-/\/-monopropionic acid (ASMP), iminodisuccinic acid (IDA), A/-(2-sulfomethyl)-aspartic acid (SMAS), A/-(2-sulfoethyl)-aspartic acid (SEAS), N-(2- sulfomethyl)-glutamic acid (SMGL), A/-(2-sulfoethyl)-glutamic acid (SEGL), /V-methyliminodiacetic acid (MIDA), a-alanin e-N, /V-diacetic acid (a-ALDA), serin e-N, /V-diacetic acid (SEDA), isoserine- N, /V-diacetic acid (ISDA), phenylalanine-/V, /V-diacetic acid (PHDA), anthranilic acid-/V, /V-diacetic acid (ANDA), sulfanilic acid -N, /V-diacetic acid (SLDA), taurin e-N, /V-diacetic acid (TUDA) and sulfomethyl-/V, /V-diacetic acid (SMDA), /V-(2-hydroxyethyl)-ethylidenediamine-/V, N’, /V -triacetate (HEDTA), diethanolglycine (DEG), diethylenetriamine penta(methylenephosphonic acid)
(DTPMP), aminotris(methylenephosphonic acid) (ATMP), and combinations and salts thereof. Further exemplary builders and/or co-builders are described in, e.g., WO 2009/102854 and US 5,977,053.
The first and second protease of the invention may also be formulated into a dishwashing composition, preferably an automatic dishwashing composition (ADW), comprising:
a) at least 0.01 mg of active protease, and
b) 10-50 wt % builder preferably selected from citric acid, methylglycine-N,N-diacetic acid (MGDA) and/or glutamic acid-N,N-diacetic acid (GLDA) and mixtures thereof, and
c) at least one bleach component.
Bleaching Systems
The detergent may contain 0-50% by weight, such as about 0.1 % to about 25%, of a bleaching system. Bleach systems remove discolor often by oxidation, and many bleaches also have strong bactericidal properties, and are used for disinfecting and sterilizing. Any bleaching system known in the art for use in laundry detergents may be utilized. Suitable bleaching system components include bleaching catalysts, photobleaches, bleach activators, sources of hydrogen peroxide such as sodium percarbonate and sodium perborates, preformed peracids and mixtures thereof. Suitable preformed peracids include, but are not limited to, peroxycarboxylic acids and salts, percarbonic acids and salts, perimidic acids and salts, peroxymonosulfuric acids and salts, for example, Oxone (R), and mixtures thereof. Non-limiting examples of bleaching systems include peroxide-based bleaching systems, which may comprise, for example, an inorganic salt, including alkali metal salts such as sodium salts of perborate (usually mono- or tetra- hydrate), percarbonate, persulfate, perphosphate, persilicate salts, in combination with a peracid-forming bleach activator.
The term bleach activator is meant herein as a compound which reacts with peroxygen bleach like hydrogen peroxide to form a peracid. The peracid thus formed constitutes the activated bleach. Suitable bleach activators to be used herein include those belonging to the class of esters amides, imides or anhydrides. Suitable examples are tetracetylethylene diamine (TAED), sodium 4-[(3,5,5-trimethylhexanoyl)oxy]benzene sulfonate (ISONOBS), diperoxy dodecanoic acid, 4- (dodecanoyloxy)benzenesulfonate (LOBS), 4-(decanoyloxy)benzenesulfonate, 4- (decanoyloxy)benzoate (DOBS), 4-(nonanoyloxy)-benzenesulfonate (NOBS), and/or those disclosed in WO 98/17767. A particular family of bleach activators of interest was disclosed in EP 624154 and particularly preferred in that family is acetyl triethyl citrate (ATC). ATC or a short chain triglyceride like triacetin has the advantage that it is environmentally friendly as it eventually degrades into citric acid and alcohol. Furthermore, acetyl triethyl citrate and triacetin have good hydrolytic stability in the product upon storage and are efficient bleach activators. Finally, ATC provides a good building capacity to the laundry additive. Alternatively, the bleaching system may
comprise peroxyacids of, for example, the amide, imide, or sulfone type. The bleaching system may also comprise peracids such as 6-(phthalimido)peroxyhexanoic acid (PAP). The bleaching system may also include a bleach catalyst or a booster.
Some non-limiting examples of bleach catalysts that may be used in the compositions of the present invention include manganese oxalate, manganese acetate, manganese-collagen, cobalt-amine catalysts and manganese triazacyclononane (MnTACN) catalysts; particularly preferred are complexes of manganese with 1 ,4,7-trimethyl-1 ,4,7-triazacyclononane (Me3- TACN) or 1 ,2,4,7-tetramethyl-1 ,4,7-triazacyclononane (Me4-TACN), in particular Me3-TACN, such as the dinuclear manganese complex [(Me3-TACN)Mn(0)3Mn(Me3-TACN)](PF6)2, and [2,2',2"-nitrilotris(ethane-1 ,2-diylazanylylidene-KN-methanylylidene)triphenolato- K30]manganese(lll). The bleach catalysts may also be other metal compounds, such as iron or cobalt complexes.
In some embodiments, the bleach component may be an organic catalyst selected from the group consisting of organic catalysts having the following formula:
(iii) and mixtures thereof; wherein each R1 is independently a branched alkyl group containing from 9 to 24 carbons or linear alkyl group containing from 11 to 24 carbons, preferably each R1 is independently a branched alkyl group containing from 9 to 18 carbons or linear alkyl group containing from 1 1 to 18 carbons, more preferably each R1 is independently selected from the group consisting of 2-propylheptyl, 2-butyloctyl, 2-pentylnonyl, 2-hexyldecyl, n-dodecyl, n- tetradecyl, n-hexadecyl, n-octadecyl, iso-nonyl, iso-decyl, iso-tridecyl and iso-pentadecyl. Other exemplary bleaching systems are described, e.g., in WO 2007/087258, WO 2007/087244, WO 2007/087259 and WO 2007/087242. Suitable photobleaches may for example be sulfonated zinc phthalocyanine.
Hydrotropes
A hydrotrope is a compound that solubilizes hydrophobic compounds in aqueous solutions (or oppositely, polar substances in a non-polar environment). Typically, hydrotropes have both hydrophilic and hydrophobic characters (so-called amphiphilic properties as known from surfactants); however, the molecular structures of hydrotropes generally do not favour spontaneous self-aggregation, see, e.g., review by Hodgdon and Kaler, 2007, Current Opinion in Colloid & Interface Science 12: 121-128. Hydrotropes do not display a critical concentration above which self-aggregation occurs as found for surfactants and lipids forming miceller, lamellar or
other well defined meso-phases. Instead, many hydrotropes show a continuous-type aggregation process where the sizes of aggregates grow as concentration increases. However, many hydrotropes alter the phase behaviour, stability, and colloidal properties of systems containing substances of polar and non-polar character, including mixtures of water, oil, surfactants, and polymers. Hydrotropes are classically used across industries from pharma, personal care and food to technical applications. Use of hydrotropes in detergent compositions allows for example more concentrated formulations of surfactants (as in the process of compacting liquid detergents by removing water) without inducing undesired phenomena such as phase separation or high viscosity.
The detergent may contain 0-5% by weight, such as about 0.5 to about 5%, or about 3% to about 5%, of a hydrotrope. Any hydrotrope known in the art for use in detergents may be utilized. Non-limiting examples of hydrotropes include sodium benzene sulfonate, sodium p- toluene sulfonate (STS), sodium xylene sulfonate (SXS), sodium cumene sulfonate (SCS), sodium cymene sulfonate, amine oxides, alcohols and polyglycolethers, sodium hydroxynaphthoate, sodium hydroxynaphthalene sulfonate, sodium ethylhexyl sulfate, and combinations thereof.
Polymers
The detergent may contain 0-10% by weight, such as 0.5-5%, 2-5%, 0.5-2% or 0.2-1 % of a polymer. Any polymer known in the art for use in detergents may be utilized. The polymer may function as a co-builder as mentioned above, or may provide antiredeposition, fiber protection, soil release, dye transfer inhibition, grease cleaning and/or anti-foaming properties. Some polymers may have more than one of the above-mentioned properties and/or more than one of the below-mentioned motifs. Exemplary polymers include (carboxymethyl)cellulose (CMC), poly(vinyl alcohol) (PVA), poly(vinylpyrrolidone) (PVP), poly(ethyleneglycol) or poly(ethylene oxide) (PEG), ethoxylated poly(ethyleneimine), carboxymethyl inulin (CMI), and polycarboxylates such as PAA, PAA/PMA, poly-aspartic acid, and lauryl methacrylate/acrylic acid copolymers, hydrophobically modified CMC (HM-CMC) and silicones, copolymers of terephthalic acid and oligomeric glycols, copolymers of poly(ethylene terephthalate) and poly(oxyethene terephthalate) (PET-POET), PVP, poly(vinylimidazole) (PVI), poly(vinylpyridine-A/-oxide) (PVPO or PVPNO) and polyvinylpyrrolidone-vinylimidazole (PVPVI). Further exemplary polymers include sulfonated polycarboxylates, polyethylene oxide and polypropylene oxide (PEO-PPO) and diquaternium ethoxy sulfate. Other exemplary polymers are disclosed in, e.g., WO 2006/130575. Salts of the above-mentioned polymers are also contemplated.
Fabric hueing agents
The detergent compositions of the present invention may also include fabric hueing agents
such as dyes or pigments, which when formulated in detergent compositions can deposit onto a fabric when the fabric is contacted with a wash liquor comprising the detergent compositions and thus altering the tint of the fabric through absorption/reflection of visible light. Fluorescent whitening agents emit at least some visible light. In contrast, fabric hueing agents alter the tint of a surface as they absorb at least a portion of the visible light spectrum. Suitable fabric hueing agents include dyes and dye-clay conjugates, and may also include pigments. Suitable dyes include small molecule dyes and polymeric dyes. Suitable small molecule dyes include small molecule dyes selected from the group consisting of dyes falling into the Colour Index (C.l.) classifications of Direct Blue, Direct Red, Direct Violet, Acid Blue, Acid Red, Acid Violet, Basic Blue, Basic Violet and Basic Red, or mixtures thereof, for example as described in WO 2005/003274, WO 2005/003275, WO 2005/003276 and EP 1876226 (hereby incorporated by reference). The detergent composition preferably comprises from about 0.00003 wt. % to about 0.2 wt. %, from about 0.00008 wt. % to about 0.05 wt. %, or even from about 0.0001 wt. % to about 0.04 wt. % fabric hueing agent. The composition may comprise from 0.0001 wt % to 0.2 wt. % fabric hueing agent, this may be especially preferred when the composition is in the form of a unit dose pouch. Suitable hueing agents are also disclosed in, e.g., WO 2007/087257 and WO 2007/087243.
Additional Enzymes
A detergent additive or detergent composition may comprise one or more additional enzymes such as an amylase, an arabinase, a carbohydrase, a cellulase (e.g., endoglucanase), a cutinase, a deoxyribonuclease, a galactanase, a haloperoxygenase, a lipase, a mannanase, an oxidase, e.g., a laccase and/or peroxidase, a pectinase, a pectin lyase, an additional protease, a xylanase, a xanthanase or a xyloglucanase.
The properties of the selected enzyme(s) should be compatible with the selected detergent (e.g. pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.).
Cellulases
Suitable cellulases include mono-component and mixtures of enzymes of bacterial or fungal origin. Chemically modified or protein engineered mutants are also contemplated. The cellulase may for example be a mono-component or a mixture of mono-component endo-1 ,4- beta-glucanase also referred to as endoglucanase.
Suitable cellulases include those from the genera Bacillus, Pseudomonas, Humicola, Myceliophthora, Fusarium, Thielavia, Trichoderma, and Acremonium. Exemplary cellulases include a fungal cellulase from Humicola insolens (US 4,435,307) or from Trichoderma, e.g. T. reesei or T. viride. Other suitable cellulases are from Thielavia e.g. Thielavia terrestris as
described in WO 96/29397 or the fungal cellulases produced from Myceliophthora thermophila and Fusarium oxysporum disclosed in US 5,648,263, US 5,691 , 178, US 5,776,757, WO 89/09259 and WO 91/17244. Also relevant are cellulases from Bacillus as described in WO 02/099091 and JP 2000210081. Suitable cellulases are alkaline or neutral cellulases having care benefits. Examples of cellulases are described in EP 0 495 257, EP 0 531 372, WO 96/1 1262, WO 96/29397, WO 98/08940. Other examples are cellulase variants such as those described in WO 94/07998, EP 0 531 315, US 5,457,046, US 5,686,593, US 5,763,254, WO 95/24471 , WO 98/12307.
Other cellulases are endo-beta-1 ,4-glucanase enzyme having a sequence of at least 97% identity to the amino acid sequence of position 1 to position 773 of SEQ ID NO:2 of WO 2002/099091 or a family 44 xyloglucanase, which a xyloglucanase enzyme having a sequence of at least 60% identity to positions 40-559 of SEQ ID NO: 2 of WO 2001/062903.
Commercially available cellulases include Carezyme®, Carezyme® Premium, Celluzyme®, Celluclean®, Celluclast®, Endolase®, Renozyme®; Whitezyme® Celluclean® Classic, Cellusoft® (Novozymes A/S), Puradax®, Puradax HA, and Puradax EG (available from Genencor International Inc.) and KAC-500(B)™ (Kao Corporation).
Mannanases
Suitable mannanases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included. The mannanase may be an alkaline mannanase of Family 5 or 26. It may be a wild-type from Bacillus or Humicola, particularly B. agaradhaerens, B. licheniformis, B. halodurans, B. clausii, or H. insolens. Suitable mannanases are described in WO 1999/064619. A commercially available mannanase is Mannaway® (Novozymes A/S).
Proteases
The composition may, in addition to the first and second proteases as disclosed herein, comprise one or more additional proteases including those of bacterial, fungal, plant, viral or animal origin. Proteases of microbial origin are preferred. The protease may be an alkaline protease, such as a serine protease or a metalloprotease. A serine protease may for example be of the S1 family, such as trypsin, or the S8 family such as subtilisin. A metalloprotease may for example be a thermolysin from, e.g., family M4 or another metalloprotease such as those from M5, M7 or M8 families.
Examples of metalloproteases are the neutral metalloproteases as described in WO 2007/044993 (Genencor Int.) such as those derived from Bacillus amyloliquefaciens.
Suitable commercially available protease enzymes include those sold under the trade names Alcalase®, DuralaseTm, DurazymTm, Relase®, Relase® Ultra, Savinase®, Savinase® Ultra, Primase®, Polarzyme®, Kannase®, Liquanase®, Liquanase® Ultra, Ovozyme®, Coronase®, Coronase® Ultra, Blaze®, Blaze Evity® 100T, Blaze Evity® 125T, Blaze Evity®
150T, Neutrase®, Everlase®, Esperase®, Progress® Uno and Progress® Excel (Novozymes A/S), those sold under the tradenames Maxatase®, Maxacal®, Maxapem®, Purafect®™, Purafect® Ox, Purafect® OxP, Purafect Prime®, Puramax®, FN2®, FN3®, FN4®, Excellase®, Excellenz P1000™, Excellenz P1250™, Eraser®, Preferenz® P100, Preferenz® P110, Effectenz P1000™, Effectenz P1050™, Effectenz P2000™, Purafast®, Properase®, Opticlean® and Optimase® (Danisco/DuPont), Axapem™ (Gist-Brocases N.V.), BLAP (sequence shown in Figure 29 of US5352604) and variants hereof (Henkel AG) and KAP ( Bacillus alkalophilus subtilisin) from Kao.
Lipases and Cutinases
Suitable lipases and cutinases include those of bacterial or fungal origin. Chemically modified or protein engineered mutant enzymes are included. Examples include lipase from Thermomyces, e.g., from T. lanuginosus (previously named Humicola lanuginosa) as described in EP 258068 and EP 305216, cutinase from Humicola, e.g., H. insolens (WO 96/13580), lipase from strains of Pseudomonas (some of these now renamed to Burkholderia), e.g., P. alcaligenes or P. pseudoalcaligenes (EP 218272), P. cepacia (EP 331376), P. sp. strain SD705 (WO 95/06720 & WO 96/27002), P. wisconsinensis (WO 96/12012), GDSL-type Streptomyces lipases (WO 2010/065455), cutinase from Magnaporthe grisea (WO 2010/107560), cutinase from Pseudomonas mendocina (US 5,389,536), lipase from Thermobifida fusca (WO 2011/084412), Geobacillus stearothermophilus lipase (WO 2011/084417), lipase from Bacillus subtilis (WO 201 1/084599), and lipase from Streptomyces griseus (WO 2011/150157) and S. pristinaespiralis (WO 2012/137147).
Other examples are lipase variants such as those described in EP 407225, WO 92/05249, WO 94/01541 , WO 94/25578, WO 95/14783, WO 95/30744, WO 95/35381 , WO 95/22615, WO 96/00292, WO 97/04079, WO 97/07202, WO 00/34450, WO 00/60063, WO 01/92502, WO 2007/87508 and WO 2009/109500.
Preferred commercial lipase products include Lipolase™, Lipex™; Lipolex™ and Lipoclean™ (Novozymes A/S), Lumafast (originally from Genencor) and Lipomax (originally from Gist-Brocades).
Still other examples are lipases sometimes referred to as acyltransferases or perhydrolases, e.g., acyltransferases with homology to Candida antarctica lipase A (WO 2010/11 1143), acyltransferase from Mycobacterium smegmatis (WO 2005/056782), perhydrolases from the CE 7 family (WO 2009/067279), and variants of the M. smegmatis perhydrolase, in particular the S54V variant used in the commercial product Gentle Power Bleach from Huntsman Textile Effects Pte Ltd (WO 2010/100028).
Amylases
Suitable amylases which can be used together with the protease may be an alpha- amylase or a glucoamylase and may be of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, alpha-amylases obtained from Bacillus, e.g., a special strain of Bacillus licheniformis, described in more detail in GB 1 ,296,839.
Suitable amylases include amylases having SEQ ID NO: 2 in WO 95/10603 or variants having 90% sequence identity to SEQ ID NO: 3 thereof. Preferred variants are described in WO 94/02597, WO 94/18314, WO 97/43424 and SEQ ID NO: 4 of WO 99/19467, such as variants with substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 178, 179, 181 , 188, 190, 197, 201 , 202, 207, 208, 209, 211 , 243, 264, 304, 305, 391 , 408, and 444.
Different suitable amylases include amylases having SEQ ID NO: 6 in WO 02/10355 or variants thereof having 90% sequence identity to SEQ ID NO: 6. Preferred variants of SEQ ID NO: 6 are those having a deletion in positions 181 and 182 and a substitution in position 193.
Other amylases which are suitable are hybrid alpha-amylases comprising residues 1-33 of the alpha-amylase derived from B. amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006/066594 and residues 36-483 of the B. licheniformis alpha-amylase shown in SEQ ID NO: 4 of WO 2006/066594 or variants having 90% sequence identity thereof. Preferred variants of this hybrid alpha-amylase are those having a substitution, a deletion or an insertion in one of more of the following positions: G48, T49, G107, H156, A181 , N 190, M197, 1201 , A209 and Q264. Most preferred variants of the hybrid alpha-amylase comprising residues 1-33 of the alpha-amylase derived from B. amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006/066594 and residues 36- 483 of SEQ ID NO: 4 are those having the substitutions:
M197T;
H 156Y+A 181 T+ N 190F+A209V+Q264S; or
G48A+T49I+G107A+ H 156Y+A 181 T+N 190F+ 1201 F+A209V+Q264S.
Other suitable amylases are amylases having the sequence of SEQ ID NO: 6 in WO 99/19467 or variants thereof having 90% sequence identity to SEQ ID NO: 6. Preferred variants of SEQ ID NO: 6 are those having a substitution, a deletion or an insertion in one or more of the following positions: R181 , G182, H183, G184, N195, I206, E212, E216 and K269. Particularly preferred amylases are those having deletion in positions R181 and G182, or positions H183 and G184.
Additional amylases which can be used are those having SEQ ID NO: 1 , SEQ ID NO: 3, SEQ ID NO: 2 or SEQ ID NO: 7 of WO 96/23873 or variants thereof having 90% sequence identity to SEQ ID NO: 1 , SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 7. Preferred variants of SEQ ID NO: 1 , SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 7 are those having a substitution, a deletion
or an insertion in one or more of the following positions: 140, 181 , 182, 183, 184, 195, 206, 212, 243, 260, 269, 304 and 476, using SEQ ID 2 of WO 96/23873 for numbering. More preferred variants are those having a deletion in two positions selected from 181 , 182, 183 and 184, such as 181 and 182, 182 and 183, or positions 183 and 184. Most preferred amylase variants of SEQ ID NO: 1 , SEQ ID NO: 2 or SEQ ID NO: 7 are those having a deletion in positions 183 and 184 and a substitution in one or more of positions 140, 195, 206, 243, 260, 304 and 476.
Other amylases which can be used are amylases having SEQ ID NO: 2 of WO 2008/153815, SEQ ID NO: 10 in WO 01/66712 or variants thereof having 90% sequence identity to SEQ ID NO: 2 of WO 2008/153815 or 90% sequence identity to SEQ ID NO: 10 in WO 01/66712. Preferred variants of SEQ ID NO: 10 in WO 01/66712 are those having a substitution, a deletion or an insertion in one of more of the following positions: 176, 177, 178, 179, 190, 201 , 207, 21 1 and 264.
Further suitable amylases are amylases having SEQ ID NO: 2 of WO 2009/061380 or variants having 90% sequence identity to SEQ ID NO: 2 thereof. Preferred variants of SEQ ID NO: 2 are those having a truncation of the C-terminus and/or a substitution, a deletion or an insertion in one of more of the following positions: Q87, Q98, S125, N128, T131 , T165, K178, R180, S181 , T182, G183, M201 , F202, N225, S243, N272, N282, Y305, R309, D319, Q320, Q359, K444 and G475. More preferred variants of SEQ ID NO: 2 are those having the substitution in one of more of the following positions: Q87E,R, Q98R, S125A, N128C, T131 I, T165I, K178L, T182G, M201 L, F202Y, N225E.R, N272E.R, S243Q,A,E,D, Y305R, R309A, Q320R, Q359E, K444E and G475K and/or deletion in position R180 and/or S181 or of T182 and/or G183. Most preferred amylase variants of SEQ ID NO: 2 are those having the substitutions:
N 128C+K178L+T182G+Y305R+G475K;
N 128C+K178L+T182G+F202Y+Y305R+D319T+G475K;
S125A+N 128C+K178L+T182G+Y305R+G475K; or
S125A+N 128C+T131 I+T165I+K178L+T182G+Y305R+G475K,
wherein the variants are C-terminally truncated and optionally further comprise a substitution at position 243 and/or a deletion at position 180 and/or position 181.
Further suitable amylases are amylases having SEQ ID NO: 1 of WO 2013/184577 or variants having 90% sequence identity to SEQ ID NO: 1 thereof. Preferred variants of SEQ ID NO: 1 are those having a substitution, a deletion or an insertion in one of more of the following positions: K176, R178, G179, T180, G181 , E187, N192, M199, I203, S241 , R458, T459, D460, G476 and G477. More preferred variants of SEQ ID NO: 1 are those having the substitution in one of more of the following positions: K176L, E187P, N192FYH, M199L, I203YF, S241QADN, R458N, T459S, D460T, G476K and G477K and/or a deletion in position R178 and/or S179 or of T180 and/or G181. Most preferred amylase variants of SEQ ID NO: 1 comprise the substitutions:
E187P+I203Y+G476K
E187P+I203Y+R458N+T459S+D460T+G476K
and optionally further comprise a substitution at position 241 and/or a deletion at position 178 and/or position 179.
Further suitable amylases are amylases having SEQ ID NO: 1 of WO 2010/104675 or variants having 90% sequence identity to SEQ ID NO: 1 thereof. Preferred variants of SEQ ID NO: 1 are those having a substitution, a deletion or an insertion in one of more of the following positions: N21 , D97, V128 K177, R179, S180, 1181 , G182, M200, L204, E242, G477 and G478.
More preferred variants of SEQ ID NO: 1 are those having the substitution in one of more of the following positions: N21 D, D97N, V128I K177L, M200L, L204YF, E242QA, G477K and G478K and/or a deletion in position R179 and/or S180 or of 1181 and/or G182. Most preferred amylase variants of SEQ ID NO: 1 comprise the substitutions N21 D+D97N+V128I, and optionally further comprise a substitution at position 200 and/or a deletion at position 180 and/or position 181.
Other suitable amylases are the alpha-amylase having SEQ ID NO: 12 in WO 01/66712 or a variant having at least 90% sequence identity to SEQ ID NO: 12. Preferred amylase variants are those having a substitution, a deletion or an insertion in one of more of the following positions of SEQ ID NO: 12 in WO 01/66712: R28, R118, N 174; R181 , G182, D183, G184, G186, W189, N195, M202, Y298, N299, K302, S303, N306, R310, N314; R320, H324, E345, Y396, R400, W439, R444, N445, K446, Q449, R458, N471 , N484. Particularly preferred amylases include variants having a deletion of D183 and G184 and having the substitutions R1 18K, N195F, R320K and R458K, and a variant additionally having substitutions in one or more position selected from the group: M9, G149, G182, G186, M202, T257, Y295, N299, M323, E345 and A339, most preferred a variant that additionally has substitutions in all these positions.
Other examples are amylase variants such as those described in WO 201 1/098531 , WO 2013/001078 and WO 2013/001087. Commercially available amylases include Duramyl™, Termamyl™, Fungamyl™, Stainzyme™, Stainzyme Plus™, Natalase™, Liquozyme X, BAN™, Amplify® and Amplify® Prime (from Novozymes A/S), and Rapidase™, Purastar™/Effectenz™, Powerase, Preferenz S1000, Preferenz S100 and Preferenz S110 (from Genencor International Inc./DuPont).
One preferred amylase is a variant of the amylase having SEQ ID NO: 13 in WO 2016/180748 with the alterations H1*+N54S+ V56T+ K72R+G109A+ F113Q+ R1 16Q+ W167F+ Q172G+ A174S+ G182*+D183*+ G184T+ N195F+ V206L+ K391A+ P473R+ G476K.
Another preferred amylase is a variant of the amylase having SEQ ID NO: 1 in WO 2013/001078 with the alterations D183*+G184*+W140Y+N195F+V206Y+Y243F+E260G+ G304R+G476K.
Another preferred amylase is a variant of the amylase having SEQ ID NO: 1 in WO 2018/141707 with the alterations H1*+G7A+G109A+W140Y+G182*+D183*+N195F+V206Y+
Y243F+E260G+N280S+G304R+E391A+G476K.
A further preferred amylase is a variant of the amylase having SEQ ID NO: 1 in WO 2017/191160 with the alterations L202M + T246V.
Peroxidases/Oxidases
Suitable peroxidases/oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g., from C. cinereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257.
Commercially available peroxidases include Guardzyme™ (Novozymes A/S).
Deoxyribonucleases (DNases)
Suitable deoxyribonucleases (DNases) are any enzyme that catalyzes the hydrolytic cleavage of phosphodiester linkages in the DNA backbone, thus degrading DNA. Bacterial DNases are preferred, in particular a DNase which is obtainable from a species of Bacillus is preferred, in particular a DNase which is obtainable from Bacillus subtilis or Bacillus licheniformis. Examples of such DNases are described in WO 201 1/098579 and WO 2014/087011.
Adjunct materials
Any detergent components known in the art for use in laundry detergents may also be utilized. Other optional detergent components include anti-corrosion agents, anti-shrink agents, anti-soil redeposition agents, anti-wrinkling agents, bactericides, binders, corrosion inhibitors, disintegrants/disintegration agents, dyes, enzyme stabilizers (including boric acid, borates, CMC, and/or polyols such as propylene glycol), fabric conditioners including clays, fillers/processing aids, fluorescent whitening agents/optical brighteners, foam boosters, foam (suds) regulators, perfumes, soil-suspending agents, softeners, suds suppressors, tarnish inhibitors, and wicking agents, either alone or in combination. Any ingredient known in the art for use in laundry detergents may be utilized. The choice of such ingredients is well within the skill of the artisan.
Dispersants: The detergent compositions of the present invention can also contain dispersants. In particular powdered detergents may comprise dispersants. Suitable water-soluble organic materials include the homo- or co-polymeric acids or their salts, in which the polycarboxyl ic acid comprises at least two carboxyl radicals separated from each other by not more than two carbon atoms. Suitable dispersants are for example described in Powdered Detergents, Surfactant Science Series, volume 71 , Marcel Dekker, Inc., 1997.
Dye Transfer Inhibiting Agents: The detergent compositions of the present invention may also include one or more dye transfer inhibiting agents. Suitable polymeric dye transfer inhibiting agents include, but are not limited to, polyvinylpyrrolidone polymers, polyamine N-oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidones and
polyvinylimidazoles or mixtures thereof. When present in a subject composition, the dye transfer inhibiting agents may be present at levels from about 0.0001 % to about 10%, from about 0.01 % to about 5% or even from about 0.1 % to about 3% by weight of the composition.
Fluorescent whitening agent: The detergent compositions of the present invention will preferably also contain additional components that may tint articles being cleaned, such as fluorescent whitening agent or optical brighteners. Where present the brightener is preferably at a level of about 0.01 % to about 05%. Any fluorescent whitening agent suitable for use in a laundry detergent composition may be used in the composition of the present invention. The most commonly used fluorescent whitening agents are those belonging to the classes of diaminostilbene-sulphonic acid derivatives, diarylpyrazoline derivatives and bisphenyl-distyryl derivatives. Examples of the diaminostilbene-sulphonic acid derivative type of fluorescent whitening agents include the sodium salts of: 4,4'-bis-(2-diethanolamino-4-anilino-s-triazin-6- ylamino) stilbene-2,2'-disulphonate; 4,4'-bis-(2,4-dianilino-s-triazin-6-ylamino) stilbene-2.2'- disulphonate; 4,4'-bis-(2-anilino-4(N-methyl-N-2-hydroxy-ethylamino)-s-triazin-6-ylamino) stilbene-2,2'-disulphonate, 4,4'-bis-(4-phenyl-2, 1 ,3-triazol-2-yl)stilbene-2,2'-disulphonate; 4,4'- bis-(2-anilino-4(1-methyl-2-hydroxy-ethylamino)-s-triazin-6-ylamino) stilbene-2,2'-disulphonate and 2-(stilbyl-4"-naptho-1.,2':4,5)-1 ,2,3-trizole-2"-sulphonate. Preferred fluorescent whitening agents are Tinopal DMS and Tinopal CBS available from Ciba-Geigy AG, Basel, Switzerland. Tinopal DMS is the disodium salt of 4,4'-bis-(2-morpholino-4 anilino-s-triazin-6-ylamino) stilbene disulphonate. Tinopal CBS is the disodium salt of 2,2'-bis-(phenyl-styryl) disulphonate. Also preferred are fluorescent whitening agents is the commercially available Parawhite KX, supplied by Paramount Minerals and Chemicals, Mumbai, India. Other fluorescers suitable for use in the invention include the 1-3-diaryl pyrazolines and the 7-alkylaminocoumarins. Suitable fluorescent brightener levels include lower levels of from about 0.01 , from 0.05, from about 0.1 or even from about 0.2 wt. % to upper levels of 0.5 or even 0.75 wt. %.
Soil release polymers: The detergent compositions of the present invention may also include one or more soil release polymers which aid the removal of soils from fabrics such as cotton and polyester based fabrics, in particular the removal of hydrophobic soils from polyester based fabrics. The soil release polymers may for example be nonionic or anionic terephthalte based polymers, polyvinyl caprolactam and related copolymers, vinyl graft copolymers, polyester polyamides see for example Chapter 7 in Powdered Detergents, Surfactant science series volume 71 , Marcel Dekker, Inc. Another type of soil release polymers are amphiphilic alkoxylated grease cleaning polymers comprising a core structure and a plurality of alkoxylate groups attached to that core structure. The core structure may comprise a polyalkylenimine structure or a polyalkanolamine structure as described in detail in WO 2009/087523 (hereby incorporated by reference). Furthermore, random graft co-polymers are suitable soil release polymers Suitable graft co-polymers are described in more detail in WO 2007/138054, WO 2006/108856 and WO
2006/113314 (hereby incorporated by reference). Other soil release polymers are substituted polysaccharide structures especially substituted cellulosic structures such as modified cellulose deriviatives such as those described in EP 1867808 or WO 03/040279 (both are hereby incorporated by reference). Suitable cellulosic polymers include cellulose, cellulose ethers, cellulose esters, cellulose amides and mixtures thereof. Suitable cellulosic polymers include anionically modified cellulose, nonionically modified cellulose, cationically modified cellulose, zwitterionically modified cellulose, and mixtures thereof. Suitable cellulosic polymers include methyl cellulose, carboxy methyl cellulose, ethyl cellulose, hydroxyl ethyl cellulose, hydroxyl propyl methyl cellulose, ester carboxy methyl cellulose, and mixtures thereof.
Anti-redeposition agents: The detergent compositions of the present invention may also include one or more anti-redeposition agents such as carboxymethylcellulose (CMC), polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), polyoxyethylene and/or polyethyleneglycol (PEG), homopolymers of acrylic acid, copolymers of acrylic acid and maleic acid, and ethoxylated polyethyleneimines. The cellulose based polymers described under soil release polymers above may also function as anti-redeposition agents.
Other suitable adjunct materials include, but are not limited to, anti-shrink agents, anti wrinkling agents, bactericides, binders, carriers, dyes, enzyme stabilizers, fabric softeners, fillers, foam regulators, hydrotropes, perfumes, pigments, sod suppressors, solvents, and structurants for liquid detergents and/or structure elasticizing agents.
Formulation of Detergent Products
The detergent enzymes, i.e. the first and second proteases and optionally one or more additional enzymes, may be included in a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising these enzymes.
As noted above, the detergent composition may, e.g., be in the form of a powder, a granulate, a tablet, a pouch, a paste, a gel or a liquid.
Pouches
Pouches (pods) can be configured as single or multiple compartments and can be of any form, shape and material suitable to hold the composition, without allowing the release of the composition from the pouch prior to water contact. The pouch is made from water soluble film which encloses an inner volume. The inner volume can be divided into compartments of the pouch. Preferred films are polymeric materials, preferably polymers which are formed into a film or sheet. Preferred polymers, copolymers or derivates thereof are selected from polyacrylates, and water-soluble acrylate copolymers, methyl cellulose, carboxy methyl cellulose, sodium dextrin, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, maltodextrin, polymethacrylates, most preferably polyvinyl alcohol copolymers and hydroxypropyl methyl cellulose (HPMC). Preferably the level of polymer in the film for example PVA is at least about
60%. The preferred average molecular weight will typically be about 20,000 to about 150,000. Films can also be of blend compositions comprising hydrolytically degradable and water-soluble polymer blends such as polylactide and polyvinyl alcohol (known under the Trade reference M8630 as sold by Chris Craft In. Prod of Gary, Indiana, US) plus plasticizers like glycerol, ethylene glycerol, propylene glycol, sorbitol and mixtures thereof. The pouches can for example comprise a solid laundry detergent composition or part components and/or a liquid cleaning composition or part components separated by the water-soluble film. The compartment for liquid components can be different in composition than compartments containing solids. See, e.g., US 2009/001 1970.
Detergent ingredients can be separated physically from each other by compartments in water dissolvable pouches or in different layers of tablet, thereby avoiding negative storage interaction between components. Different dissolution profiles of each of the compartments can also give rise to delayed dissolution of selected components in the wash solution.
Liquids and gels
A liquid or gel detergent which is not unit dosed may be aqueous, typically containing at least 20% by weight and up to 95% water, such as up to about 70% water, up to about 65% water, up to about 55% water, up to about 45% water, up to about 35% water. Other types of liquids, including without limitation, alkanols, amines, diols, ethers and polyols may be included in an aqueous liquid or gel. An aqueous liquid or gel detergent may contain from 0-30% organic solvent.
A liquid or gel detergent may also be non-aqueous.
Granular detergent formulations
Enzymes in the form of granules, comprising an enzyme-containing core and optionally one or more coatings, are commonly used in granular (powder) detergents. Various methods for preparing the core are well-known in the art and include, for example, a) spray drying of a liquid enzyme-containing solution, b) production of layered products with an enzyme coated as a layer around a pre-formed inert core particle, e.g. using a fluid bed apparatus, c) absorbing an enzyme onto and/or into the surface of a pre-formed core, d) extrusion of an enzyme-containing paste, e) suspending an enzyme-containing powder in molten wax and atomization to result in prilled products, f) mixer granulation by adding an enzyme-containing liquid to a dry powder composition of granulation components, g) size reduction of enzyme-containing cores by milling or crushing of larger particles, pellets, etc., and h) fluid bed granulation. The enzyme-containing cores may be dried, e.g. using a fluid bed drier or other known methods for drying granules in the feed or enzyme industry, to result in a water content of typically 0.1 -10% w/w water.
The enzyme-containing cores are optionally provided with a coating to improve storage stability and/or to reduce dust formation. One type of coating that is often used for enzyme
granulates for detergents is a salt coating, typically an inorganic salt coating, which may e.g. be applied as a solution of the salt using a fluid bed. Other coating materials that may be used are, for example, polyethylene glycol (PEG), methyl hydroxy-propyl cellulose (MHPC) and polyvinyl alcohol (PVA). The granules may contain more than one coating, for example a salt coating followed by an additional coating of a material such as PEG, MHPC or PVA.
For further information on enzyme granules and production thereof, see WO 2013/007594 as well as e.g. WO 2009/092699, EP 1705241 , EP 1382668, WO 2007/001262, US 6,472,364, WO 2004/074419 and WO 2009/102854.
Formulation of enzyme in co-granule
The enzyme of the invention may be formulated as a granule for example as a co-granule that combines one or more enzymes. Each enzyme will then be present in more granules securing a more uniform distribution of enzymes in the detergent. This also reduces the physical segregation of different enzymes due to different particle sizes. Methods for producing multi enzyme co-granulates for the detergent industry are disclosed in the IP.com disclosure I PCOM000200739D.
Another example of formulation of enzymes by the use of co-granulates are disclosed in WO 2013/188331 , which relates to a detergent composition comprising (a) a multi-enzyme co granule; (b) less than 10 wt% zeolite (anhydrous basis); and (c) less than 10 wt% phosphate salt (anhydrous basis), wherein said enzyme co-granule comprises from 10 to 98 wt% moisture sink components and the composition additionally comprises from 20 to 80 wt% detergent moisture sink components.
WO 2013/188331 also relates to a method of treating and/or cleaning a surface, preferably a fabric surface comprising the steps of (i) contacting said surface with the detergent composition as claimed and described herein in an aqueous wash liquor, (ii) rinsing and/or drying the surface.
The multi-enzyme co-granule may comprise an enzyme of the invention and (a) one or more enzymes selected from the group consisting of first- wash lipases, cleaning cellulases, xyloglucanases, perhydrolases, peroxidases, lipoxygenases, laccases and mixtures thereof; and (b) one or more enzymes selected from the group consisting of hemicellulases, proteases, care cellulases, cellobiose dehydrogenases, xylanases, phospho lipases, esterases, cutinases, pectinases, mannanases, pectate lyases, keratinases, reductases, oxidases, phenoloxidases, ligninases, pullulanases, tannases, pentosanases, lichenases glucanases, arabinosidases, hyaluronidase, chondroitinase, amylases, and mixtures thereof.
Laundry soap bars
The polypeptides of the invention may be added to laundry soap bars and used for hand washing laundry, fabrics and/or textiles. The term laundry soap bar includes laundry bars, soap
bars, combo bars, syndet bars and detergent bars. The types of bar usually differ in the type of surfactant they contain, and the term laundry soap bar includes those containing soaps from fatty acids and/or synthetic soaps. The laundry soap bar has a physical form which is solid and not a liquid, gel or a powder at room temperature. The term solid is defined as a physical form which does not significantly change over time, i.e. if a solid object (e.g. laundry soap bar) is placed inside a container, the solid object does not change to fill the container it is placed in. The bar is a solid typically in bar form but can be in other solid shapes such as round or oval.
Bar soaps for hand laundry may be in the form of either“soap bars” (oil-based) or“non soap detergent” (NSD) bars. As the name implies, non-soap detergent bars are characterized by a lack of fatty acid soap ingredients from plant or animal sources, and instead are based on synthetic detergents such as LAS (linear alkylbenzene sulfonate).
Laundry bars comprising the first and second protease of the invention may be produced by methods conventionally known and used to produce soap bars and using conventional laundry bar making equipment such as but not limited to: mixers, plodders, e.g. a two-stage vacuum plodder, extruders, roll mills, cutters, logo-stampers, cooling tunnels and wrappers.
Uses
The present invention is also directed to methods for using the detergent compositions in laundering of textiles and fabrics, including household laundry and industrial laundry applications. The invention also relates to use of a composition of the present in a cleaning process, such as laundry or hard surface cleaning such as dishwashing. In preferred embodiment, the compositions of the invention are designed for and used in laundry applications. In a further preferred embodiment, the composition may be in the form of a liquid laundry formulation.
A detergent composition of the present invention may be formulated, for example, as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations.
The cleaning process or the textile care process may for example be a laundry process, a dishwashing process or cleaning of hard surfaces such as bathroom tiles, floors, table tops, drains, sinks and washbasins. Laundry processes can for example be household laundering, but may also be industrial laundering. Furthermore, the invention relates to a process for laundering of fabrics and/or garments, where the process comprises treating fabrics with a washing solution containing a detergent composition of the invention. The cleaning process or a textile care process can for example be carried out in a machine washing or manually. The washing solution can for example be an aqueous washing solution containing a detergent composition.
The invention further concerns the use of the detergent compositions in a proteinaceous
stain removing process. The proteinaceous stains may be stains such as food stains, e.g., baby food, cocoa, egg or milk, or other stains such as sebum, blood, ink or grass, or a combination hereof.
This aspect further relates to a method of cleaning, especially for cleaning fabrics or textiles, or for dishwashing, comprising contacting fabrics/textiles or dishes with the detergent composition of this aspect under conditions suitable for cleaning the fabrics/textiles or dishes.
The first and second proteases in the composition according to this aspect, and for use thereof and a method of cleaning, may be any of the proteases described herein.
Washing Method
The present invention provides a method of cleaning, especially for cleaning fabrics or textiles, i.e. laundry, or for dishwashing, with a detergent composition of the invention comprising a first protease and a second protease.
The method of cleaning comprises contacting an object with a detergent composition comprising the first and second protease under conditions suitable for cleaning the object. In a preferred embodiment the detergent composition is used in a laundry process.
Another embodiment relates to a method for removing stains from fabrics or textiles, which comprises contacting the fabric or textile with a composition of the invention under conditions suitable for cleaning the object.
Another embodiment relates to a method for removing stains from dishware, which comprises contacting the dishware with a composition of the invention under conditions suitable for cleaning the object.
The compositions may be employed at concentrations from about 100 ppm, preferably 500 ppm to about 15,000 ppm in solution. The water temperatures typically range from about 5°C to about 95°C, including about 10°C, about 15°C, about 20°C, about 25°C, about 30°C, about 35°C, about 40°C, about 45°C, about 50°C, about 55°C, about 60°C, about 65°C, about 70°C, about 75°C, about 80°C, about 85°C and about 90°C. The water to fabric ratio is typically from about 1 : 1 to about 30: 1.
The enzymes of the detergent composition of the invention may be stabilized using conventional stabilizing agents and protease inhibitors, e.g., a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, different salts such as NaCI; KCI; lactic acid, formic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid, or a peptide aldehyde such as di-, tri- or tetrapeptide aldehydes or aldehyde analogues (either of the form B1-B0-R wherein, R is H, CH3, CX3, CHX2, or CH2X (X=halogen), B0 is a single amino acid residue (preferably with an optionally substituted aliphatic or aromatic side chain); and B1 consists of one or more amino acid residues (preferably one, two or three), optionally comprising an N-terminal protection group, or as described in WO
2009/118375, WO 98/13459) or a protease inhibitor of the protein type such as RASI , BASI , WASI (bifunctional alpha-amylase/subtilisin inhibitors of rice, barley and wheat) or CI2 or SSI. The composition may be formulated as described in, e.g., WO 92/19709, WO 92/19708 and US 6,472,364. In some embodiments, the enzymes employed herein are stabilized by the presence of water-soluble sources of zinc (II), calcium (II) and/or magnesium (II) ions in the finished compositions that provide such ions to the enzymes, as well as other metal ions (e.g., barium (II), scandium (II), iron (II), manganese (II), aluminum (III), Tin (II), cobalt (II), copper (II), Nickel (II), and oxovanadium (IV)).
Methods of production
The first and second protease may be produced by standard methods that are well-known in the art, using cultivation of host cells cultivated in a suitable nutrient medium
The host cell may be any cell useful in recombinant enzyme production, e.g., a prokaryote or a eukaryote.
The prokaryotic host cell will typically be a Gram-positive or Gram-negative bacterium, such as a Gram-positive bacterium selected from Bacillus, Clostridium, Enterococcus, Geobacillus, Lactobacillus, Lactococcus, Oceanobacillus, Staphylococcus, Streptococcus and Streptomyces, or a Gram-negative bacterium selected from Campylobacter, E. coli, Flavobacterium, Fusobacterium, Helicobacter, llyobacter, Neisseria, Pseudomonas, Salmonella and Ureaplasma.
The bacterial host cell may e.g. be a Bacillus cell selected from Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus firmus, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus pumilus, Bacillus stearothermophilus, Bacillus subtilis and Bacillus thuringiensis cells.
For information on suitable host cells, see e.g. WO 2017/207762.
Host cells may, for example, be cultivated by shake flask cultivation, or small-scale or large-scale fermentation (including continuous, batch, fed-batch, or solid-state fermentations) in laboratory or industrial fermentors performed in a suitable medium and under conditions allowing the variant to be expressed and/or isolated. The cultivation takes place in a suitable nutrient medium comprising carbon and nitrogen sources and inorganic salts, using procedures known in the art. Suitable media are available from commercial suppliers or may be prepared according to published compositions (e.g., in catalogues of the American Type Culture Collection). If the variant is secreted into the nutrient medium, the variant can be recovered directly from the medium. If the variant is not secreted, it can be recovered from cell lysates.
The variant may be detected using methods known in the art that are specific for the variants with protease activity, and may be recovered and purified using methods known in the art. See e.g. WO 2017/207762 for further information.
The present invention is further described by the following examples that should not be construed as limiting the scope of the invention.
EXAMPLES Materials and methods
Preparation and purification of polypeptides
Mutation and introduction of expression cassettes into Bacillus subtilis was performed by standard methods known in the art. All DNA manipulations were performed by PCR (e.g. as described by Sambrook et al. , Molecular Cloning 3rd Ed., 2001 , Cold Spring Harbor Laboratory Press) using standard methods known to the skilled person.
Recombinant B. subtilis constructs encoding subtilase polypeptides were inoculated into and cultivated in a complex medium (TBgly) for 24h at 37°C. Shake flasks containing a rich media (PS-1 : 100 g/L Sucrose (Danisco cat.no. 109-0429), 40 g/L crust soy (soy bean flour), 10g/L Na2HPC>4.12H20 (Merck cat.no. 106579), 0.1 ml/L Dowfax63N10 (Dow) were inoculated in a ratio of 1 :100 with the overnight culture. Shake flask cultivation was performed for 4 days at 30°C shaking at 270 rpm.
Purification of culture supernatants was performed as follows:
The culture broth is centrifuged at 26000 x g for 20 minutes and the supernatant is carefully decanted from the precipitate. The supernatant is filtered through a Nalgene 0.2 pm filtration unit in order to remove the remains of the host cells. The pH in the 0.2 pm filtrate is adjusted to pH 8 with 3 M Tris base and the pH-adjusted filtrate is applied to a MEP Hypercel column (Pall Corporation) equilibrated in 20 mM Tris/HCI, 1 mM CaCh, pH 8.0. After washing the column with the equilibration buffer, the column is step-eluted with 20 mM CHsCOOH/NaOH, 1 mM CaCh, pH 4.5. Fractions from the column are analyzed for protease activity using the Suc-AAPF-pNA assay at pH 9 and peak fractions are pooled. The pH of the pool from the MEP Hypercel column is adjusted to pH 6 with 20% (v/v) CH3COOH or 3 M Tris base and the pH-adjusted pool is diluted with deionized water to the same conductivity as 20 mM MES/NaOH, 2 mM CaCh, pH 6.0. The diluted pool is applied to an SP-Sepharose® Fast Flow column (GE Healthcare) equilibrated in 20 mM MES/NaOH, 2 mM CaCh, pH 6.0. After washing the column with the equilibration buffer, the protease variant is eluted with a linear NaCI gradient (0 0.5 M) in the same buffer over five column volumes. Fractions from the column are analyzed for protease activity using the Suc- AAPF- pNA assay at pH 9 and active fractions are analyzed by SDS-PAGE. Fractions in which
only one band is observed on the Coomassie stained SDS-PAGE gel are pooled as the purified preparation and used for further experiments.
Automatic Mechanical Stress Assay (AMSA) for laundry
Experiments were performed to assess the wash performance of selected protease variants in laundry detergent compositions. The proteases were tested using the Automatic Mechanical Stress Assay (AMSA). With the AMSA, the wash performance of a large quantity of small volume enzyme-detergent solutions can be examined. The AMSA plate has a number of slots for test solutions and a lid firmly squeezing the test sample to be washed (a textile swatch for testing a laundry detergent) against the slot openings. During the washing time, the plate, test solutions, test sample and lid are vigorously shaken to bring the test solution into contact with the soiled test sample and to apply mechanical stress in a regular, periodic oscillating manner. For further description see WO 02/42740 especially the paragraph "Special method embodiments" at page 23-24.
The performance of the enzyme variants and blends thereof was in this example measured as the brightness of the colour of textile samples washed with a specific protease or a protease blend. The brightness can be expressed as the intensity of the light reflected from the textile sample when illuminated with white light. When the textile is stained, the intensity of the reflected light is lower than that of a clean textile. Therefore, the intensity of the reflected light can be used to measure wash performance of the proteases and the protease blends.
Colour measurements are made with a professional flatbed scanner (Epson Expression 10000XL), which is used to capture an image of the washed textile samples.
To extract a value for the light intensity from the scanned images, a specially designed software application is used ( Novozymes Color Vector Analyzer). The program retrieves the values from the image and converts them into values for red, green and blue (RGB). The intensity value (Int) is calculated by adding the RGB values together as vectors and then taking the length of the resulting vector:
Standard textile pieces were obtained from Center for Testmaterials BV, P.O. Box 120, 3133 KT Vlaardingen, The Netherlands. The detergent for the wash performance tests was a liquid laundry model detergent. The composition of the detergent as well as other test parameters are given in the table below.
Table 2 outlines the proteases that were tested. These were SEQ ID NO: 1 and variants thereof, with position numbers based on the numbering of SEQ ID NO: 2, and with the net formal charge relative to SEQ ID NO: 1 indicated.
Table 2: Proteases tested in charge combinations
Example 1
Wash performance of different variants of SEQ ID NO: 1 with the mutations indicated in Tables 3 and 4 below having a net charge of -4 or -3 relative to SEQ ID NO: 1 were tested in AMSA as described above either alone (“single enzyme”) or together with a variant of SEQ ID NO: 1 having the substitution K27M and a net charge of -1 relative to SEQ ID NO: 1. The wash performance of the K27M variant alone was also tested in AMSA.
For each enzyme concentration (0.25, 0.5, 1 and 2 mg enzyme protein/liter as described above) a delta intensity value was calculated for the single enzymes and the 1 :1 mixtures as the intensity value (Int) of a test material washed with the detergent containing a single enzyme or mixture minus the intensity value of a test material washed with the detergent alone, i.e. without any enzyme. The delta intensity values for each of the four enzyme concentrations were added together for each treatment (single enzyme or 1 :1 mixture) to obtain a sum of delta intensity for each treatment for each of the two stains PC-10 and PC-03.
The sums of delta intensity for the 1 : 1 mixtures were then compared to the sums of delta intensity for the single enzymes in the mixture, and the relative performance of the mixture compared to a single enzyme was determined for the PC-10 and PC-03 stains. The relative performance values in Tables 3 and 4 below for the individual stains PC-10 and PC-03, expressed
as percent relative performance against a single enzyme, were determined by dividing the sum of delta intensity for a mixture by the sum of delta intensity for a single enzyme.
In Table 3 the mixtures are compared to single enzymes with a net formal charge of -4 or -3 relative to SEQ ID NO: 1 (enzymes (a), (b), (c), (d) in the column“Variant / single enzyme”), while Table 4 compares the mixtures to the K27M variant alone.
Finally, to give an indication of the overall performance of the mixtures compared to the single enzymes on a set of different protein-based stains, the last column in each table,“PC-03 + PC-10”, provides the percent relative performance of the mixtures compared to single enzymes calculated in the same manner as described above for the individual stains PC-10 and PC-03. In this case, however, the sums of delta intensity for a mixture on both PC-10 and PC-03 were added together and divided by the sums of delta intensity for a single enzyme on both PC-10 and PC- 03.
Table 3: Relative performance of charge mixtures with variant K27M against single enzymes (a), (b), (c), (d)
Table 4: Relative performance of charge mixtures with variant K27M against variant K27M alone
Wash performance of different variants of SEQ ID NO: 1 with the mutations indicated in Tables 5 and 6 below having a net charge of -4 relative to SEQ ID NO: 1 were tested in AMSA as described above either alone (“single enzyme”) or together with SEQ ID NO: 1 (Savinase®). The wash performance of SEQ ID NO: 1 alone was also tested in AMSA.
Determination of delta intensity values for each treatment for each of the two stains PC- 10 and PC-03, calculation of the percent relative performance of the mixtures compared to single enzymes, and calculation of the overall performance of the mixtures compared to the single enzymes on the set of stains (PC-03 + PC-10) was performed as described in Example 1.
In Table 5 the mixtures are compared to single enzymes with a net formal charge of -4 relative to SEQ ID NO: 1 (enzymes (a), (b), (c) in the column“Variant / single enzyme”), while Table 6 compares the mixtures to SEQ ID NO: 1 alone.
Table 5: Relative performance of charge mixtures with SEQ ID NO: 1 against single enzymes (a) (b) (c)
Table 6: Relative performance of charge mixtures with SEQ ID NO: 1 against SEQ ID NO: 1 alone
Example 3
Wash performance of different variants of SEQ ID NO: 1 with the mutations indicated in Tables 7 and 8 below having a net charge of -4 or -3 relative to SEQ ID NO: 1 were tested in
AMSA as described above either alone (“single enzyme”) or together with a variant of SEQ ID NO: 1 having the mutation S99AD (net charge of -1 relative to SEQ ID NO: 1). The wash performance of the S99AD variant alone was also tested in AMSA.
Determination of delta intensity values for each treatment for each of the two stains PC- 10 and PC-03, calculation of the percent relative performance of the mixtures compared to single enzymes, and calculation of the overall performance of the mixtures compared to the single enzymes on the set of stains (PC-03 + PC-10) was performed as described in Example 1.
In Table 7 the mixtures are compared to single enzymes with a net formal charge of 4 or 3 relative to SEQ ID NO: 1 (enzymes (a), (b), (c), (d), (e) in the column“Variant / single enzyme”), while Table 8 compares the mixtures to the S99AD variant alone.
Table 7: Relative performance of charge mixtures with variant S99AD against single enzymes
(a), (b), (c). (d). (e)
Table 8: Relative performance of charge mixtures with variant S99AD against variant S99AD alone
Example 4
Wash performance of different variants of SEQ ID NO: 1 with the mutations indicated in Tables 9 and 10 below having a net charge of -5, -4 or -3 relative to SEQ ID NO: 1 were tested in AMSA as described above either alone (“single enzyme”) or together with a variant of SEQ ID NO: 1 having the substitutions G97D Y209W A215K (net charge of 0 relative to SEQ ID NO: 1). The wash performance of the G97D Y209WA215K variant alone was also tested in AMSA.
Determination of delta intensity values for each treatment for each of the two stains PC- 10 and PC-03, calculation of the percent relative performance of the mixtures compared to single enzymes, and calculation of the overall performance of the mixtures compared to the single enzymes on the set of stains (PC-03 + PC-10) was performed as described in Example 1.
In Table 9 the mixtures are compared to single enzymes with a net formal charge of -5, -4 or -3 relative to SEQ ID NO: 1 (enzymes (a), (b), (c), (d) in the column“Variant / single enzyme”), while Table 10 compares the mixtures to the G97D Y209W A215K variant alone.
Table 9: Relative performance of charge mixtures with variant G97D Y209W A215K against single enzymes (a), (b), (c), (d)
Table 10: Relative performance of charge mixtures with variant G97D Y209W A215K against variant G97D Y209W A215K alone
Example 5
Wash performance of different variants of SEQ ID NO: 1 with the mutations indicated in Tables 11 and 12 below having a net charge of -5, -4 or -3 relative to SEQ ID NO: 1 were tested in AMSA as described above either alone (“single enzyme”) or together with a variant of SEQ ID NO: 1 having the substitutions G97D N117R Y209WA215K (net charge of +1 relative to SEQ ID NO: 1). The wash performance of the G97D N117R Y209WA215K variant alone was also tested in AMSA.
Determination of delta intensity values for each treatment for each of the two stains PC- 10 and PC-03, calculation of the percent relative performance of the mixtures compared to single enzymes, and calculation of the overall performance of the mixtures compared to the single enzymes on the set of stains (PC-03 + PC-10) was performed as described in Example 1.
In Table 11 the mixtures are compared to single enzymes with a net formal charge of -5, -4 or -3 relative to SEQ ID NO: 1 (enzymes (a), (b), (c) in the column“Variant / single enzyme”), while Table 12 compares the mixtures to the G97D N117R Y209W A215K variant alone.
Table 11 : Relative performance of charge mixtures with variant G97D N117R Y209W A215K against single enzymes (a), (b), (c)
Table 12: Relative performance of charge mixtures with variant G97D N117R Y209W A215K against variant G97D N117R Y209W A215K alone
The data presented in Examples 1 to 5 above demonstrates that the combination of a first protease with a net charge of -5, -4, or -3 compared to SEQ ID NO: 1 and a second protease with a net charge of -1 , 0 or +1 compared to SEQ ID NO: 1 results in an improved wash performance. In most cases, the mixtures provide a substantial improvement in wash performance over the single enzymes on both the PC-10 and the PC-03 stains and thus a substantial improvement in the overall wash performance. In a few cases, the mixture has resulted in a poorer performance on PC-03, but this has been outweighed by improved wash performance on PC-10, so that the overall performance of the mixtures on PC-03 + PC-10 is still better than that of the single enzymes.
Example 6
Wash performance of SEQ ID NO: 1 or variants thereof with the mutations indicated in Tables 13 and 14 below having a net charge of 0 or -1 relative to SEQ ID NO: 1 were tested in AMSA as described above either alone or in combination with a variant having the mutations S9R S99D S101 E S103A V104I S156D G160S Q245R L262E compared to SEQ ID NO: 1 (net charge of -2 relative to SEQ ID NO: 1). The wash performance of the S9R S99D S101 E S103A V104I S156D G160S Q245R L262E variant alone was also tested in AMSA.
Determination of delta intensity values for each treatment for each of the two stains PC- 10 and PC-03, calculation of the percent relative performance of the mixtures compared to single enzymes, and calculation of the overall performance of the mixtures compared to the single enzymes on the set of stains (PC-03 + PC-10) was performed as described in Example 1.
In Table 13 the mixtures are compared to single enzymes with a net formal charge of -1 or O relative to SEQ ID NO: 1 (enzymes (a), (b), (c) in the column“Variant / single enzyme”), while in Table 14 the mixtures are compared to the variant S9R S99D S101 E S103A V104I S156D G160S Q245R L262E alone.
Table 13: Relative performance of charge mixtures with S9R S99D S101 E S103A V104I S156D G160S Q245R L262E against single enzymes (a), (b), (c)
S156D G160S Q245R L262E alone
Example 7
Wash performance of SEQ ID NO: 1 or variants thereof with the mutations indicated in
Tables 15 and 16 below were tested in AMSA as described above either alone (“single enzyme”) or together with a variant of SEQ ID NO: 1 having the substitutions N76D G97D N140D S156D Y209W A215K L262E (net charge of -4 relative to SEQ ID NO: 1). The wash performance of the N76D G97D N140D S156D Y209W A215K L262E variant alone was also tested in AMSA.
Determination of delta intensity values for each treatment for each of the two stains PC-
10 and PC-03, calculation of the percent relative performance of the mixtures compared to single enzymes, and calculation of the overall performance of the mixtures compared to the single enzymes on the set of stains (PC-03 + PC-10) was performed as described in Example 1.
In Table 15 the mixtures are compared to the single enzymes (enzymes (a), (b), (c) listed in the column“Variant / single enzyme”), while Table 16 compares the mixtures to the N76D G97D N140D S156D Y209W A215K L262E variant alone.
Table 15: Relative performance of charge mixtures with N76D G97D N140D S156D Y209W A215K L262E against single enzymes (a), (b), (c)
Table 16: Relative performance of charge mixtures against variant N76D G97D N140D S156D Y209W A215K L262E alone
Example 8
Wash performance of SEQ ID NO: 1 or variants thereof with the mutations indicated in Tables 17 and 18 below were tested in AMSA as described above either alone (“single enzyme”) or together with a variant of SEQ ID NO: 1 having the substitutions K27M N77D G97D S156D Y209W A215K L262E (net charge of -4 relative to SEQ ID NO: 1). The wash performance of the K27M N77D G97D S156D Y209W A215K L262E variant alone was also tested in AMSA.
Determination of delta intensity values for each treatment for each of the two stains PC- 10 and PC-03, calculation of the percent relative performance of the mixtures compared to single enzymes, and calculation of the overall performance of the mixtures compared to the single enzymes on the set of stains (PC-03 + PC-10) was performed as described in Example 1.
In Table 17 the mixtures are compared to the single enzymes (enzymes (a), (b), (c) listed in the column“Variant / single enzyme”), while Table 18 compares the mixtures to the K27M N77D G97D S156D Y209W A215K L262E variant alone. Table 17: Relative performance of charge mixtures with K27M N77D G97D S156D Y209W
A215K L262E against single enzymes (a), (b), (c)
Table 18: Relative performance of charge mixtures against variant K27M N77D G97D S156D
Y209W A215K L262E alone
Example 9
Wash performance of variants of SEQ ID NO: 1 with the mutations indicated in Tables 19 and 20 below were tested in AMSA as described above either alone (“single enzyme”) or together with a variant of SEQ ID NO: 1 having the substitutions G97D S156D Y209WA215K L262E (net charge of -2 relative to SEQ ID NO: 1). The wash performance of the G97D S156D Y209WA215K L262E variant alone was also tested in AMSA.
Determination of delta intensity values for each treatment for each of the two stains PC- 10 and PC-03, calculation of the percent relative performance of the mixtures compared to single enzymes, and calculation of the overall performance of the mixtures compared to the single enzymes on the set of stains (PC-03 + PC-10) was performed as described in Example 1.
In Table 19 the mixtures are compared to the single enzymes with a net formal charge of +1 , -1 , -3 or -4 (enzymes (a), (b), (c), (d), (e), (f), (g), (h), (i) listed in the column“Variant / single
enzyme”), while Table 20 compares the mixtures to the variant G97D S156D Y209W A215K L262E alone.
Table 19: Relative performance of charge mixtures with G97D S156D Y209W A215K L262E against single enzymes (a), (b), (c), (d), (e), (f), (g), (h), (i)
Table 20: Relative performance of charge mixtures against variant G97D S156D Y209W A215K
L262E alone
Example 10
The wash performance of variants of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K and at least one additional substitution as indicated in Table 21 below was tested in the AMSA assay as described above and compared to the performance of the protease of SEQ ID NO: 1.
Determination of delta intensity values for each enzyme for each of the two stains PC-10 and PC-03, calculation of the percent relative performance of the enzymes compared to SEQ ID NO: 1 , and calculation of the overall performance of each enzyme compared to SEQ ID NO: 1 on the set of stains (PC-03 + PC-10) was performed as described in Example 1. In this example only individual enzymes were tested. Table 21 shows that all of the tested variants comprising the substitutions G97D+Y209W+A215K exhibited improved wash performance over the reference protease with SEQ ID NO: 1.
Table 21 : Relative performance of variants of SEQ ID NO: 1 compared to SEQ ID NO: 1
Example 11
The wash performance of variants of SEQ ID NO: 1 comprising the substitutions G97D+Y209W+A215K and additional substitutions as indicated in Table 22 below was tested in the AMSA assay as described above and compared to the performance of a variant of SEQ ID NO: 1 with the substitutions S99D+S101 E+S103A+V104I+G160S as a reference. This example
tests variants of SEQ ID NO: 1 with the substitutions G97D+S156D+Y209W+A215K+L262E and at least one additional substitution selected from S87N, S101G/N, V104N, G118V and A194P.
Determination of delta intensity values for each enzyme for each of the two stains PC-03 and PC-10 and calculation of the percent relative performance of the enzymes compared to the reference protease was performed as described in Example 1. In this example only individual enzymes were tested.
Table 22: Relative performance of variants of SEQ ID NO: 1 compared to SEQ ID NO: 1 +
S99D S101 E S103A V104I G160S
Table 22 shows that all of the tested variants exhibited improved wash performance over the reference protease SEQ ID NO: 1 + S99D+S101 E+S103A+V104I+G160S, which in itself exhibits good cleaning performance. On the PC-03 stain the tested variants had at least on-par performance, and in most cases improved performance over the reference protease, while on the PC-10 stain all of the tested variants had improved performance over the reference protease. As explained above, the PC-10 stain mimics natural sebum stains, thus providing a good indication of how an enzymatic detergent composition will perform on this difficult to remove natural stain.
Claims
1. A detergent composition comprising a first protease and a second protease, wherein:
1) the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1 ; or
2) the first protease has a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -1 , 0 or +1 relative to the protease of SEQ ID NO: 1.
2. The detergent composition of claim 1 , wherein the first protease has a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -2 relative to the protease of SEQ ID NO: 1 , e.g. wherein the first protease has a net formal charge of -3 or -4 relative to the protease of SEQ ID NO: 1.
3. The detergent composition of claim 1 , wherein the first protease has a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -1 , 0 or +1 relative to the protease of SEQ ID NO: 1 , e.g. wherein the first protease has a net formal charge of -3 relative to the protease of SEQ ID NO: 1 , and the second protease has a net formal charge of -1 relative to the protease of SEQ ID NO: 1.
4. The detergent composition of any of the preceding claims, comprising a first and a second protease that each have a net formal charge of -1 , -2, -3 or -4 relative to the protease of SEQ ID NO: 1 , and where the net formal charge of the first and second protease differ from each other by 1 or 2.
5. The detergent composition of claim 4, wherein the composition comprises:
a) a first protease with a net formal charge of -4 and a second protease with a net formal charge of -2 relative to the protease of SEQ ID NO: 1 ;
b) a first protease with a net formal charge of -3 and a second protease with a net formal charge of -2 relative to the protease of SEQ ID NO: 1 ; or
c) a first protease with a net formal charge of -3 and a second protease with a net formal charge of -1 relative to the protease of SEQ ID NO: 1.
6. The detergent composition of any of claims 1 -2 or 4-5, comprising a first protease with a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1 and a second protease with a net formal charge of -2 relative to the protease of SEQ ID NO: 1 , wherein the second protease
is a variant of SEQ ID NO: 1 comprising the substitutions G97D+S156D+Y209W+A215K+L262E or S9R+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E, wherein position numbers are based on the numbering of SEQ ID NO: 2.
7. The detergent composition of any of claims 1 -2 or 4-6, comprising a first protease with a net formal charge of -1 , -3 or -4 relative to the protease of SEQ ID NO: 1 and a second protease with a net formal charge of -2 relative to the protease of SEQ ID NO: 1 , wherein the first protease is a variant of SEQ ID NO: 1 having a set of mutations selected from the group consisting of:
• K27M;
• S99AD;
• G97D+S156D+Y209W+A215K;
• G97D+Y209W+A215K+L262E;
• S9R+S99D+S101 E+S103A+V104I+S156D+G160S+K235M+Q245R+L262E;
• S9R+S99D+S101 E+S103A+V104I+S156D+G160S+L262E;
• S9E+N43R+N76D+V205I+Q206L+Y209W+S259D+N261W+L262E;
• N62D+N76D+G97D+Y209W+A215K+L262E;
• N62D+G97D+S101 E+V177I+Y209W+A215K+L262E;
• N62D+G97D+S101 E+Y209W+A215K+L262E;
• G97D+S101 E+S156D+A172V+Y209W+A215K+L262E;
• S99D+S101 E+S103A+V104I+S156D+G160S+L262E;
• K27H+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E;
• S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+L262E;
• N76D+G97D+N 140D+S156D+Y209W+A215K+L262E; and
• K27M+N77D+G97D+S156D+Y209W+A215K+L262E;
wherein position numbers are based on the numbering of SEQ ID NO: 2
8. The detergent composition of any of claims 1 or 3-5 comprising a first protease with a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1 and a second protease with a net formal charge of -1 , 0 or +1 relative to the protease of SEQ ID NO: 1 , wherein the first protease is a variant of SEQ ID NO: 1 comprising a set of mutations selected from the group consisting of:
• S99D+S101 E+S103A+V104I+S156D+G160S+L262E;
• K27H+S99D+S101 E+S103A+V104I+S156D+G160S+Q245R+L262E;
• S9R+S99D+S101 E+S103A+V104I+S156D+G160S+K235M+Q245R+L262E;
• S9R+S99D+S101 E+S103A+V104I+S156D+G160S+L262E;
• S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+L262E;
• S9E+N43R+N76D+V205I+Q206L+Y209W+S259D+N261W+L262E;
• S9E+N43R+N76D+N185E+S188E+Q191 N+A194P+Q206L+Y209W+S259D+L262E;
• *36D+N76D+H120D+G195E+K235L;
• S9R+K27M+S99A+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+L262E;
• S9R+K27M+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+L262E;
• S9R+K27M+S99D+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+Q245R+ L262E;
• S9R+K27M+N43R+S99D+S101 E+S103A+V104I+S156D+G160S+K237M+Q245R+ L262E;
• S9R+N43R+S99D+S101 E+S103A+V104I+S156D+G160S+N173D+K235M+Q245R +L262E;
• S9E+G97D+S156D+Y209W+A215K+L262E;
• G97D+S101 E+S156D+A172V+Y209W+A215K+L262E;
• N76D+G97D+N140D+S156D+Y209W+A215K+L262E;
• N76D+G97D+S101 E+T180A+Y209W+A215K+L262E;
• N76D+G97D+S101 E+Y209W+A215K+L262E;
• N62D+G97D+S101 E+Y209W+A215K+L262E;
• N62D+G97D+S101 E+V177I+Y209W+A215K+L262E;
• N62D+N76D+G97D+Y209W+A215K+L262E;
• K27M+G97D+S156D+Y209W+A215K+L262E;
• K27M+N77D+G97D+S156D+Y209W+A215K+L262E;
• K27M+N76D+G97D+Y209W+A215K+L262E;
• K27M+N62D+G97D+Y209W+A215K+L262E;
• S9E+G97D+S101 E+Y209W+A215K+L262E;
• S9E+N76D+G97D+Y209W+A215K+L262E+A270T;
• S9E+N76D+G97D+Y209W+A215K+L262E;
• S9E+N62D+G97D+Y209W+A215K+L262E;
• S9E+K27M+G97D+Y209W+A215K+L262E;
• S9E+N43R+N76D+N 185E+S188E+Q191 N+A194P+Q206L+Y209W+A215K+Q245R +S259D+L262E;
• S9E+N43R+N76D+S188E+Q191 N+A194P+Q206L+Y209W+A215K+S259D+L262E;
• S9E+N43R+N76D+N 185E+S188E+Q191 N+A194P+Q206L+Y209W+A215K+S259D +L262Q; and
• S9E+N43R+N76D+N 185E+S188E+Q191 N+A194P+Q206L+Y209W+Q245R+S259D +L262Q;
wherein position numbers are based on the numbering of SEQ ID NO: 2.
9. The detergent composition of any of claims 1 , 3-5 or 8 comprising a first protease with a net formal charge of -3, -4 or -5 relative to the protease of SEQ ID NO: 1 and a second protease with a net formal charge of -1 , 0 or +1 relative to the protease of SEQ ID NO: 1 , wherein the second protease is the protease of SEQ ID NO: 1 or a variant of SEQ ID NO: 1 comprising a set of mutations selected from the group consisting of:
• K27M;
• S99AD;
• G97D+Y209W+A215K;
• G97D+N1 17R+Y209W+A215K;
• S9R+K27M+N43R+N76D+V205I+Q206L+Y209W+A215K+Q245R+S259D+N261W+ L262E;
• S9R+N43R+N76D+V205I+Q206L+Y209W+A215K+S259D+N261W+L262E;
• S9R+N43R+N76D+V205I+Q206L+Y209W+S259D+N261W+L262E;
• S9R+S99A+S101 E+S103A+V104I+S156D+G160S+A215K+K235M+Q245R+L262E;
• S9R+K27M+N43R+S99A+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+ Q245R+L262E;
• S9R+K27M+N43R+S101 E+S103A+V104I+S156D+G160S+A215K+K237M+Q245R +L262E;
• Y167A+R170S+A194P;
• S9R+A15T +V68A+N218D+Q245R;
• S9R+A15T+G61 E+V68A+A194P+V205I+Q245R+N261 D;
• S9R+A15T +V68A+S99G+Q245R+N261 D;
• S9R+A15T+V68A+H 120D+P131 S+Q137H+Q245R;
• S9R+A15T+V68A+H 120N+P131 S+Q137H+Q245M;
• S9R+A15T+G61 E+V68A+A98S+S99G+N218D+Q245R;
• S3T+V4I+S99D+S101 R+S103A+V104I+G160S+V205I+L217D;
• S3T+V4I+S99D+S101 R+S103A+V104I+G160S+A194P+V205I+L217D;
• G97D+Y209W+A215K+L262E; and
• G97D+S156D+Y209W+A215K;
wherein position numbers are based on the numbering of SEQ ID NO: 2.
10. The detergent composition of any of the preceding claims, wherein the first protease and the second protease each have an amino acid sequence that has at least 60% sequence identity to SEQ ID NO: 1 , for example at least 70%, at least 80%, at least 85% or at least 90% sequence identity to SEQ ID NO: 1.
11. The detergent composition of any of the preceding claims, wherein the composition is a laundry detergent composition.
12. The detergent composition of claim 11 , wherein the composition is a liquid laundry detergent composition.
13. The detergent composition of any of the preceding claims, wherein the composition has an improved wash performance in laundry compared to the same composition comprising either the first protease or the second protease; e.g. wherein the composition has an improved wash performance on the PC-10 stain compared to the same composition comprising either the first protease or the second protease, and/or wherein the composition has an improved overall wash performance on a set of standard stains comprising at least PC-10 and PC-03 compared to the same composition comprising either the first protease or the second protease.
14. Use of a composition according to any of claims 1-13 in a cleaning process, in particular for laundry.
15. A method of cleaning, especially for cleaning fabrics or textiles, comprising contacting a fabrics or textile with a detergent composition according to any of claims 1-13 under conditions suitable for cleaning the fabrics or textile.
16. A protease variant comprising the substitutions X97D, X209W and X215K, e.g. G97D, Y209W and A215K, wherein position numbers are based on the numbering of SEQ ID NO: 2, and the variant has protease activity and has at least 80% but less than 100% sequence identity to SEQ ID NO: 1.
17. The protease variant of claim 16, wherein the protease is a variant of SEQ ID NO: 1 comprising a set of substitutions selected from the group consisting of:
G97D+Y209W+A215K;
G97D+S156D+Y209W+A215K;
G97D+Y209W+A215K+L262E;
G97D+N117R+Y209W+A215K;
S9E+G97D+S156D+Y209W+A215K+L262E;
N62D+G97D+Y209W+A215K+L262E;
G97D+S101 E+S156D+A172V+Y209W+A215K+L262E;
N76D+G97D+N140D+S156D+Y209W+A215K+L262E;
N76D+G97D+S101 E+T180A+Y209W+A215K+L262E;
N76D+G97D+S101 E+Y209W+A215K+L262E;
N62D+G97D+S101 E+Y209W+A215K+L262E;
N62D+G97D+S101 E+V177I+Y209W+A215K+L262E;
N62D+N76D+G97D+Y209W+A215K+L262E;
K27M+G97D+S156D+Y209W+A215K+L262E;
K27M+N77D+G97D+S156D+Y209W+A215K+L262E;
K27M+N76D+G97D+Y209W+A215K+L262E;
K27M+N62D+G97D+Y209W+A215K+L262E;
S9E+G97D+S101 E+Y209W+A215K+L262E;
S9E+N76D+G97D+Y209W+A215K+L262E+A270T;
S9E+N76D+G97D+Y209W+A215K+L262E;
S9E+N62D+G97D+Y209W+A215K+L262E;
S9E+K27M+G97D+Y209W+A215K+L262E;
G97D+S156D+Y209W+A215K+L262E;
G97D+S101 E+Y209W+A215K+L262E;
N76D+G97D+Y209W+A215K+L262E;
K27M+G97D+Y209W+A215K+L262E;
S9E+G97D+Y209W+A215K+L262E;
S87N+G97D+S156D+Y209W+A215K+L262E;
G97D+S101 G+S156D+Y209W+A215K+L262E;
G97D+S101 N+S156D+Y209W+A215K+L262E;
G97D+V104N+S156D+Y209W+A215K+L262E;
G97D+G1 18V+S156D+Y209W+A215K+L262E;
G97D+S156D+A194P+Y209W+A215K+L262E;
S87N+G97D+S101G+S156D+Y209W+A215K+L262E;
S87N+G97D+S101 N+S156D+Y209W+A215K+L262E;
S87N+G97D+V104N+S156D+Y209W+A215K+L262E;
S87N+G97D+G118V+S156D+Y209W+A215K+L262E;
S87N+G97D+S156D+A194P+Y209W+A215K+L262E;
G97D+S101 G+G118V+S156D+Y209W+A215K+L262E;
G97D+S101 G+S156D+A194P+Y209W+A215K+L262E; and G97D+S101 N+V104N+S156D+Y209W+A215K+L262E;
wherein position numbers are based on the numbering of SEQ ID NO: 2.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20705768.8A EP3931315A1 (en) | 2019-03-01 | 2020-02-26 | Detergent compositions comprising two proteases |
CN202080013079.5A CN113474455A (en) | 2019-03-01 | 2020-02-26 | Detergent composition comprising two proteases |
US17/435,555 US20220145220A1 (en) | 2019-03-01 | 2020-02-26 | Detergent Compositions Comprising Two Proteases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19160301.8 | 2019-03-01 | ||
EP19160301.8A EP3702452A1 (en) | 2019-03-01 | 2019-03-01 | Detergent compositions comprising two proteases |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020178102A1 true WO2020178102A1 (en) | 2020-09-10 |
Family
ID=65657385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2020/055043 WO2020178102A1 (en) | 2019-03-01 | 2020-02-26 | Detergent compositions comprising two proteases |
Country Status (4)
Country | Link |
---|---|
US (1) | US20220145220A1 (en) |
EP (2) | EP3702452A1 (en) |
CN (1) | CN113474455A (en) |
WO (1) | WO2020178102A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022106400A1 (en) * | 2020-11-18 | 2022-05-27 | Novozymes A/S | Combination of immunochemically different proteases |
WO2023138535A1 (en) * | 2022-01-21 | 2023-07-27 | Novozymes A/S | Cleaning method, use of enzymes and cleaning composition |
WO2024050346A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Detergent compositions and methods related thereto |
WO2024050343A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Subtilisin variants and methods related thereto |
Citations (126)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1296839A (en) | 1969-05-29 | 1972-11-22 | ||
US4435307A (en) | 1980-04-30 | 1984-03-06 | Novo Industri A/S | Detergent cellulase |
EP0218272A1 (en) | 1985-08-09 | 1987-04-15 | Gist-Brocades N.V. | Novel lipolytic enzymes and their use in detergent compositions |
EP0258068A2 (en) | 1986-08-29 | 1988-03-02 | Novo Nordisk A/S | Enzymatic detergent additive |
EP0305216A1 (en) | 1987-08-28 | 1989-03-01 | Novo Nordisk A/S | Recombinant Humicola lipase and process for the production of recombinant humicola lipases |
WO1989006279A1 (en) | 1988-01-07 | 1989-07-13 | Novo-Nordisk A/S | Mutated subtilisin genes |
EP0331376A2 (en) | 1988-02-28 | 1989-09-06 | Amano Pharmaceutical Co., Ltd. | Recombinant DNA, bacterium of the genus pseudomonas containing it, and process for preparing lipase by using it |
WO1989009259A1 (en) | 1988-03-24 | 1989-10-05 | Novo-Nordisk A/S | A cellulase preparation |
EP0407225A1 (en) | 1989-07-07 | 1991-01-09 | Unilever Plc | Enzymes and enzymatic detergent compositions |
WO1991017244A1 (en) | 1990-05-09 | 1991-11-14 | Novo Nordisk A/S | An enzyme capable of degrading cellulose or hemicellulose |
WO1992005249A1 (en) | 1990-09-13 | 1992-04-02 | Novo Nordisk A/S | Lipase variants |
EP0495257A1 (en) | 1991-01-16 | 1992-07-22 | The Procter & Gamble Company | Compact detergent compositions with high activity cellulase |
WO1992019708A1 (en) | 1991-04-30 | 1992-11-12 | The Procter & Gamble Company | Liquid detergents with aromatic borate ester to inhibit proteolytic enzyme |
WO1992019709A1 (en) | 1991-04-30 | 1992-11-12 | The Procter & Gamble Company | Built liquid detergents with boric-polyol complex to inhibit proteolytic enzyme |
EP0531372A1 (en) | 1990-05-09 | 1993-03-17 | Novo Nordisk As | A cellulase preparation comprising an endoglucanase enzyme. |
WO1993024618A1 (en) | 1992-06-01 | 1993-12-09 | Novo Nordisk A/S | Peroxidase variants with improved hydrogen peroxide stability |
WO1994001541A1 (en) | 1992-07-06 | 1994-01-20 | Novo Nordisk A/S | C. antarctica lipase and lipase variants |
WO1994002597A1 (en) | 1992-07-23 | 1994-02-03 | Novo Nordisk A/S | MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT |
WO1994007998A1 (en) | 1992-10-06 | 1994-04-14 | Novo Nordisk A/S | Cellulase variants |
WO1994018314A1 (en) | 1993-02-11 | 1994-08-18 | Genencor International, Inc. | Oxidatively stable alpha-amylase |
US5352604A (en) | 1989-08-25 | 1994-10-04 | Henkel Research Corporation | Alkaline proteolytic enzyme and method of production |
WO1994025578A1 (en) | 1993-04-27 | 1994-11-10 | Gist-Brocades N.V. | New lipase variants for use in detergent applications |
EP0624154A1 (en) | 1991-12-13 | 1994-11-17 | The Procter & Gamble Company | Acylated citrate esters as peracid precursors |
US5389536A (en) | 1986-11-19 | 1995-02-14 | Genencor, Inc. | Lipase from Pseudomonas mendocina having cutinase activity |
WO1995006720A1 (en) | 1993-08-30 | 1995-03-09 | Showa Denko K.K. | Novel lipase, microorganism producing the lipase, process for producing the lipase, and use of the lipase |
WO1995010603A1 (en) | 1993-10-08 | 1995-04-20 | Novo Nordisk A/S | Amylase variants |
WO1995010602A1 (en) | 1993-10-13 | 1995-04-20 | Novo Nordisk A/S | H2o2-stable peroxidase variants |
WO1995014783A1 (en) | 1993-11-24 | 1995-06-01 | Showa Denko K.K. | Lipase gene and variant lipase |
WO1995022615A1 (en) | 1994-02-22 | 1995-08-24 | Novo Nordisk A/S | A method of preparing a variant of a lipolytic enzyme |
WO1995024471A1 (en) | 1994-03-08 | 1995-09-14 | Novo Nordisk A/S | Novel alkaline cellulases |
WO1995030744A2 (en) | 1994-05-04 | 1995-11-16 | Genencor International Inc. | Lipases with improved surfactant resistance |
WO1995035381A1 (en) | 1994-06-20 | 1995-12-28 | Unilever N.V. | Modified pseudomonas lipases and their use |
WO1996000292A1 (en) | 1994-06-23 | 1996-01-04 | Unilever N.V. | Modified pseudomonas lipases and their use |
WO1996011262A1 (en) | 1994-10-06 | 1996-04-18 | Novo Nordisk A/S | An enzyme and enzyme preparation with endoglucanase activity |
WO1996012012A1 (en) | 1994-10-14 | 1996-04-25 | Solvay S.A. | Lipase, microorganism producing same, method for preparing said lipase and uses thereof |
WO1996013580A1 (en) | 1994-10-26 | 1996-05-09 | Novo Nordisk A/S | An enzyme with lipolytic activity |
WO1996023873A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | Amylase variants |
WO1996027002A1 (en) | 1995-02-27 | 1996-09-06 | Novo Nordisk A/S | Novel lipase gene and process for the production of lipase with the use of the same |
WO1996029397A1 (en) | 1995-03-17 | 1996-09-26 | Novo Nordisk A/S | Novel endoglucanases |
WO1997004079A1 (en) | 1995-07-14 | 1997-02-06 | Novo Nordisk A/S | A modified enzyme with lipolytic activity |
WO1997007202A1 (en) | 1995-08-11 | 1997-02-27 | Novo Nordisk A/S | Novel lipolytic enzymes |
US5648263A (en) | 1988-03-24 | 1997-07-15 | Novo Nordisk A/S | Methods for reducing the harshness of a cotton-containing fabric |
WO1997043424A1 (en) | 1996-05-14 | 1997-11-20 | Genencor International, Inc. | MODIFIED α-AMYLASES HAVING ALTERED CALCIUM BINDING PROPERTIES |
WO1998008940A1 (en) | 1996-08-26 | 1998-03-05 | Novo Nordisk A/S | A novel endoglucanase |
WO1998012307A1 (en) | 1996-09-17 | 1998-03-26 | Novo Nordisk A/S | Cellulase variants |
WO1998013459A1 (en) | 1996-09-24 | 1998-04-02 | The Procter & Gamble Company | Liquid detergents containing proteolytic enzyme, peptide aldehyde and calcium ions |
WO1998015257A1 (en) | 1996-10-08 | 1998-04-16 | Novo Nordisk A/S | Diaminobenzoic acid derivatives as dye precursors |
WO1998017767A1 (en) | 1996-10-18 | 1998-04-30 | The Procter & Gamble Company | Detergent compositions |
WO1999019467A1 (en) | 1997-10-13 | 1999-04-22 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
US5977053A (en) | 1995-07-31 | 1999-11-02 | Bayer Ag | Detergents and cleaners containing iminodisuccinates |
WO1999064619A2 (en) | 1998-06-10 | 1999-12-16 | Novozymes A/S | Novel mannanases |
WO2000034450A1 (en) | 1998-12-04 | 2000-06-15 | Novozymes A/S | Cutinase variants |
JP2000210081A (en) | 1999-01-21 | 2000-08-02 | Kao Corp | Heat-resistant alkali cellulase gene |
WO2000060063A1 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Lipase variant |
WO2001062903A1 (en) | 2000-02-24 | 2001-08-30 | Novozymes A/S | Family 44 xyloglucanases |
WO2001066712A2 (en) | 2000-03-08 | 2001-09-13 | Novozymes A/S | Variants with altered properties |
WO2001092502A1 (en) | 2000-06-02 | 2001-12-06 | Novozymes A/S | Cutinase variants |
WO2002010355A2 (en) | 2000-08-01 | 2002-02-07 | Novozymes A/S | Alpha-amylase mutants with altered stability |
WO2002042740A1 (en) | 2000-11-27 | 2002-05-30 | Novozymes A/S | Automated mechanical stress assay for screening cleaning ingredients |
US6472364B1 (en) | 1998-10-13 | 2002-10-29 | The Procter & Gamble Company | Detergent compositions or components |
WO2002099091A2 (en) | 2001-06-06 | 2002-12-12 | Novozymes A/S | Endo-beta-1,4-glucanase from bacillus |
WO2003040279A1 (en) | 2001-11-09 | 2003-05-15 | Unilever Plc | Polymers for laundry applications |
WO2003062381A2 (en) * | 2002-01-16 | 2003-07-31 | Genencor International, Inc. | Multiply-substituted protease variants |
EP1382668A1 (en) | 2002-06-11 | 2004-01-21 | Unilever N.V. | Detergent tablets |
WO2004074419A2 (en) | 2003-02-18 | 2004-09-02 | Novozymes A/S | Detergent compositions |
WO2005003276A1 (en) | 2003-06-18 | 2005-01-13 | Unilever Plc | Laundry treatment compositions |
WO2005003275A1 (en) | 2003-06-18 | 2005-01-13 | Unilever Plc | Laundry treatment compositions |
WO2005003274A1 (en) | 2003-06-18 | 2005-01-13 | Unilever Plc | Laundry treatment compositions |
WO2005056782A2 (en) | 2003-12-03 | 2005-06-23 | Genencor International, Inc. | Perhydrolase |
WO2005105826A1 (en) | 2004-04-28 | 2005-11-10 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Tyropeptin a analogue |
WO2006066594A2 (en) | 2004-12-23 | 2006-06-29 | Novozymes A/S | Alpha-amylase variants |
EP1705241A1 (en) | 2005-03-23 | 2006-09-27 | Unilever N.V. | Detergent compositions in tablet form |
WO2006108856A2 (en) | 2005-04-15 | 2006-10-19 | Basf Aktiengesellschaft | Amphiphilic water-soluble alkoxylated polyalkylenimines with an internal polyethylene oxide block and an external polypropylene oxide block |
WO2006113314A1 (en) | 2005-04-15 | 2006-10-26 | The Procter & Gamble Company | Liquid laundry detergent compositions with modified polyethyleneimine polymers and lipase enzyme |
WO2006130575A2 (en) | 2005-05-31 | 2006-12-07 | The Procter & Gamble Company | Polymer-containing detergent compositions and their use |
WO2007001262A1 (en) | 2005-06-17 | 2007-01-04 | The Procter & Gamble Company | Organic catalyst with enhanced enzyme compatibility |
WO2007044993A2 (en) | 2005-10-12 | 2007-04-19 | Genencor International, Inc. | Use and production of storage-stable neutral metalloprotease |
WO2007087259A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Enzyme and photobleach containing compositions |
WO2007087257A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Enzyme and fabric hueing agent containing compositions |
WO2007087258A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | A composition comprising a lipase and a bleach catalyst |
WO2007087243A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
WO2007087244A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
WO2007087242A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | A composition comprising a lipase and a bleach catalyst |
WO2007087508A2 (en) | 2006-01-23 | 2007-08-02 | Novozymes A/S | Lipase variants |
WO2007138054A1 (en) | 2006-05-31 | 2007-12-06 | The Procter & Gamble Company | Cleaning compositions with amphiphilic graft polymers based on polyalkylene oxides and vinyl esters |
EP1867808A1 (en) | 2006-06-06 | 2007-12-19 | Brose Schliesssysteme GmbH & Co. KG | Motor vehicle lock |
EP1876226A1 (en) | 2006-07-07 | 2008-01-09 | The Procter and Gamble Company | Detergent compositions |
WO2008153815A2 (en) | 2007-05-30 | 2008-12-18 | Danisco Us, Inc., Genencor Division | Variants of an alpha-amylase with improved production levels in fermentation processes |
US20090011970A1 (en) | 2007-07-02 | 2009-01-08 | Marc Francois Theophile Evers | Laundry multi-compartment pouch composition |
WO2009021867A2 (en) | 2007-08-10 | 2009-02-19 | Henkel Ag & Co. Kgaa | Agents containing proteases |
WO2009061380A2 (en) | 2007-11-05 | 2009-05-14 | Danisco Us Inc., Genencor Division | VARIANTS OF BACILLUS sp. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES |
WO2009067279A1 (en) | 2007-11-21 | 2009-05-28 | E.I. Du Pont De Nemours And Company | Production of peracids using an enzyme having perhydrolysis activity |
WO2009087523A2 (en) | 2008-01-04 | 2009-07-16 | The Procter & Gamble Company | A laundry detergent composition comprising glycosyl hydrolase |
WO2009092699A1 (en) | 2008-01-24 | 2009-07-30 | Unilever Nv | Machine dishwash detergent compositions |
WO2009102854A1 (en) | 2008-02-15 | 2009-08-20 | The Procter & Gamble Company | Cleaning compositions |
WO2009109500A1 (en) | 2008-02-29 | 2009-09-11 | Novozymes A/S | Polypeptides having lipase activity and polynucleotides encoding same |
WO2009118375A2 (en) | 2008-03-26 | 2009-10-01 | Novozymes A/S | Stabilized liquid enzyme compositions |
WO2010065455A2 (en) | 2008-12-01 | 2010-06-10 | Danisco Us Inc. | Enzymes with lipase activity |
WO2010100028A2 (en) | 2009-03-06 | 2010-09-10 | Huntsman Advanced Materials (Switzerland) Gmbh | Enzymatic textile bleach-whitening methods |
WO2010104675A1 (en) | 2009-03-10 | 2010-09-16 | Danisco Us Inc. | Bacillus megaterium strain dsm90-related alpha-amylases, and methods of use, thereof |
WO2010107560A2 (en) | 2009-03-18 | 2010-09-23 | Danisco Us Inc. | Fungal cutinase from magnaporthe grisea |
WO2010111143A2 (en) | 2009-03-23 | 2010-09-30 | Danisco Us Inc. | Cal a-related acyltransferases and methods of use, thereof |
WO2011084599A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing bacillus subtilis lipase and methods of use thereof |
WO2011084412A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing thermobifida fusca lipase and methods of use thereof |
WO2011084417A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing geobacillus stearothermophilus lipase and methods of use thereof |
WO2011098531A1 (en) | 2010-02-10 | 2011-08-18 | Novozymes A/S | Variants and compositions comprising variants with high stability in presence of a chelating agent |
WO2011098579A1 (en) | 2010-02-12 | 2011-08-18 | University Of Newcastle Upon Tyne | Bacterial deoxyribonuclease compounds and methods for biofilm disruption and prevention |
WO2011150157A2 (en) | 2010-05-28 | 2011-12-01 | Danisco Us Inc. | Detergent compositions containing streptomyces griseus lipase and methods of use thereof |
WO2012137147A1 (en) | 2011-04-08 | 2012-10-11 | Danisco Us, Inc. | Compositions |
WO2013001087A2 (en) | 2011-06-30 | 2013-01-03 | Novozymes A/S | Method for screening alpha-amylases |
WO2013001078A1 (en) | 2011-06-30 | 2013-01-03 | Novozymes A/S | Alpha-amylase variants |
WO2013007594A1 (en) | 2011-07-12 | 2013-01-17 | Novozymes A/S | Storage-stable enzyme granules |
US20130228995A1 (en) * | 2010-01-20 | 2013-09-05 | Alexander Serkh | Planetary gear mechanism for a bicycle |
WO2013184577A1 (en) | 2012-06-08 | 2013-12-12 | Danisco Us Inc. | Alpha-amylase variants derived from the alpha amylase of cytophaga sp.amylase|(cspamy2). |
WO2013188331A1 (en) | 2012-06-11 | 2013-12-19 | The Procter & Gamble Company | Detergent composition |
WO2014087011A1 (en) | 2012-12-07 | 2014-06-12 | Novozymes A/S | Preventing adhesion of bacteria |
WO2014177430A1 (en) | 2013-04-30 | 2014-11-06 | Henkel Ag & Co. Kgaa | Cleaning agent containing proteases |
WO2016000970A1 (en) | 2014-06-30 | 2016-01-07 | Henkel Ag & Co. Kgaa | Cleaning agent containing proteases |
WO2016000971A1 (en) | 2014-06-30 | 2016-01-07 | Henkel Ag & Co. Kgaa | Liquid cleaning agent containing liquid and solid enzyme formulations |
WO2016087619A1 (en) | 2014-12-04 | 2016-06-09 | Novozymes A/S | Liquid cleaning compositions comprising protease variants |
WO2016180748A1 (en) | 2015-05-08 | 2016-11-17 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2016202839A2 (en) * | 2015-06-18 | 2016-12-22 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
WO2017191160A1 (en) | 2016-05-03 | 2017-11-09 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding the same |
WO2017207762A1 (en) | 2016-06-03 | 2017-12-07 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
EP3275987A1 (en) * | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
WO2018141707A2 (en) | 2017-02-01 | 2018-08-09 | Novozymes A/S | Alpha-amylase variants |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA24811A1 (en) * | 1997-10-23 | 1999-12-31 | Procter & Gamble | WASHING COMPOSITIONS CONTAINING MULTISUBSTITUTED PROTEASE VARIANTS |
AU2004231193B2 (en) * | 1998-12-21 | 2008-04-10 | Genencor International, Inc. | Chemically modified enzymes with multiple charged variants |
EP2832853A1 (en) * | 2013-07-29 | 2015-02-04 | Henkel AG&Co. KGAA | Detergent composition comprising protease variants |
EP3237609B1 (en) * | 2014-12-22 | 2020-03-25 | Novozymes A/S | Detergent compositions, lipase variants and polynucleotides encoding same |
-
2019
- 2019-03-01 EP EP19160301.8A patent/EP3702452A1/en active Pending
-
2020
- 2020-02-26 US US17/435,555 patent/US20220145220A1/en active Pending
- 2020-02-26 WO PCT/EP2020/055043 patent/WO2020178102A1/en unknown
- 2020-02-26 CN CN202080013079.5A patent/CN113474455A/en active Pending
- 2020-02-26 EP EP20705768.8A patent/EP3931315A1/en active Pending
Patent Citations (133)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1296839A (en) | 1969-05-29 | 1972-11-22 | ||
US4435307A (en) | 1980-04-30 | 1984-03-06 | Novo Industri A/S | Detergent cellulase |
EP0218272A1 (en) | 1985-08-09 | 1987-04-15 | Gist-Brocades N.V. | Novel lipolytic enzymes and their use in detergent compositions |
EP0258068A2 (en) | 1986-08-29 | 1988-03-02 | Novo Nordisk A/S | Enzymatic detergent additive |
US5389536A (en) | 1986-11-19 | 1995-02-14 | Genencor, Inc. | Lipase from Pseudomonas mendocina having cutinase activity |
EP0305216A1 (en) | 1987-08-28 | 1989-03-01 | Novo Nordisk A/S | Recombinant Humicola lipase and process for the production of recombinant humicola lipases |
WO1989006279A1 (en) | 1988-01-07 | 1989-07-13 | Novo-Nordisk A/S | Mutated subtilisin genes |
EP0331376A2 (en) | 1988-02-28 | 1989-09-06 | Amano Pharmaceutical Co., Ltd. | Recombinant DNA, bacterium of the genus pseudomonas containing it, and process for preparing lipase by using it |
US5691178A (en) | 1988-03-22 | 1997-11-25 | Novo Nordisk A/S | Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase |
WO1989009259A1 (en) | 1988-03-24 | 1989-10-05 | Novo-Nordisk A/S | A cellulase preparation |
US5648263A (en) | 1988-03-24 | 1997-07-15 | Novo Nordisk A/S | Methods for reducing the harshness of a cotton-containing fabric |
US5776757A (en) | 1988-03-24 | 1998-07-07 | Novo Nordisk A/S | Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase and method of making thereof |
EP0407225A1 (en) | 1989-07-07 | 1991-01-09 | Unilever Plc | Enzymes and enzymatic detergent compositions |
US5352604A (en) | 1989-08-25 | 1994-10-04 | Henkel Research Corporation | Alkaline proteolytic enzyme and method of production |
US5457046A (en) | 1990-05-09 | 1995-10-10 | Novo Nordisk A/S | Enzyme capable of degrading cellullose or hemicellulose |
WO1991017244A1 (en) | 1990-05-09 | 1991-11-14 | Novo Nordisk A/S | An enzyme capable of degrading cellulose or hemicellulose |
EP0531315A1 (en) | 1990-05-09 | 1993-03-17 | Novo Nordisk As | An enzyme capable of degrading cellulose or hemicellulose. |
US5686593A (en) | 1990-05-09 | 1997-11-11 | Novo Nordisk A/S | Enzyme capable of degrading cellulose or hemicellulose |
US5763254A (en) | 1990-05-09 | 1998-06-09 | Novo Nordisk A/S | Enzyme capable of degrading cellulose or hemicellulose |
EP0531372A1 (en) | 1990-05-09 | 1993-03-17 | Novo Nordisk As | A cellulase preparation comprising an endoglucanase enzyme. |
WO1992005249A1 (en) | 1990-09-13 | 1992-04-02 | Novo Nordisk A/S | Lipase variants |
EP0495257A1 (en) | 1991-01-16 | 1992-07-22 | The Procter & Gamble Company | Compact detergent compositions with high activity cellulase |
WO1992019708A1 (en) | 1991-04-30 | 1992-11-12 | The Procter & Gamble Company | Liquid detergents with aromatic borate ester to inhibit proteolytic enzyme |
WO1992019709A1 (en) | 1991-04-30 | 1992-11-12 | The Procter & Gamble Company | Built liquid detergents with boric-polyol complex to inhibit proteolytic enzyme |
EP0624154A1 (en) | 1991-12-13 | 1994-11-17 | The Procter & Gamble Company | Acylated citrate esters as peracid precursors |
WO1993024618A1 (en) | 1992-06-01 | 1993-12-09 | Novo Nordisk A/S | Peroxidase variants with improved hydrogen peroxide stability |
WO1994001541A1 (en) | 1992-07-06 | 1994-01-20 | Novo Nordisk A/S | C. antarctica lipase and lipase variants |
WO1994002597A1 (en) | 1992-07-23 | 1994-02-03 | Novo Nordisk A/S | MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT |
WO1994007998A1 (en) | 1992-10-06 | 1994-04-14 | Novo Nordisk A/S | Cellulase variants |
WO1994018314A1 (en) | 1993-02-11 | 1994-08-18 | Genencor International, Inc. | Oxidatively stable alpha-amylase |
WO1994025578A1 (en) | 1993-04-27 | 1994-11-10 | Gist-Brocades N.V. | New lipase variants for use in detergent applications |
WO1995006720A1 (en) | 1993-08-30 | 1995-03-09 | Showa Denko K.K. | Novel lipase, microorganism producing the lipase, process for producing the lipase, and use of the lipase |
WO1995010603A1 (en) | 1993-10-08 | 1995-04-20 | Novo Nordisk A/S | Amylase variants |
WO1995010602A1 (en) | 1993-10-13 | 1995-04-20 | Novo Nordisk A/S | H2o2-stable peroxidase variants |
WO1995014783A1 (en) | 1993-11-24 | 1995-06-01 | Showa Denko K.K. | Lipase gene and variant lipase |
WO1995022615A1 (en) | 1994-02-22 | 1995-08-24 | Novo Nordisk A/S | A method of preparing a variant of a lipolytic enzyme |
WO1995024471A1 (en) | 1994-03-08 | 1995-09-14 | Novo Nordisk A/S | Novel alkaline cellulases |
WO1995030744A2 (en) | 1994-05-04 | 1995-11-16 | Genencor International Inc. | Lipases with improved surfactant resistance |
WO1995035381A1 (en) | 1994-06-20 | 1995-12-28 | Unilever N.V. | Modified pseudomonas lipases and their use |
WO1996000292A1 (en) | 1994-06-23 | 1996-01-04 | Unilever N.V. | Modified pseudomonas lipases and their use |
WO1996011262A1 (en) | 1994-10-06 | 1996-04-18 | Novo Nordisk A/S | An enzyme and enzyme preparation with endoglucanase activity |
WO1996012012A1 (en) | 1994-10-14 | 1996-04-25 | Solvay S.A. | Lipase, microorganism producing same, method for preparing said lipase and uses thereof |
WO1996013580A1 (en) | 1994-10-26 | 1996-05-09 | Novo Nordisk A/S | An enzyme with lipolytic activity |
WO1996023873A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | Amylase variants |
WO1996027002A1 (en) | 1995-02-27 | 1996-09-06 | Novo Nordisk A/S | Novel lipase gene and process for the production of lipase with the use of the same |
WO1996029397A1 (en) | 1995-03-17 | 1996-09-26 | Novo Nordisk A/S | Novel endoglucanases |
WO1997004079A1 (en) | 1995-07-14 | 1997-02-06 | Novo Nordisk A/S | A modified enzyme with lipolytic activity |
US5977053A (en) | 1995-07-31 | 1999-11-02 | Bayer Ag | Detergents and cleaners containing iminodisuccinates |
WO1997007202A1 (en) | 1995-08-11 | 1997-02-27 | Novo Nordisk A/S | Novel lipolytic enzymes |
WO1997043424A1 (en) | 1996-05-14 | 1997-11-20 | Genencor International, Inc. | MODIFIED α-AMYLASES HAVING ALTERED CALCIUM BINDING PROPERTIES |
WO1998008940A1 (en) | 1996-08-26 | 1998-03-05 | Novo Nordisk A/S | A novel endoglucanase |
WO1998012307A1 (en) | 1996-09-17 | 1998-03-26 | Novo Nordisk A/S | Cellulase variants |
WO1998013459A1 (en) | 1996-09-24 | 1998-04-02 | The Procter & Gamble Company | Liquid detergents containing proteolytic enzyme, peptide aldehyde and calcium ions |
WO1998015257A1 (en) | 1996-10-08 | 1998-04-16 | Novo Nordisk A/S | Diaminobenzoic acid derivatives as dye precursors |
WO1998017767A1 (en) | 1996-10-18 | 1998-04-30 | The Procter & Gamble Company | Detergent compositions |
WO1999019467A1 (en) | 1997-10-13 | 1999-04-22 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
WO1999064619A2 (en) | 1998-06-10 | 1999-12-16 | Novozymes A/S | Novel mannanases |
US6472364B1 (en) | 1998-10-13 | 2002-10-29 | The Procter & Gamble Company | Detergent compositions or components |
WO2000034450A1 (en) | 1998-12-04 | 2000-06-15 | Novozymes A/S | Cutinase variants |
JP2000210081A (en) | 1999-01-21 | 2000-08-02 | Kao Corp | Heat-resistant alkali cellulase gene |
WO2000060063A1 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Lipase variant |
WO2001062903A1 (en) | 2000-02-24 | 2001-08-30 | Novozymes A/S | Family 44 xyloglucanases |
WO2001066712A2 (en) | 2000-03-08 | 2001-09-13 | Novozymes A/S | Variants with altered properties |
WO2001092502A1 (en) | 2000-06-02 | 2001-12-06 | Novozymes A/S | Cutinase variants |
WO2002010355A2 (en) | 2000-08-01 | 2002-02-07 | Novozymes A/S | Alpha-amylase mutants with altered stability |
WO2002042740A1 (en) | 2000-11-27 | 2002-05-30 | Novozymes A/S | Automated mechanical stress assay for screening cleaning ingredients |
WO2002099091A2 (en) | 2001-06-06 | 2002-12-12 | Novozymes A/S | Endo-beta-1,4-glucanase from bacillus |
WO2003040279A1 (en) | 2001-11-09 | 2003-05-15 | Unilever Plc | Polymers for laundry applications |
WO2003062381A2 (en) * | 2002-01-16 | 2003-07-31 | Genencor International, Inc. | Multiply-substituted protease variants |
EP1382668A1 (en) | 2002-06-11 | 2004-01-21 | Unilever N.V. | Detergent tablets |
WO2004074419A2 (en) | 2003-02-18 | 2004-09-02 | Novozymes A/S | Detergent compositions |
WO2005003276A1 (en) | 2003-06-18 | 2005-01-13 | Unilever Plc | Laundry treatment compositions |
WO2005003275A1 (en) | 2003-06-18 | 2005-01-13 | Unilever Plc | Laundry treatment compositions |
WO2005003274A1 (en) | 2003-06-18 | 2005-01-13 | Unilever Plc | Laundry treatment compositions |
WO2005056782A2 (en) | 2003-12-03 | 2005-06-23 | Genencor International, Inc. | Perhydrolase |
WO2005105826A1 (en) | 2004-04-28 | 2005-11-10 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Tyropeptin a analogue |
WO2006066594A2 (en) | 2004-12-23 | 2006-06-29 | Novozymes A/S | Alpha-amylase variants |
EP1705241A1 (en) | 2005-03-23 | 2006-09-27 | Unilever N.V. | Detergent compositions in tablet form |
WO2006108856A2 (en) | 2005-04-15 | 2006-10-19 | Basf Aktiengesellschaft | Amphiphilic water-soluble alkoxylated polyalkylenimines with an internal polyethylene oxide block and an external polypropylene oxide block |
WO2006113314A1 (en) | 2005-04-15 | 2006-10-26 | The Procter & Gamble Company | Liquid laundry detergent compositions with modified polyethyleneimine polymers and lipase enzyme |
WO2006130575A2 (en) | 2005-05-31 | 2006-12-07 | The Procter & Gamble Company | Polymer-containing detergent compositions and their use |
WO2007001262A1 (en) | 2005-06-17 | 2007-01-04 | The Procter & Gamble Company | Organic catalyst with enhanced enzyme compatibility |
WO2007044993A2 (en) | 2005-10-12 | 2007-04-19 | Genencor International, Inc. | Use and production of storage-stable neutral metalloprotease |
WO2007087259A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Enzyme and photobleach containing compositions |
WO2007087257A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Enzyme and fabric hueing agent containing compositions |
WO2007087258A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | A composition comprising a lipase and a bleach catalyst |
WO2007087243A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
WO2007087244A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
WO2007087242A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | A composition comprising a lipase and a bleach catalyst |
WO2007087508A2 (en) | 2006-01-23 | 2007-08-02 | Novozymes A/S | Lipase variants |
WO2007138054A1 (en) | 2006-05-31 | 2007-12-06 | The Procter & Gamble Company | Cleaning compositions with amphiphilic graft polymers based on polyalkylene oxides and vinyl esters |
EP1867808A1 (en) | 2006-06-06 | 2007-12-19 | Brose Schliesssysteme GmbH & Co. KG | Motor vehicle lock |
EP1876226A1 (en) | 2006-07-07 | 2008-01-09 | The Procter and Gamble Company | Detergent compositions |
WO2008153815A2 (en) | 2007-05-30 | 2008-12-18 | Danisco Us, Inc., Genencor Division | Variants of an alpha-amylase with improved production levels in fermentation processes |
US20090011970A1 (en) | 2007-07-02 | 2009-01-08 | Marc Francois Theophile Evers | Laundry multi-compartment pouch composition |
WO2009021867A2 (en) | 2007-08-10 | 2009-02-19 | Henkel Ag & Co. Kgaa | Agents containing proteases |
WO2009061380A2 (en) | 2007-11-05 | 2009-05-14 | Danisco Us Inc., Genencor Division | VARIANTS OF BACILLUS sp. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES |
WO2009067279A1 (en) | 2007-11-21 | 2009-05-28 | E.I. Du Pont De Nemours And Company | Production of peracids using an enzyme having perhydrolysis activity |
WO2009087523A2 (en) | 2008-01-04 | 2009-07-16 | The Procter & Gamble Company | A laundry detergent composition comprising glycosyl hydrolase |
WO2009092699A1 (en) | 2008-01-24 | 2009-07-30 | Unilever Nv | Machine dishwash detergent compositions |
WO2009102854A1 (en) | 2008-02-15 | 2009-08-20 | The Procter & Gamble Company | Cleaning compositions |
WO2009109500A1 (en) | 2008-02-29 | 2009-09-11 | Novozymes A/S | Polypeptides having lipase activity and polynucleotides encoding same |
WO2009118375A2 (en) | 2008-03-26 | 2009-10-01 | Novozymes A/S | Stabilized liquid enzyme compositions |
WO2010065455A2 (en) | 2008-12-01 | 2010-06-10 | Danisco Us Inc. | Enzymes with lipase activity |
WO2010100028A2 (en) | 2009-03-06 | 2010-09-10 | Huntsman Advanced Materials (Switzerland) Gmbh | Enzymatic textile bleach-whitening methods |
WO2010104675A1 (en) | 2009-03-10 | 2010-09-16 | Danisco Us Inc. | Bacillus megaterium strain dsm90-related alpha-amylases, and methods of use, thereof |
WO2010107560A2 (en) | 2009-03-18 | 2010-09-23 | Danisco Us Inc. | Fungal cutinase from magnaporthe grisea |
WO2010111143A2 (en) | 2009-03-23 | 2010-09-30 | Danisco Us Inc. | Cal a-related acyltransferases and methods of use, thereof |
WO2011084599A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing bacillus subtilis lipase and methods of use thereof |
WO2011084412A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing thermobifida fusca lipase and methods of use thereof |
WO2011084417A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing geobacillus stearothermophilus lipase and methods of use thereof |
US20130228995A1 (en) * | 2010-01-20 | 2013-09-05 | Alexander Serkh | Planetary gear mechanism for a bicycle |
WO2011098531A1 (en) | 2010-02-10 | 2011-08-18 | Novozymes A/S | Variants and compositions comprising variants with high stability in presence of a chelating agent |
WO2011098579A1 (en) | 2010-02-12 | 2011-08-18 | University Of Newcastle Upon Tyne | Bacterial deoxyribonuclease compounds and methods for biofilm disruption and prevention |
WO2011150157A2 (en) | 2010-05-28 | 2011-12-01 | Danisco Us Inc. | Detergent compositions containing streptomyces griseus lipase and methods of use thereof |
WO2012137147A1 (en) | 2011-04-08 | 2012-10-11 | Danisco Us, Inc. | Compositions |
WO2013001087A2 (en) | 2011-06-30 | 2013-01-03 | Novozymes A/S | Method for screening alpha-amylases |
WO2013001078A1 (en) | 2011-06-30 | 2013-01-03 | Novozymes A/S | Alpha-amylase variants |
WO2013007594A1 (en) | 2011-07-12 | 2013-01-17 | Novozymes A/S | Storage-stable enzyme granules |
WO2013184577A1 (en) | 2012-06-08 | 2013-12-12 | Danisco Us Inc. | Alpha-amylase variants derived from the alpha amylase of cytophaga sp.amylase|(cspamy2). |
WO2013188331A1 (en) | 2012-06-11 | 2013-12-19 | The Procter & Gamble Company | Detergent composition |
WO2014087011A1 (en) | 2012-12-07 | 2014-06-12 | Novozymes A/S | Preventing adhesion of bacteria |
WO2014177430A1 (en) | 2013-04-30 | 2014-11-06 | Henkel Ag & Co. Kgaa | Cleaning agent containing proteases |
WO2016000970A1 (en) | 2014-06-30 | 2016-01-07 | Henkel Ag & Co. Kgaa | Cleaning agent containing proteases |
WO2016000971A1 (en) | 2014-06-30 | 2016-01-07 | Henkel Ag & Co. Kgaa | Liquid cleaning agent containing liquid and solid enzyme formulations |
US20170198243A1 (en) | 2014-06-30 | 2017-07-13 | Henkel Ag & Co. Kgaa | Liquid cleaning agent containing liquid and solid enzyme formulations |
WO2016087619A1 (en) | 2014-12-04 | 2016-06-09 | Novozymes A/S | Liquid cleaning compositions comprising protease variants |
WO2016180748A1 (en) | 2015-05-08 | 2016-11-17 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2016202839A2 (en) * | 2015-06-18 | 2016-12-22 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
WO2017191160A1 (en) | 2016-05-03 | 2017-11-09 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding the same |
WO2017207762A1 (en) | 2016-06-03 | 2017-12-07 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
EP3275987A1 (en) * | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
WO2018141707A2 (en) | 2017-02-01 | 2018-08-09 | Novozymes A/S | Alpha-amylase variants |
Non-Patent Citations (23)
Title |
---|
"Powdered Detergents, Surfactant Science Series", vol. 71, 1997, MARCEL DEKKER, INC. |
CUNNINGHAMWELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085 |
EDGAR, NUCLEIC ACIDS RESEARCH, vol. 32, 2004, pages 1792 - 1797 |
EUR. J. BIOCHEM., vol. 223, 1994, pages 1 - 5 |
EUR. J. BIOCHEM., vol. 232, 1995, pages 1 - 6 |
EUR. J. BIOCHEM., vol. 237, 1996, pages 1 - 5 |
EUR. J. BIOCHEM., vol. 250, 1997, pages 1 - 6 |
EUR. J. BIOCHEM., vol. 264, 1999, pages 610 - 650 |
H. NEURATHR.L. HILL: "The Protein", 1979, ACADEMIC PRESS |
HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708 |
HODGDONKALER, CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, vol. 12, 2007, pages 121 - 128 |
KATOH ET AL., NUCLEIC ACIDS RESEARCH, vol. 33, 2005, pages 511 - 518 |
KATOH, METHODS IN MOLECULAR BIOLOGY, vol. 537, 2009, pages 39 - 64 |
KATOHKUMA, NUCLEIC ACIDS RESEARCH, vol. 30, 2002, pages 3059 - 3066 |
KATOHTOH, BIOINFORMATICS, vol. 23, 2007, pages 372 - 374 |
KATOHTOH, BIOINFORMATICS, vol. 26, 2010, pages 1899 - 1900 |
NEEDLEMANWUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453 |
RICE ET AL.: "EMBOSS: The European Molecular Biology Open Software Suite", TRENDS GENET., vol. 16, 2000, pages 276 - 277, XP004200114, DOI: 10.1016/S0168-9525(00)02024-2 |
SAMBROOK ET AL.: "Powdered Detergents, Surfactant science series", vol. 71, 2001, COLD SPRING HARBOR LABORATORY PRESS |
SMITH, J. MOL. BIOL., vol. 224, 1992, pages 899 - 904 |
THOMPSON, NUCLEIC ACIDS RESEARCH, vol. 22, 1994, pages 4673 - 4680 |
VOS, SCIENCE, vol. 255, 1992, pages 306 - 312 |
WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022106400A1 (en) * | 2020-11-18 | 2022-05-27 | Novozymes A/S | Combination of immunochemically different proteases |
WO2023138535A1 (en) * | 2022-01-21 | 2023-07-27 | Novozymes A/S | Cleaning method, use of enzymes and cleaning composition |
WO2024050346A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Detergent compositions and methods related thereto |
WO2024050343A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Subtilisin variants and methods related thereto |
Also Published As
Publication number | Publication date |
---|---|
US20220145220A1 (en) | 2022-05-12 |
EP3702452A1 (en) | 2020-09-02 |
EP3931315A1 (en) | 2022-01-05 |
CN113474455A (en) | 2021-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11591585B2 (en) | Subtilase variants and polynucleotides encoding same | |
US11597894B2 (en) | Detergent composition comprising subtilase variants | |
US11591586B2 (en) | Subtilase variants and polynucleotides encoding same | |
US20240132807A1 (en) | Subtilase variants | |
US20240093125A1 (en) | Liquid Cleaning Compositions Comprising Protease Variants | |
US20220112476A1 (en) | Subtilase variants and compositions comprising same | |
US20180148670A1 (en) | Detergent composition comprising subtilase variants | |
US20220145220A1 (en) | Detergent Compositions Comprising Two Proteases | |
US20240117332A1 (en) | Subtilase Variants and Compositions Comprising Same | |
US20210189297A1 (en) | Subtilase variants and compositions comprising same | |
WO2020114968A1 (en) | Powder detergent compositions | |
WO2021239818A1 (en) | Subtilase variants and compositions comprising same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20705768 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2020705768 Country of ref document: EP Effective date: 20211001 |